V O LU M E
T H I RT Y
S I X
INTERNATIONAL REVIEW OF
RESEARCH IN MENTAL RETARDATION
Board of Associate Editors
PHILIP DAVIDSON University of Rochester School of Medicine and Dentistry
ELISABETH DYKENS Vanderbilt University
MICHAEL GURALNICK University of Washington
RICHARD HASTINGS University of Wales, Bangor
LINDA HICKSON Columbia University
CONNIE KASARI University of California, Los Angeles
WILLIAM McILVANE E. K. Shriver Center
GLYNIS MURPHY University of Kent
TED NETTELBECK Adelaide University
MARSHA M. SELTZER University of Wisconsin-Madison
JAN WALLANDER Sociometrics Corporation
V O LU M E
T H I RT Y
S I X
INTERNATIONAL REVIEW OF
RESEARCH IN MENTAL RETARDATION Edited by
LARAINE MASTERS GLIDDEN Department of Psychology St. Mary’s College of Maryland St. Mary’s City, Maryland
AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier
Academic Press is an imprint of Elsevier 525 B Street, Suite 1900, San Diego, CA 92101-4495, USA 30 Corporate Drive, Suite 400, Burlington, MA 01803, USA 84 Theobald’s Road, London WC1X 8RR, UK Radarweg 29, PO Box 211, 1000 AE Amsterdam, The Netherlands First edition 2008 Copyright ß 2008, Elsevier Inc. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email:
[email protected]. Alternatively you can submit your request online by visiting the Elsevier web site at http://elsevier.com/locate/permissions, and selecting Obtaining permission to use Elsevier material Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library Library of Congress Cataloging-in-Publication Data A catalog record for this book is available from the Library of Congress ISBN: 978-0-12-374476-0 ISSN: 0074-7750 For information on all Academic Press publications visit our website at books.elsevier.com Printed and bound in the United States of America 08 09 10 10 9 8 7 6 5 4 3 2 1
CONTENTS
Contributors Preface
ix xi
1. Newborn Screening for Intellectual Disability: Past, Present, and Future
1
Don Bailey 1. Introduction 2. Evolving Guidelines and Practices for Newborn Screening 3. Current Issues in Newborn Screening 4. The Nature of the Condition 5. Test Characteristics 6. Benefits From Screening 7. Summary and Future Directions References
2. Responsive Parenting: Closing the Learning Gap for Children with Early Developmental Problems
2 4 8 8 13 15 19 22
27
Susan H. Landry, Heather B. Taylor, Cathy Guttentag, and Karen E. Smith 1. 2. 3. 4. 5. 6.
Introduction School-Age Developmental Characteristics Shared Challenges for Effective Learning What is Responsive Parenting? What Supports Responsive Parenting? Evidence for the Specialized Support of Responsive Parenting for Core Deficits 7. Evidence from Longitudinal Studies for Closing the Learning Gap for At-risk Children 8. Evidence from Experimental Findings for Closing the Learning Gap 9. Summary and Conclusions, Implications and Future Directions References
28 30 31 36 38 39 44 45 50 54
v
vi
Contents
3. Trisomy 21: Causes and Consequences
61
Jeannie Visootsak and Stephanie L. Sherman 1. Introduction 2. Major Cause of DS: Meiotic Nondisjunction in Oocytes 3. Prevalence and Survival of Individuals with DS Throughout the Life Span 4. Etiology of DS-Associated Medical Disorders 5. Neurodevelopmental Outcomes of Comorbid Medical Conditions in DS 6. Psychiatric and Neurobehavioral Issues in DS 7. Summary References
4. Alzheimer’s Disease in Adults with Down Syndrome
61 64 72 77 82 87 89 90
103
Warren B. Zigman, Darlynne A. Devenny, Sharon J. Krinsky-McHale, Edmund C. Jenkins, Tiina K. Urv, Jerzy Wegiel, Nicole Schupf, and Wayne Silverman 1. Introduction 2. Down Syndrome/Alzheimer’s Disease Research Program References
104 108 135
5. Foolish Action in Adults with Intellectual Disabilities: The Forgotten Problem of Risk-Unawareness
147
Stephen Greenspan 1. Introduction 2. A Four-Factor Model of Foolish Action 3. Varieties of Foolish Acts Committed By Different Populations 4. Brain Damage and Foolish Action: FASD as an Exemplar 5. Research and Policy Implications 6. Conclusion References
6. Animal Models of Self-Injurious Behavior: Induction, Prevention, and Recovery
148 152 162 176 182 188 189
195
Stephen R. Schroeder, Pippa S. Loupe, and Richard E. Tessel 1. Introduction 2. Animal Models of Induction of SIB 3. Animal Models of Prevention of SIB 4. Animal Models of Recovery from SIB 5. Overall Summary and Future Directions References
196 199 209 210 220 224
Contents
7. Theoretical and Methodological Issues in Sibling Research
vii
233
J. Carolyn Graff, Susan Neely-Barnes, and Heather Smith 1. Introduction 2. Themes in Sibling Research 3. Theoretical Approach 4. Research Method 5. Frontiers and Directions for Sibling Research 6. Conclusion References
8. Understanding Individual Differences in Adaptation in Parents of Children with Intellectual Disabilities: A Risk and Resilience Perspective
234 235 240 245 265 269 271
281
Malin B. Olsson 1. Introduction 2. Risk and Protective Factors in the Field of Families with a Child with ID 3. Risk Factors 4. Protective Factors 5. Outcomes 6. Discussion 7. Conclusion References
9. ‘‘What do you Think if . . .’’: Using Vignettes to Study Attitudes Toward Adult Sibling Caregiving and Competence of Parents of Children with Disabilities
282 285 287 293 301 303 307 307
317
Brian M. Jobe and Laraine M. Glidden 1. Introduction 2. Topic 1: Young Adults’ Levels of Caregiving for Hypothetical Siblings 3. Topic 2: Stereotypic Views of Parental Competence and Family Expansion 4. Summary and General Discussion References Index Contents of Previous Volumes
318 320 326 331 337 343 351
This page intentionally left blank
CONTRIBUTORS
Numbers in parentheses indicate the pages on which the authors’ contributions begin.
Don Bailey (1) RTI International, Research Triangle Park, North Carolina 27709-2194 Darlynne A. Devenny (103) New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314 Laraine M. Glidden (317) Center on Health and Education, Georgetown University, and Department of Psychology, St. Mary’s College of Maryland J. Carolyn Graff (233) University of Memphis, College of Nursing, Boiling Center for Developmental Disabilities, Memphis, Tennessee 38105 Stephen Greenspan (147) University of Colorado Health Sciences Center, Colorado 80045; Email: stephen.
[email protected] Cathy Guttentag (27) University of Texas Health Science Center, Houston, Texas 77030 Edmund C. Jenkins (103) New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314 Brian M. Jobe (317) University of Maryland, Baltimore, Maryland 21228; Email:
[email protected] Sharon J. Krinsky-McHale (103) New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314 Susan H. Landry (27) The University of Texas Health Science Center, Houston, Texas 77030 Pippa S. Loupe (195) Bureau of Child Research, University of Kansas, Dole Human Development Center, Lawrence, Kansas 66045-7555 Susan Neely-Barnes (233) University of Tennessee, College of Social Work, Memphis, Tennessee 38103 ix
x
Contributors
Malin B. Olsson (281) Department of Psychology, Go¨teborg University, Go¨teborg, Sweden Stephen R. Schroeder (195) Bureau of Child Research, University of Kansas, Dole Human Development Center, Lawrence, Kansas 66045-7555 Nicole Schupf (103) New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314 Stephanie L. Sherman (61) Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30033 Wayne Silverman (103) New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314 Heather Smith (233) University of North Carolina, North Carolina 27599 Karen E. Smith (27) University of Texas Medical Branch at Galveston, Houston, Texas 77030 Heather B. Taylor (27) University of Texas Health Science Center, Houston, Texas 77030 Richard E. Tessel (195) Bureau of Child Research, University of Kansas, Dole Human Development Center, Lawrence, Kansas 66045-7555 Tiina K. Urv (103) Mental Retardation & Developmental Disabilities Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 Jeannie Visootsak (61) Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30033 Jerzy Wegiel (103) New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314 Warren B. Zigman (103) New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314
PREFACE
As you have come to expect in eclectic volumes of the International Review of Research in Mental Retardation, the range of focus in Volume 36 is broad. The empirical work described includes animal models and research as well as investigations with human participants. The core domains intersect with medical decision-making, intervention approaches, social psychology, and family issues. Two chapters focus on Trisomy 21/Down syndrome, although from quite different perspectives, and important theoretical issues are addressed in a number of chapters with intent sometimes to address the entire field of intellectual disabilities and other times a selected portion of it. As usual, both as editor and as reader, I owe a great deal to the individuals who provided expert review for these highly diverse original manuscripts. Collectively, they were able to span the breadth of the field of intellectual disability from its basic biological underpinnings to its applications for ameliorating learning problems. Three of these reviewers were members of the Board of Associate Editors and I am especially grateful to Mike Guralnick, Richard Hastings, and Linda Hickson for their continuing support in multiple ways, as well as to Elisabeth Dykens who coauthored a chapter in this volume. Listed in alphabetical order, the following additional reviewers provided timely and constructive comments: Rhonda Black, Monica Cuskelly, Bob Edgerton, Charlotte Hobbs, Rodney Howell, Jim Leffert, Mark Lewis, Gael Orsmond, Sonja Rasmussen, Curt Sandman, Davida Sears, Travis Thompson, Steve Warren, and Michael Watson. The first two chapters focus early in the lifespan. In Chapter 1, Don Bailey gives us a peek into the future as he anticipates the brave new world of newborn screening for intellectual disability. He cautions us that economic and cultural factors cannot be divorced from medical decisionmaking and that challenges lay ahead regardless of the course that is charted. Susan H. Landry, Heather Taylor, Cathy Guttentag, and Karen E. Smith address a different set of challenges in Chapter 2 on responsive parenting. They review the importance of the parental role in early development of children with spina bifida, Down syndrome, and very low birthweight. Their longitudinal research with children from this last group provides
xi
xii
Preface
convincing evidence that risk can be ameliorated with effective environmental manipulations such as contingent responsiveness and rich verbal input. Jeannie Visootsak and Stephanie L. Sherman also focus on Trisomy 21 leading to Down syndrome. Their emphasis is on the causes of meiotic nondisjunction in oocytes, the most frequently occurring etiology of Trisomy 21, as well as how associated defects affect neurodevelopmental outcomes. Their emphasis is on children, but they do briefly address symptoms of dementia arising later in the lifespan, an excellent segue into Chapter 4 on Alzheimer’s disease in adults with Down syndrome by a research team that has been studying this condition for many years. Warren B. Zigman and his seven coauthors document that despite the elevated risk for Alzheimer’s disease faced by adults with Down syndrome, substantial variability in outcomes is part of the profile, and is interesting and important both for science and human services. Stephen Greenspan takes us on quite a different journey in Chapter 5 in which he develops and explains a new (but rooted in historical writings) theory of the core deficit in mental retardation/intellectual disability. Even the title—Foolish Action in Adults with Intellectual Disabilities: The Forgotten Problem of Risk-Unawareness—in intriguing, and its promise of provoking an examination of the meaning of mental retardation is fulfilled by the end of the chapter. You may not agree with everything that Steve Greenspan has written here, but you will, nonetheless, be glad that he has written it. In Chapter 6, Stephen R. Schroeder, Pippa S. Loupe, and Richard E. Tessel (deceased) review five decades of research on animal models of selfinjurious behavior (SIB), concluding that four models have been especially productive in inducing it. Some readers will be especially interested in the authors’ own 10-year program of research involving research for training from recovery from SIB, as it has important implications for treatment. In the next three chapters, the focus is on family. J. Carolyn Graff and her coauthors, Susan Neely-Barnes and Heather Smith (Chapter 7) and Malin Broberg Olsson (Chapter 8), review extensive research databases with an aim to understanding the themes and issues that have dominated their field. Siblings are in the forefront in Chapter 7, whereas parents are the primary interest in Chapter 8. Nonetheless, some of the core constructs, such as adaptation, risk, and resilience, and the factors that influence them are themes in both the chapters. My coauthored chapter with Brian M. Jobe is squarely in the tradition of the experimental psychology of intellectual disability. In taking this approach, we tackle two different domains of family—sibling caregiving and judged parent competence. We propose and (I hope) persuade that the use of vignettes to study the attitudes of people about disability issues has value both for the data it contributes to the field and also the didactic and training opportunities it affords.
Preface
xiii
Finally, writing this preface is a bittersweet task for me. This volume is the penultimate one for my editorship, and the last one that is eclectic and singly edited. After Volume 37, which I will coedit with Marsha Seltzer with Families as its theme, the Series Editorship will be assumed by Bob Hodapp of Vanderbilt University. Indeed, as I write this preface, Bob is developing Volume 38. Please contact him for information about the Series as it moves forward. He has some exciting plans and I am grateful to have him as my successor. To all the readers, regular or occasional, I thank you for your interest and urge you to continue your loyalty to the International Review of Research in Mental Retardation. LARAINE MASTERS GLIDDEN
This page intentionally left blank
C H A P T E R
O N E
Newborn Screening for Intellectual Disability: Past, Present, and Future Don Bailey* Contents 2 4 8 8 13 15 19 21 22
1. Introduction 2. Evolving Guidelines and Practices for Newborn Screening 3. Current Issues in Newborn Screening 4. The Nature of the Condition 5. Test Characteristics 6. Benefits From Screening 7. Summary and Future Directions Acknowledgments References
Abstract Newborn screening began in the 1960s with a condition causing severe intellectual disability, phenylketonuria, a disease that could be remediated through a dietary change that prevented intellectual disability. Since then newborn screening has become a significant public health initiative offered in every birthing hospital in the United States, sometimes for more than 50 conditions. The landscape of newborn screening is changing rapidly, however, as a result of new gene discoveries, technological developments, advocacy efforts, and private market forces. Soon it will be possible to screen for many conditions causing intellectual disability, but for which there will be no immediate medical treatment, evoking issues related to the ethics of disclosing genetic information about ‘‘untreatable conditions’’ and the support systems that would be necessary to help families and children cope with this information. Fundamental questions have been asked about the likelihood of various costs and benefits of early identification, prompting a whole new set of demands for data on the efficacy of earlier psychosocial interventions and the timing of treatments. This
* RTI International, Research Triangle Park, North Carolina 27709–2194
International Review of Research in Mental Retardation, Volume 36 ISSN 0074-7750, DOI: 10.1016/S0074-7750(08)00001-3
#
2008 Elsevier Inc. All rights reserved.
1
2
Don Bailey
chapter reviews the history and current status of newborn screening for intellectual disability, envisions a likely future of possible genetic disclosure, and identifies research questions that will need to be answered to help inform public policy.
1. Introduction The history of newborn screening is well-known and has been described extensively in a number of publications (e.g., American Academy of Pediatrics Newborn Screening Task Force, 2000). Of special relevance to the International Review of Research in Mental Retardation is that the disease that prompted the development of newborn screening was phenylketonuria, a well-known cause of intellectual disability. Individuals with untreated PKU typically have moderate to severe intellectual disability. A dietary change can almost completely prevent intellectual disability from occurring, but to be effective, the altered diet must begin shortly after birth, since damage caused by untreated PKU is difficult to reverse. Unlike Down syndrome, the phenotype for PKU is not obvious at birth through symptoms or physical features, and can only reliably be detected for purposes of prevention through a diagnostic test. Robert Guthrie’s work in developing a technique using blood spots to cheaply and easily detect PKU made newborn screening for this condition technically possible, and subsequent research showed dramatic differences in IQ scores of individuals treated following early identification (e.g., Berry, O’Grady, Perlmutter, & Bofinger, 1979; Koch & de la Cruz, 1999). These powerful data set the stage for advocacy efforts that led to newborn screening for PKU. However, it took nearly a decade for screening to be established in every state, as the United States had not established a public health infrastructure for newborn screening, policies had not been set establishing criteria for selecting conditions to be screened, and concerns were expressed about both the specificity of the treatment and uncertainties about whether every identified child actually needed treatment (Watson, 2006). In the ensuing years, newborn screening has grown into a mature public health program in the United States and continues to expand. But this expansion has been variable across states due to variations in such factors as laboratory capabilities, financial resources, governmental leadership, and advocacy efforts. Until recently most states in the United States screened for fewer than 10 conditions. Intense lobbying by various advocacy groups, advances in screening technology, and a recent task force report issued under the auspice of the American College of Medical Genetics (Watson, Mann, Lloyd-Puryear, Rinaldo, & Howell, 2006) have led to a significant expansion of the number of conditions screened just in the last
Newborn Screening for Intellectual Disability
3
few years. Most states now screen for more than 40 conditions, and this number is likely to continue to increase over the next few years. Internationally, newborn screening programs vary widely by region. Most countries screen for many fewer conditions than does the United States (Bodamer, Hoffman, & Lindner, 2007; Borrajo, 2007; Padilla & Therrell, 2007; Saadallah & Rashed, 2007; Therrell & Adams, 2007). Cross-country differences are accounted for by a wide range of variables, including limited financial resources, differences in the incidence rate of selected conditions across countries, variable advocacy initiatives, and differences in cultural perspectives and values (Pollit, 2007). In some regions, there are countries that have no newborn screening program at all, or if they do, it focuses on only a few conditions and is not universal. For many developing countries, newborn screening may pale in comparison to much larger risk factors (e.g., stunting, inadequate cognitive stimulation, iodine deficiency, and iron deficiency anemia) that must be addressed to reduce adverse outcomes and avoid the loss of developmental potential in millions of young children worldwide (Engle et al., 2007; Walker et al., 2007). A recent commentary stated ‘‘Few things we do in preventive medicine have been as remarkably successful as has newborn screening’’ (Howell, 2006a, p. 229). Despite this glowing assessment, however, the continued expansion of newborn screening is a topic of much current debate. Historically this debate has pitted ‘‘advocates’’ (often parents of affected children whose condition could have been prevented or lessened had newborn screening been available) against a more conservative public health system that insists on strong evidence for proven benefit (reduced morbidity and mortality) in a cost-effective fashion. However, rapid advances in technology will likely lead to testing platforms in the next 5–10 years in which literally hundreds of conditions or gene variants could be screened cheaply and simultaneously, making the cost of adding a new condition irrelevant from a laboratory perspective. This likely scenario has led to renewed and intensified discussions about problematic ethical, legal, and social issues surrounding the disclosure of complex genetic information at birth (Bailey, Armstrong, Kemper, Skinner, & Warren, 2008; Botkin et al., 2006), and expanding conceptions of what constitutes ‘‘benefit’’ when determining whether to screen for a particular condition (Bailey, Skinner, & Warren, 2005; Bailey, Beskow, Davis, & Skinner, 2006; Grosse, Boyle, Kenneson, Khoury, & Wilfond, 2006). A 2004 review revealed 282 molecularly identified genes related to intellectual disability (Inlow & Restifo, 2004). More have subsequently been discovered, and the authors estimate that hundreds more mental retardation genes remain to be identified. Obviously, only a few of these conditions are currently included in newborn screening. As gene discovery and technological innovation proceed at a rapid pace, how do genetic conditions causing intellectual and developmental disabilities fit into
4
Don Bailey
newborn screening, both now and in the future? To answer this question, we begin by reviewing the evolving criteria for newborn screening over the past 50 years. Issues evoked in a possible ‘‘second-generation’’ of newborn screening are described and an aggressive research agenda is proposed to assure that expanded screening maximizes benefit and minimizes harm.
2. Evolving Guidelines and Practices for Newborn Screening Since the possibility of widespread genetic testing through programs such as newborn screening was first realized, several major organizations have formed committees and issued reports to guide decision-making about newborn screening. These include the World Health Organization, often referred to as the seminal work on this topic led by Wilson and Junger (1968), the National Academy of Sciences (Committee for the Study of Inborn Errors of Metabolism, 1975), the Institute of Medicine (Andrews, Fullarton, Holtzman, & Motulsky, 1994), the American Society of Human Genetics and the American College of Medical Genetics (ASHG/ACMG, 1995), the National Institutes of Health in partnership with the Department of Energy (Holtzman & Watson, 1997), and the American Academy of Pediatrics Newborn Screening Task Force (AAP, 2000). For the most part, these reports have been remarkably consistent in their recommendations. Newborn screening should be conducted for conditions that meet four core standards: (1) The condition must be a significant public health problem, one that has serious consequences for the infant’s physical health, development, or life itself, and occurs frequently enough in the population to warrant universal screening. (2) A screening test must be available that is economical, acceptable to parents, rapid, and very accurate, with virtually no false negatives (missing no children who actually have the condition) and only a small number of false positives (unnecessarily incurring the expense of follow-up testing and heightening anxiety for parents). (3) There must be a demonstrable benefit to the infant, almost always defined as a medical treatment or nutritional intervention that reduces morbidity and mortality associated with the condition. (4) A comprehensive system of services must be in place so that primary care providers and families get screening information in a timely fashion, families receive adequate information and support, and appropriate treatments and follow-up services are available. Despite these standards, however, states vary widely in the conditions actually screened, for several reasons. From the beginning, newborn screening was determined to be a state, not federal, responsibility. Each state operates an independent newborn screening program through its
Newborn Screening for Intellectual Disability
5
department of health, often guided by an advisory committee. Decisions about which conditions to include are entirely the responsibility of states, and therefore much variability has been due to state-by-state variations in laboratory capacity, advocacy efforts, or professional initiatives. As new conditions were discovered, new treatments developed, and new technologies created, cross-state discrepancies became more obvious. To address this problem, in 2000, the March of Dimes launched a national campaign, mobilizing local chapters and volunteers to advocate that each U.S. state and territory screen all infants for a core set of 10 conditions: PKU, congenital hypothyroidism, congenital adrenal hyperplasia, biotinidase deficiency, maple syrup urine disease, galactosemia, homocystinuria, sickle cell disease, medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, and hearing impairment (Howse, Weiss, & Green, 2006). This campaign was buttressed by a simultaneous call from the American Academy of Pediatrics Newborn Screening Task Force (2000) for a national agenda on state newborn screening programs and a subsequent report from the U.S. General Accounting Office (2003) highlighting cross-state discrepancies in screening and urging action to insure equity in access to comparable screening tests across the country. In 2003, the Health Resources and Services Administration in the U.S. Department of Health and Human Services established a Secretary’s Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children to advise the Secretary of Health regarding newborn screening policy and practice. But almost as soon as these efforts had begun, other forces began pushing for even greater expansion, a movement catalyzed by the introduction of tandem mass spectrometry (MS/MS) as the technology of choice for newborn screening (Materin & Rinaldo, 2003). MS/MS dramatically expanded the number of disorders that could rapidly be detected in a single blood spot, with great precision and cheaply. In fact, the cost of detecting one condition was essentially the same as detecting multiple conditions. As states began to acquire tandem mass equipment or have access to regional labs with MS/MS capacity, they quickly faced important decisions about how to report MS/MS results, as some detected conditions did not meet the traditional criteria for newborn screening (i.e., no treatment available). Since the equipment is expensive and not every state could afford it, for several years MS/MS actually increased cross-state discrepancies in the number of conditions screened. But it also provided advocacy groups further ammunition to push for standardized expanded screening across all states. Since the authority to determine screened conditions rests with states, federal agencies faced a fundamental dilemma: How to support expansion and standardization of screening in the absence of any mechanism for requiring it. To address this issue, the Maternal and Child Health Bureau of the Health Resources and Services Administration funded the American College of Medical Genetics to convene experts and reach consensus
6
Don Bailey
on: (1) an expanded set of standards for deciding which conditions should be included in newborn screening and (2) a uniform screening panel based on current best knowledge about a set of candidate conditions. A scoring system for evaluating conditions was developed, and nearly 300 experts and other stakeholders were invited to use the system to evaluate one or more of 78 potential conditions for screening, resulting in nearly 4,000 ratings (Watson et al., 2006). As a result of these efforts, the committee recommended that all states screen for a core panel of 29 conditions for which there is an accurate screening test and strong agreement on the overall benefits of screening. The committee also recommended 25 additional ‘‘secondary targets,’’ conditions for which there was less agreement about the desirability of screening (e.g., very rare conditions or those for which there is no current treatment), but which would necessarily be identified when using techniques such as MS/MS to identify the 29 core conditions. The scoring system developed by the expert group to evaluate conditions for newborn screening is displayed in Fig. 1.1. Fourteen categories are proposed with scoring criteria for each. Some items are given more weight than others, based on the committee’s evaluation of their relative importance. The maximum score a condition could be rated is 2,100 points. Interestingly, no disease or condition received a perfect score. The highest mean score was assigned to MCAD deficiency, with a score of 1,799. MCAD is an autosomal recessive disease that affects the body’s ability to metabolize fat. Undetected, MCAD can result in death (30–50% death rate) if a child goes for even a relatively short period of time without eating (over 10–12 h), as might occur when the child has some other illness. The main treatment is to avoid fasting and aggressively treat any illnesses. Other conditions receiving high scores include congenital hypothyroidism (loss of thyroid function that leads to intellectual impairment, treatable by thyroxine supplements; score of 1,718), PKU (1,663), biotinidase deficiency (a condition in which the body is unable to reuse or recycle the vitamin biotin, resulting in delays and physical impairments, treatable by a form of biotin that does not bind to protein or other molecules; score of 1,542), and sickle cell anemia (1,533). Neonatal hyperbilirubinemia also received a high score (1,584) but was not recommended for screening due to lack of a test. The scoring system, expert ratings, and full recommendations were published in a special supplement to Genetics in Medicine (Watson et al., 2006). In the remainder of this chapter, these components are collectively referred to as the ACMG report. The scoring system, which was developed by a subcommittee known as the Newborn Screening Conditions and Criteria Work Group, is referred to as the Newborn Screening Condition Evaluation Tool. The 29 conditions recommended for newborn screening are referred to as the Core Panel. The conditions recommended as ‘‘reportout’’ conditions (those that do not fully meet the standards for newborn
7
Newborn Screening for Intellectual Disability
CRITERIA
CATEGORIES
SCORE >1:5,000 >1:25,000
Incidence of condition
>1:50,000 >1:75,000 <1:100,000 Never
Sign & Symptoms clinically identifiable in the first 48 hours
<25% of cases <50% of cases <75% of cases Always Profound
Burden of disease (Natural Hx if untreated)
Severe Moderate Mild Minimal
Does a sensitive AND specific screening test currently exist?
YES NO Doable in neonatal blood spots OR by a simple, in-nursery physical method High throughput (>200/day/FTE)
Test characteristics (Yes = apply score; No = zero)
Overall analytical cost <1$ per test per condition Multiple analytes relevant to one condition are detected in same run Other conditions identified by same analytes Multiple conditions detected by same test (multiplex platform) Treatment exists and is widely available in most communities
Availability of treatment
Treatment exists but availability is limited No treatment available or necessary
Cost of treatment
Inexpensive Expensive (>$50,000/patient/year) To prevent ALL negative consequences
Potential efficacy of existing treatment
To prevent MOST negative consequences To prevent SOME negative consequences Treatment efficacy not proven
Benefits of early intervention (INDIVIDUAL OUTCOME) Benefits of early identification (FAMILY & SOCIETY)
Clear scientific evidence that early intervention resulting from screening optimizes outcome Some scientific evidence that early intervention resulting from screening optimizes outcome No scientific evidence that early intervention resulting from screening optimizes outcome
Early identification provides clear benefits to family and society (education, understanding prevalence and natural history, cost effectiveness) Early identification provides some benefits to family and society No evidence of benefits
Early diagnosis and treatment prevent mortality Availability of diagnostic confirmation
YES NO Providers of diagnostic confirmation are widely available Limited availability of providers of diagnostic confirmation Diagnostic confirmation is available only in a few centers Providers of acute management are widely available
Acute management
Limited availability of providers of acute management Acute management is available only in a few centers Management at the primary care or family level
Simplicity of therapy
Requires periodic involvement of a specialist Requires regular involvement of a specialist Max score
100 75 50 25 0 100 75 50 25 0 100 75 50 25 0 200 0 100 50 50 50 50 200 50 25 0 50 0 200 100 50 0 200 100 0 100 50 0 100 0 100 50 0 100 50 0 200 100 0 2100
Figure 1.1 The Newborn Screening Condition Evaluation Tool. Reprinted with permission, American College of Medical Genetics.
screening but should be reported since they are detected when testing for the Core Panel) are referred to as the Secondary Panel. Collectively these efforts have resulted in dramatic changes in the number of conditions screened by states, as evidenced in Fig. 1.2. In 2001, most states screened for fewer than 10 conditions. By 2007, most states were screening for more than 40 conditions, and the numbers change monthly. The National Newborn Screening and Genetics Resource Center
8
Don Bailey
40
Number of states
35
2001 2005 2007
30 25 20 15 10 5 0
<10
<20
<40 <50 <30 Number of disorders screened
≥50
Figure 1.2 Number of disorders included in state-mandated newborn screening programs by year. (Figure created from data published online by the National Newborn Screening and Genetics Resource Center: http://genes-r-us.uthscsa.edu/nbsdisorders.pdf).
maintains an updated website funded by the Maternal and Child Health Bureau listing the status of newborn screening for each state and for each condition screened: http://genes-r-us.uthscsa.edu/nbsdisorders.pdf.
3. Current Issues in Newborn Screening As described earlier, the criteria for making decisions about newborn screening have remained relatively consistent for the past 30 years. However, in each of the major domains, significant changes are underway that challenge these criteria. This section addresses three sets of issues that are now under intense discussion: the nature of the condition, characteristics of the screening test, and benefits from screening. Historical perspectives on each are reviewed and examples of current or potential controversies are described.
4. The Nature of the Condition As depicted in the Newborn Screening Condition Evaluation Tool (Fig. 1.1), three features of a disease or condition traditionally have been considered when evaluating screening and these features remain at the core of the recent ACMG report: incidence rate, clinically obvious phenotype, and disease burden. Incidence rate. It is commonly accepted that screening should only be done for conditions that cross a threshold of frequency of occurrence in the
Newborn Screening for Intellectual Disability
9
general population, on the assumption that it would not be a wise investment of limited public resources to screen for extremely rare conditions. Before the ACMG report, there were no published guidelines as to what this threshold might be. The Newborn Screening Condition Evaluation Tool gives maximum credit (100 points) if the incidence rate is greater than 1 per 5,000 births. No points are given if the incidence rate is less than 1 per 100,000 births. However, an examination of the Core Panel conditions highlights challenges in using the incidence rate criterion. First, the report notes that for many of the conditions, the incidence rate is either unknown or there was significant disagreement among raters regarding incidence. This will be an inevitable problem with newly discovered conditions but often is the case with any disease, especially those that are relatively rare. Since it is virtually impossible to do systematic, population-based studies of the incidence of each and every condition, incidence rates often reflect the accumulated reports of identified cases over time, but this can underestimate incidence since many cases may be missed, and one or two cases could have a significant effect on estimates of rare conditions. For example, in a state with 100,000 births per year, the difference between 1 versus 2 identified children dramatically changes the estimated rate of occurrence from 1:100,000 to 1:50,000. Second, within the Core Panel there is wide variability in incidence rates of the recommended conditions, and many are rare. Twelve of the recommended conditions occur in less than 1 per 100,000 births and thus received the lowest rating possible for incidence rate. Only 20 cases of trifunctional protein deficiency and fewer than 50 cases of beta-ketothiolase deficiency have been reported in the literature, yet the report recommends that all states screen for these conditions. Why? Because the conditions can be identified by MS/MS (thus incurring no additional cost) and because treatments are available to prevent some of the negative consequences of these conditions. Introduction of MS/MS technology has significantly reduced the importance of incidence rate as a screening criterion. Evolving technologies such as automated fluorometric tests, microarray analyses, DNA testing, or the ‘‘ $1,000 genome’’ (the National Human Genome Research Institute is currently soliciting grant applications to develop novel technologies that will enable extremely low-cost DNA sequencing of a mammalian-sized genome for $1,000) will soon make incidence rate an irrelevant criterion. The situation is further complicated when incidence rates vary by ethnicity or country of origin, as in the case of selectively higher rates of diseases such as sickle cell anemia (African Americans), 3-hydroxy 3-methyl glutaric aciduria (Saudi Arabia), and glutaric acidemia type I (higher carrier frequency in Old Order Amish). Variable incidence rates force complicated decisions, such as whether to offer sickle cell screening in a state with a very small African American population or whether to selectively offer screening
10
Don Bailey
to families based on ethnicity or country of origin. Unfortunately, most diseases are not exclusive to one group, and limiting screening would almost certainly mean that some children would be missed. A final consideration regarding incidence rate is the opposite question of what is typically asked: What if screening identified very large numbers of individuals? A clear example of this would happen if newborn screening were conducted for fragile X syndrome (FXS) (the most common inherited cause of intellectual disability) using a screening test that would also detect carrier status. If current estimates of female carrier status are correct—about 1:257 women—a state such as North Carolina with 60,000 female births per year would identify more than 230 carrier females per year. Their parents and likely their extended family members will need extensive counseling, and state capacity to provide this service is likely to be limited. Incidence rate will continue to be a consideration in newborn screening. In some respects, its importance will diminish with the emergence of new technologies that make the cost of screening for rare conditions irrelevant. New issues will arise as screening identifies rare conditions requiring very expensive treatment in specialized clinics, and will be especially contentious, if the treatments are only partially effective. A very different set of issues will arise if screening identifies large numbers of individuals with gene variants, and will necessitate wide-spread and fundamental changes in the nature of medical practice, information systems, and family supports. Clinically obvious phenotype. A second criterion of the condition addressed in the ACMG (Fig. 1.1) report is whether signs and symptoms of the disease are clinically identifiable in the first 48 h. Experts rated most conditions in both the Core Panel (68%) and the Secondary Panel (75%) as almost never identifiable in the first 48 h through clinical features, and in almost all other cases experts rated the condition as clinically identifiable in less than 25% of the cases. The only exception was congenital adrenal hyperplasia, rated as identifiable in less than 50% of the cases, primarily because males are typically not detected (females can be detected through ambiguous genitalia). The clinically obvious phenotype criterion is inextricably linked to treatment benefit since some conditions must be treated quickly to prevent damage or death. An example of a condition causing intellectual disability that does not meet these criteria is Down syndrome. Almost all cases of Down syndrome are clinically identifiable within the first 48 h. This fact, coupled with the fact that there is no time-sensitive treatment that could reverse or prevent the effects of Down syndrome (as is the case with PKU) means that newborn screening for Down syndrome is not under consideration. Consequences of the condition. A fundamental tenet of newborn screening is that screening must only be conducted for conditions that represent significant health consequences for the infant and for which early treatment is necessary. But what constitutes a significant health problem? The ACMG
Newborn Screening for Intellectual Disability
11
report defined consequences in terms of ‘‘burden’’ of the disease if untreated; 100 points were allocated to disease burden, with a range from profound (100) to minimal (0). No definitions were given for ratings, and experts were allowed to make their own interpretations of the meanings of profound, severe, moderate, mild, and minimal. Of the 29 conditions in the Core Panel, 21 (72%) were rated as having profound impact on the individual. With one exception (3-methylcrotonylglycinuria), the remaining conditions in the Core Panel were rated as having severe impact. 3-Methylcrotonylglycinuria was rated moderate because not all individuals with the analytes associated with the condition display any clinical symptoms. Since this condition is identified through MS/MS, it is included as a primary target but the report indicates that a primary reason for this decision is that by so doing it would allow for long-term follow-up that could lead to a better understanding of the range of clinical manifestations of the condition. There is a wider range of severity levels assigned to the secondary targets, with 6 rated as having profound impact, 9 severe, 7 moderate, and 2 mild. Historically, conditions included in newborn screening have been those that result in a level of disease or a consequence that almost anyone would agree to be significant. Most of the conditions in the Core Panel result in severe intellectual or motor impairment, and several can result in death if not treated. The inclusion of conditions with mild impact in newborn screening currently occurs because these conditions are necessarily identified when screening for those with more severe impact. But similar to the situation in which considerations regarding incidence rate are changing, future technologies inevitably will allow screening for a wider array of conditions and characteristics that have milder consequences or for which the consequences will be uncertain (McGuire, Cho, McGuire, & Caulfield, 2007). This will force a reconsideration of the ‘‘line’’ across which screening currently does not cross, as evidenced by several examples. One scenario involves conditions for which the phenotype or clinical presentation is highly variable, including mild or asymptomatic cases. In the case of FXS, almost all males with the full mutation will ultimately have moderate to severe intellectual disability. Subsets of this population (probably 25–40%) will also have autism, seizures, or self-injurious behavior, although these do not necessarily co-occur. Some cases of ‘‘high functioning’’ individuals have been reported (e.g., Han, Powell, Phalin, & Chehab, 2006). For females, the variability is even greater, as some could be severely delayed, whereas others may have normal intellectual ability. The core problem is that none of this variability can be predicted based on genetic data. Botkin (2005) argues that technology could lead to a scenario in which a gene mutation or other variant is discovered through screening, but only some of the individuals identified will need or benefit from treatment, and some could actually be harmed by receiving unnecessary treatment. We address treatment issues later in this chapter, but it is worth noting here that although
12
Don Bailey
there is an explicit assumption that only the most severe cases should be identified through screening, it has been argued for years that mild cases of intellectual impairment may be the most important to identify early because those may be the most amenable to significant changes in long-term developmental outcomes or perhaps the prevention of intellectual disability (e.g., Ramey & Ramey, 1999). A recent study found that mothers of children with borderline intelligence exhibited less-positive and less-sensitive parenting than did mothers of typically developing children or mothers of children with more significant developmental disabilities (Fenning, Baker, Baker, & Crnic, 2007). The data were collected when the children were 5 years of age and none identified as a result of newborn screening. Nonetheless, these findings suggest that newborn screening could identify a group of borderline children at high risk for negative parenting styles that might be preventable through early detection and family support. Conditions for which a genetic variant or set of variants increases risk for a deleterious outcome, further exemplify these issues. For example, the BRCA-1 gene conveys a higher risk for breast cancer, but even the majority of individuals with this gene variant do not get breast cancer. Research has either identified genes associated with various developmental disabilities or has shown that conditions such as specific reading disabilities, autism, schizophrenia, and attention disorders have a high degree of heritability (Cook, 1998; DeFries & Alarcon, 1996; Plomin & McGuffin, 2003). If newborn screening could tell parents about increased risk for such conditions, what would be the implications for treatment, possible stigmatization, or the effects on parenting style (e.g., hyperanxiety or hypervigilance)? Would disclosing such information be helpful or harmful? Would individuals or parents want to know this information? These issues will require comprehensive models for thinking about genetic risk and how families can be supported in their efforts to understand and make appropriate use of information received (Rolland & Williams, 2005). A related issue regards the potential detection of carriers of a disease or condition, as will certainly be the case in the future, especially if newborn screening moves to DNA-based technologies or incorporates multi-tier testing to improve accuracy. This point was demonstrated in a study of newborn screening for cystic fibrosis (Comeau et al., 2004). The authors used a two-tiered screening system (two different tests, administered sequentially) to test for the multiple mutations that can cause cystic fibrosis. The process resulted in much greater predictive accuracy for CF detection but also increased the likelihood of detecting infants who are carriers of CF. Likewise, depending on the test used, newborn screening for FXS could detect children who are carriers of fragile X. The disclosure of infant carrier status could provide important information about the carrier status of parents, and knowledge of reproductive risk would help parents make informed decisions about whether to have additional children. And for
Newborn Screening for Intellectual Disability
13
some conditions, carriers may have late-onset characteristics that could possibly be prevented or for which adaptations could be developed, if known. For example, 20% of female carriers of FXS will develop primary ovarian insufficiency, possibly as early as their late teens or early 20s. Knowing this would be useful information when a woman is making decisions about when to have children. Male carriers of fragile X have an increased risk of developing FXTAS, a debilitating tremor/ataxia syndrome that can begin in middle age. Knowledge of this risk could heighten vigilance in symptom development so that new treatments could be tested for their efficacy. But none of this information is necessary during the early childhood period. The Institute of Medicine report on genetic testing (Andrews et al., 1994) clearly articulates the dilemmas posed by the detection of carrier status, using sickle cell anemia as an example. Carrier status alone does not meet the ‘‘burden if untreated’’ standard, as it typically does not confer a health problem on the infant, and it is possible that stigmatization could result by labeling children early. As a result, testing for carrier status is currently not recommended (American Academy of Pediatrics Committee on Bioethics, 2001). But surveys typically show that parents want information about their child’s genetic makeup, especially if that information also has implications for them and their reproductive decisions (Anido, Carlson, Taft, & Sherman, 2005; Skinner, Sparkman, & Bailey, 2003), although clearly some women do not fully understand the implications of carrier status and some are ambivalent about the value of this information (Anido et al., 2005; Anido, Carlson, & Sherman, 2007). In the near future, carrier detection will not be a primary goal of newborn screening, but rather will occur as a by-product of testing for affected children. If detected through screening, carrier status would be disclosed to parents under the general principal that it would be unethical to withhold such information.
5. Test Characteristics A diagnostic test is one that determines whether an individual has a particular disease or condition. Diagnostic confirmation may require specialized testing and be expensive, but should be definitive. A screening test differs from a diagnostic test in that its primary purpose is to identify from a large pool of individuals those who have a high probability of having a disease or condition, and who would be referred for diagnostic follow-up and confirmation. Thus newborn screening does not diagnose disease, but rather identifies individuals for further testing. The availability of an accurate and cost-effective screening test is an obvious central prerequisite to newborn screening. More than 4,000,000
14
Don Bailey
babies are born in the United States annually, so cost of screening is an important consideration. The ACMG evaluation criteria used $1.00 per test per condition as the metric against which a screening test should be evaluated, but obviously the cost of screening must be weighed against the benefits. A more expensive test may be justified if it results in significant reduction of cost to individuals or to society. In the early days of screening, separate tests were used for each condition. The advent of MS/MS technology made it possible to screen for multiple conditions using the same test. Newer technologies such as high throughput oligonucleotide microarrays and DNA-based testing will further enhance the capacity to test hundreds or even thousands of genes and gene mutations in parallel, yielding both promise for more efficient disease identification (Hacia & Collins, 1999) and concerns about a wide array of issues such as consent, privacy, clinical utility, and stigmatization (e.g., Grody, 2003). Ideally, a test should have no false negatives (never missing children who actually have the disease) and very few false positives (rarely identifying children as possibly having the disease who in reality do not). Although newborn screening, historically, has been concerned about both types of errors, concern about false negatives has been the primary consideration, due to the potentially dire consequences of missing a person with a serious condition that needs immediate treatment. An ongoing analysis of proficiency testing errors in U.S. newborn screening laboratories suggests very low rates of false negatives for all screened conditions, the highest occurring for cystic fibrosis (2.6%), congenital hypothyroidism (2.4%), and congenital adrenal hyperplasia (2.2%) (Therrell & Hannon, 2006). Ideally a screening test should differentiate those individuals who need immediate treatment from those who do not, but this is not always possible. Kemper et al. (in press) reviewed the scientific evidence in support of newborn screening for Pompe disease, a lysosomal storage disorder that leads to muscle weakness, organ damage, and death. A treatment has recently become available that leads to improved outcomes, but newborn screening cannot distinguish between infantile Pompe disease (for which it is known that early enzyme therapy is necessary) and a late-onset form of the disease (which can be just as severe but for which timing of treatments is currently unknown, including any risks associated with early treatment of a late-onset condition). Concern has been expressed that with the increased number of conditions being tested through MS/MS, there will be more false-positive results (Howell, 2006; Tarini, Christakis, & Welch, 2006). The immediate and most obvious effects of false positives relate to cost, as each false-positive screen means that a more expensive diagnostic follow-up will be conducted unnecessarily. But some research has indicated that false positives can result in significant stress for some families (Gurian, Kinnamon, Henry, & Waisbren, 2006; Hewlett & Waisbren, 2006), stress that could be avoided
Newborn Screening for Intellectual Disability
15
with a more accurate test. And Howell (2006b) suggests that too many false positives could reduce the urgency felt by practitioners as a result of a positive screen, resulting in possibly deleterious results for the infant screened.
6. Benefits From Screening ‘‘Of all the criteria that a screening test should fulfill, the ability to treat the condition adequately, when discovered, is perhaps the most important’’ (Wilson & Junger, 1968, p. 27). This 40-year-old exhortation from the first major report on genetic testing issued by the World Health Organization remains a guiding principle for newborn screening today. The essential argument, one that has been reinforced in every subsequent task force report (AAP, 2000; Andrews et al., 1994; ASHG/ACMG, 1995; Committee for the Study of Inborn Errors of Metabolism, 1975; Holtzman & Watson, 1997; Watson et al., 2006), is that screening must result in benefit to the infant by reducing morbidity or mortality associated with the condition. The ACMG report (Watson et al., 2006) gives considerable weight to treatment and the possibility of benefit, as exemplified in Fig. 1.1. Of the 2,100 total points, 1,000 are directly related to treatment efficacy and availability. Factors rated include availability and cost of treatment, potential efficacy to prevent negative consequences, including mortality, whether scientific evidence exists showing that early intervention resulting from screening optimizes outcome, the level of specialization required to provide the treatment, and the availability of providers of acute management. Although benefit is considered fundamental to newborn screening, a close examination reveals a more complex set of issues that are rapidly changing. My immersion into these issues began when my colleagues and I published a series of studies on how families discovered that their child had FXS (Bailey, Skinner, Hatton, & Roberts, 2000; Bailey, Skinner, & Sparkman, 2003). These studies showed that parents often experienced an extended ‘‘diagnostic odyssey,’’ frequently lasting two or more years until finally FXS was diagnosed. Numerous costs were associated with this journey: Parents were frustrated with the health care system, many experienced doubts about their parenting ability (seeing their child not develop normally but being told by professionals not to worry), their children did not have access to timely early intervention services, and many families had additional children with FXS without knowing their own status as carriers. We viewed these factors as ‘‘costs’’ associated with late identification, and explored a variety of strategies for earlier identification. We found that males with FXS often demonstrated developmental delays and abnormalities during the first year of life that could be detected
16
Don Bailey
through parent observations (Roberts, Hatton, & Bailey, 2001), developmental screening (Mirrett, Bailey, Roberts, & Hatton, 2004), and microanalysis of behaviors seen in videotapes of everyday activities (Baranek et al., 2005). But although delays are evident, the lack of an obvious FX phenotype during the early years, the milder phenotype exhibited by girls, and the challenges associated with instituting regular developmental screening in pediatric practice (Sices, Feudtner, McLaughlin, Drotar, & Williams, 2003) led us to recommend that the best way to facilitate early identification of FXS would be through newborn screening (Bailey, 2004; Bailey, Roberts, Mirrett, & Hatton, 2001). We argued that newborn screening would eliminate the aforementioned costs—families would avoid the prolonged frustrations and self-doubts associated with the search for a diagnosis, children would have access to early intervention programs, and families would know their carrier status and thus be able to assess reproductive risk and make informed decisions about future children. It should also be more equitable in that ethnicity or economic status should not affect timing of identification and the gap in age of identification of affected girls in comparison to affected boys (Bailey et al., 2003) would be eliminated. Not having worked in the world of newborn screening, these arguments seemed logical to us and constituted a clear set of benefits deriving from early identification. We thus were surprised when challenged by some members of the public health community who argued that since there was no medical treatment for fragile X, screening could not be justified. These views stood in sharp contrast to our interviews with parents, who strongly endorsed newborn screening for FXS (Skinner et al., 2003) and our own views about the value of early intervention, both for children and for families. It soon became clear to us that psycho-social interventions such as those provided through early intervention programs did not meet the standards held by some individuals for ‘‘benefit,’’ and there was skepticism about whether early intervention in general had been shown to be effective for children with intellectual disabilities. Furthermore, since there has never been a study (much less a randomized trial) of the efficacy of early intervention for children with FXS or data showing that earlier intervention produces better longitudinal outcomes for children than does later services, a decision to screen newborns for FX would not be evidence-based. These arguments led us to write two papers in which we directly addressed the meaning and complexity of benefit in the context of newborn screening. In the first paper (Bailey et al., 2005), we suggested that it is time to reframe presumptive benefit of newborn screening for intellectual and developmental disabilities, moving beyond the standard set by PKU (a medical treatment that essentially prevented all negative consequences of the condition) to a more expansive set of benefits that are both possible and justifiable, even in the absence of a medical treatment. We argued that newborn screening would have direct benefits for children and families,
Newborn Screening for Intellectual Disability
17
in that it would: (a) allow for optimization of the infant’s home environment and provide access to early intervention programs that have been shown to be generally effective in enhancing developmental outcomes (Guralnick, 2005) and are viewed as positive and effective by families (Bailey, Hebbeler, Scarborough, Spiker, & Mallik, 2004; Bailey, Nelson, Hebbeler, & Spiker, 2007); (b) provide access to support services and information that parents consider helpful and could help promote positive outcomes for families (Bailey, Hebbeler, et al., 2005; Bailey, Bruder, et al., 2006); (c) be consistent with extensive research on consumer preferences for information about their child’s genetic risk; and (d) provide a range of other societal benefits. For example, newborn screening could provide a better estimate of the true incidence of a condition (because screening is population-based, not selective), allow for studies of early development not possible when children are identified later, and would make possible studies of the efficacy of early intervention, therapy, or even medical treatments as they become available. We included a caveat in this paper, assuming that any screening test used would be accurate, accessible to all, and voluntary, with an adequate system for follow-up and support for families. In the second paper (Bailey et al., 2006), we conducted a historical analysis of changing perspectives on the benefits of newborn screening by reviewing the various task force reports issued in the last 40 years, examined how the conditions rated by the ACMG task force fared with respect to benefit, and analyzed how benefit was reflected in public comments submitted in response to the ACMG report. From this paper emerged several reflections on the changing concepts of benefit:
The potential for benefit is necessary to justify screening, but almost all (95%) of the 78 conditions reviewed by experts were rated as having a treatment that could prevent at least some negative consequences for the child and all (100%) could result in at least some family and societal benefits. Thus, it appears that once a screening test becomes available and at least some form of safe and partially effective medical treatment exists, a condition can be considered for screening. Clearly there is no agreed-upon threshold for ‘‘meaningful’’ benefit. Most discussions of benefit focus on improved physical health of the infant via medical treatment, although ‘‘treatment’’ and ‘‘benefit’’ have often been used interchangeably in the literature. These two concepts are related but distinct. Interestingly, however, newborn screening rarely prevents all negative consequences of a condition. Figure 1.3 summarizes the ratings assigned to the 78 conditions, and the most frequent rating across all groups was that newborn screening could prevent ‘‘some’’ of the negative consequences of the condition. Only four of the Core Panel conditions were rated as having treatments that prevented almost all negative consequences:
Percentage of conditions
18
Don Bailey
100 90 80 70 60 50 40 30 20 10 0 Core panel Prevent ALL
Secondary targets
No test
Prevent MOST
Not All conditions recommended
Prevent SOME
Treatment Unproven
Percentage of conditions
Figure 1.3 Summary of ratings of 78 conditions with respect to the potential efficacy of existing treatments. (Figure created from tables presented in Watson et al., 2006.) 100 90 80 70 60 50 40 30 20 10 0 Core panel
Secondary targets
CLEAR benefits
No test
Not recommended
SOME benefits
All conditions
NO benefits
Figure 1.4 Summary of ratings of 78 conditions with respect to benefits of early identification for family and society. (Figure created from tables presented in Watson et al., 2006.)
congenital hypothyroidism, biotinidase deficiency, PKU, and MCAD. Thus, the PKU model is not a realistic one nor is it the typical standard for newborn screening. Screening for all conditions has perceived benefits for family and society, as depicted in Fig. 1.4. Although all of the earlier task force reports acknowledge the possibility of these benefits, most considered such benefits as additive to infant benefits rather than a stand-alone justification for screening. The ACMG report was the first to include such benefits in a rating system, although the maximum number of points possible for such benefits was 100.
Newborn Screening for Intellectual Disability
19
Stakeholders differ in their expectations for and definitions of benefit. Historically, professionals have tended to insist on improved health outcomes while parents and advocacy groups consider other factors; for some, information about a condition would constitute sufficient benefit, regardless of treatment potential. Clearly benefit is a multifaceted construct that has both objective and subjective components.
These reviews suggest the critical importance of benefit but also show that benefit can only be one part of the decision-making process.
7. Summary and Future Directions In the 40 years since Guthrie developed a blood spot test for PKU, the United States and most affluent countries have developed large-scale public health programs to screen for a range of disorders that have serious health consequences for infants. Although the concept of critical periods has rarely been invoked as the basis for newborn screening (Bailey & Gariepy, 2008), this argument could easily be made, as screening has typically been limited to conditions that require treatment during the first few days or weeks of life to be effective and to prevent or reduce irreparable damage. Grosse et al. (2006) characterize these programs as resting on a ‘‘public health emergency’’ model. As a result, changes to newborn screening systems have generally been incremental, with new conditions being added slowly and with deliberation, contingent on the availability of treatments that are needed during the first weeks and months of life. Conditions causing intellectual and developmental disabilities are included in newborn screening, but only if they have medical treatments. Historically, the availability of educational, psychological, or therapeutic (i.e., speech therapy, physical therapy) interventions have not been considered sufficient benefit to warrant screening, despite 30 years of federal legislation acknowledging the importance of early intervention for children with or at risk for developmental disabilities, or those with established conditions likely to lead to disability (Bailey, 2000; Bailey, Aytch, Odom, Symons, & Wolery, 1999). I predict that we are nearing the end of this first generation of newborn screening and will soon enter a second generation, one that will differ dramatically from what is currently offered. New technologies will make it possible to screen for hundreds of gene variants, many of which are related to intellectual and developmental disabilities. Most will be rare and will not have medical treatments likely to substantially enhance developmental outcomes. For many gene variants, there may be a range of phenotypic outcomes, from severe to nonexistent. Genomics will increasingly be
20
Don Bailey
integrated into a new era of personalized medicine. As Khoury, Gwinn, Burke, Bowen, and Zimmern (2007) suggest, this could exacerbate current schisms between medicine (which focuses on individual cases) and public health (which takes a population-based approach to prevention), but could also force a movement toward what the authors refer to as a shared ‘‘population health’’ perspective. Recent surveys suggest that professionals such as pediatricians and genetic counselors are generally supportive of expanding screening to conditions such as FXS, with some reservations (Acharya, Ackerman, & Ross, 2005; Hiraki, Ormond, Kim, & Ross, 2006). But private market forces and advocacy groups will push this agenda faster and further, a goal for which most professionals are currently unprepared, and the public health system will need to make fundamental decisions about the relative roles of public health screening and private screening. A parallel system of private fee-based screening will inevitably lead to inequities in who has access to screening and for what purposes. But the public health system has limited resources both for screening and for follow up, and difficult choices will need to be made. Grosse et al. (2006) characterize this second generation of newborn screening as a shift from screening as public health emergency to public health service. But controversies exist about the nature of information that should be disclosed and the possibility of harms that could occur (Dhondt, 2007). Grob’s (2006) characterization of newborn screening in the genomic age as a ‘‘cursed blessing’’ captures the range of feelings many consumers have about both the hopes and fears associated with expanded newborn screening. Research is urgently needed to lay the groundwork for these inevitable changes and address the concerns that have been raised as well as create an infrastructure to evaluate unanticipated future challenges that will arise (Alexander & Hanson, 2006; Bailey, Skinner, Davis, Whitmarsh, & Powell, 2008; Botkin, 2005). Among the many questions that will need to be answered include the following:
What would be the public acceptability and effects of a two-tiered screening program, one that is required for all children (current status) and a second that is voluntary, with informed consent? To what extent do families from diverse cultural and ethnic groups consent to expanded newborn screening, what are their reasons for declining or accepting screening, and what family or sociocultural factors are related to screening decisions? What strategies should be used for informed consent and informed decision-making to assure that families of identified children are adequately informed about the possible results from screening and are satisfied with their decision to participate?
Newborn Screening for Intellectual Disability
21
Do families experience adverse mental health outcomes following a diagnosis, and how does adaptation vary as a function of child, family, and support variables? Is the quality or nature of parent–child relations affected by information gained through expanded newborn screening? How do parents and extended family members respond to, share, and use information gained from expanded newborn screening, and what factors are related to successful patterns of communication? To what extent is the full range of potential benefits of newborn screening (Bailey et al., 2005) achieved for both infants and families? What systems need to be in place to assure that the hoped-for benefits of screening accrue to children and families (Bailey, Armstrong et al., 2008)? How often do potential concerns raised about expanded newborn screening (e.g., Bailey, Skinner et al., 2008) occur, to what extent do they result in harm for children or families, and what factors are associated with poor outcomes? How can we quantify the wide range of benefits and costs of expanded genetic testing, differentiating appropriately between cost-effective and cost-saving interventions (Grosse, 2005; Khoury, Jones, & Grosse, 2006)?
Answering questions such as these will be complicated and require systematic, prospective longitudinal research, incorporating a wide range of variables. A research network is needed so that as new conditions are discovered or new treatments are developed, their effects can be tested. But ultimately it will be virtually impossible to conduct randomized clinical trials on the desirability of newborn screening for each individual condition, as has been the case to date. What is needed is a thorough examination of the desirability of disclosing classes of genetic information (e.g., carrier status, uncertain phenotype, probabilistic likelihoods of phenotypic outcomes) to determine whether and how such information should be shared, using a few prototypic conditions. Tunis, Stryer, and Clancy (2003) characterize such studies as ‘‘practical clinical trials,’’ studies that select clinically relevant issues with clear policy ramifications and study a range of outcomes in the context of typical practice settings. Then expensive clinical trials can be reserved for evaluating the efficacy of specific treatments for specific conditions, rather than trying to answer the more general question of whether screening and the subsequent disclosure of various forms of information about genetic variants in and of itself is desirable.
ACKNOWLEDGMENTS Preparation of this chapter was supported in part by grants from the Ethical, Legal, and Social Implications Research Program, the National Human Genome Research Institute (Grant number 1P50-HG004488), and the National Institute for Child Health and Human Development (Grant number R21-HD043616).
22
Don Bailey
REFERENCES Acharya, K., Ackerman, P. D., & Ross, L. F. (2005). Pediatricians’ attitudes toward expanding newborn screening. Pediatrics, 116, e476–e484. Alexander, D., & Hanson, J. W. (2006). NICHD research initiative in newborn screening. Mental Retardation and Developmental Disabilities Research Reviews, 12, 301–304. American Academy of Pediatrics Committee on Bioethics (2001). Ethical issues with genetic testing in pediatrics. Pediatrics, 107, 1451–1455. American Academy of Pediatrics Newborn Screening Task Force (2000). Serving the family from birth to the medical home. Newborn screening: A blueprint for the future. Pediatrics, 106(Supplement), 389–427. American Society of Human Genetics/American College of Medical Genetics (ASHG/ ACMG) (1995). Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 57, 1233–1241. Andrews, L. B., Fullarton, J. E., Holtzman, M. A., & Motulsky, A. G. (Eds.) (1994). Assessing genetic risks: Implications for health and social policy. Washington, DC: National Institute of Sciences. Anido, A., Carlson, L. M., Taft, L., & Sherman, S. L. (2005). Women’s attitudes toward testing for fragile X carrier status: A qualitative analysis. Journal of Genetic Counseling, 14, 295–301. Anido, A., Carlson, M., & Sherman, S. L. (2007). Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. Journal of Genetic Counseling, 16, 97–104. Bailey, D. B. (2000). The federal role in early intervention: Prospects for the future. Topics in Early Childhood Special Education, 20(2), 71–78. Bailey, D. B. (2004). Newborn screening for fragile X syndrome. Mental Retardation and Developmental Disabilities Research Reviews, 10, 3–10. Bailey, D. B., Armstrong, F. D., Kemper, A. R., Skinner, D., & Warren, S. F. (2008). Supporting family adaptation to pre-symptomatic and ‘‘untreatable’’ conditions in an era of expanded newborn screening. Journal of Pediatric Psychology, 33, 1–14. Bailey, D. B., Aytch, L. S., Odom, S. L., Symons, F., & Wolery, M. (1999). Early intervention as we know it. Mental Retardation and Developmental Disabilities Research Reviews, 5, 11–20. Bailey, D. B., Beskow, L. M., Davis, A. M., & Skinner, D. (2006). Changing perspectives on the benefits of newborn screening. Mental Retardation and Developmental Disabilities Research Reviews, 12, 27–279. Bailey, D. B., Bruder, M. B., Hebbeler, K., Carta, J., DeFosset, M., Greenwood, C., et al. (2006). Recommended outcomes for families of young children with disabilities. Journal of Early Intervention, 28, 227–251. Bailey, D. B., & Gariepy, J. (2008). Critical periods. In M. M. Haith, & J. B. Benson (Eds.), Encyclopedia of infant and early childhood development (pp. 322–332). San Diego, CA: Elsevier. Bailey, D. B., Hebbeler, K., Scarborough, A., Spiker, D., & Mallik, S. (2004). First experiences with early intervention: A national perspective. Pediatrics, 113, 887–896. Bailey, D. B., Hebbeler, K., Spiker, D., Scarborough, A., Mallik, S., & Nelson, L. (2005). 36-month outcomes for families of children with disabilities participating in early intervention. Pediatrics, 116, 1346–1352. Bailey, D. B., Nelson, L., Hebbeler, K., & Spiker, D. (2007). Modeling the impact of formal and informal supports for young children with disabilities and their families. Pediatrics, 120, e992–e1001. Bailey, D. B., Roberts, J. E., Mirrett, P., & Hatton, D. (2001). Identifying infants and toddlers with fragile X syndrome: Issues and recommendations. Infants and Young Children, 14, 24–33.
Newborn Screening for Intellectual Disability
23
Bailey, D. B., Skinner, D., Davis, A., Whitmarsh, I., & Powell, C. (2008). Ethical, legal, and social concerns about expanded newborn screening: Fragile X syndrome as a prototype for emerging issues. Pediatrics, 121, e693–e704. Bailey, D. B., Skinner, D., Hatton, D., & Roberts, J. (2000). Family experiences and factors associated with the diagnosis of fragile X syndrome. Developmental and Behavioral Pediatrics, 21, 315–321. Bailey, D. B., Skinner, D., & Sparkman, K. (2003). Discovering fragile X syndrome: Family experiences and perceptions. Pediatrics, 111, 407–416. Bailey, D. B., Skinner, D., & Warren, S. F. (2005). Newborn screening for developmental disability: Reframing presumptive benefit. American Journal of Public Health, 95, 1889–1893. Baranek, G. T., Danko, C. D., Skinner, M. L., Bailey, D. B., Hatton, D. D., Roberts, J. E., et al. (2005). Video analysis of sensory-motor features in infants with fragile X syndrome at 9–12 months of age. Journal of Autism and Developmental Disorders, 35, 645–656. Berry, H. K., O’Grady, D. J., Perlmutter, L. J., & Bofinger, M. K. (1979). Intellectual development and academic achievement of children treated early for phenylketonuria. Developmental Medicine and Child Neurology, 21, 311–320. Bodamer, O. A., Hoffman, G. F., & Lindner, M. (2007). Expanded newborn screening in Europe 2007. Journal of Inherited Metabolic Disorders, 30, 439–444. Borrajo, G. J. C. (2007). Newborn screening in Latin America at the beginning of the 21st century. Journal of Inherited Metabolic Disorders, 30, 466–481. Botkin, J. R. (2005). Research for newborn screening: Developing a national framework. Pediatrics, 116, 862–871. Botkin, J. R., Clayton, E. W., Fost, N. C., Burke, W., Murray, T. H., Baily, M. A., et al. (2006). Newborn screening technology: Proceed with caution. Pediatrics, 117, 1793–1799. Comeau, A. M., Parad, R. B., Dorkin, H. L., Dovey, M., Gerstle, R., Haver, K., et al. (2004). Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: A cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics, 113, 1573–1581. Committee for the Study of Inborn Errors of Metabolism (1975). Genetic screening programs, principles, and research. Washington, DC: National Academy of Sciences. Cook, E. H. (1998). Genetics of autism. Mental Retardation and Developmental Disabilities Research Reviews, 4, 113–120. DeFries, J. C., & Alarcon, M. (1996). Genetics of specific reading disability. Mental Retardation and Developmental Disabilities Research Reviews, 2, 39–47. Dhondt, J.-L. (2007). Neonatal screening: From the ‘Guthrie age’ to the ‘genetic age. Journal of Inherited Metabolic Disorders, 30, 418–422. Engle, P. L., Black, M. M., Behrman, J. R., de Mello, M. C., Gertler, P. J., Kapiriri, L., et al. (2007). Strategies to avoid the loss of developmental potential in more than 200 million children in the developing world. Lancet, 369, 229–242. Fenning, R. M., Baker, J. K., Baker, B. L., & Crnic, K. A. (2007). Parenting children with borderline intellectual functioning: A unique risk population. American Journal on Mental Retardation, 112, 107–121. Grob, R. (2006). Parenting in the genomic age: The ‘cursed blessing’ of newborn screening. New Genetics and Society, 25, 159–170. Grody, W. W. (2003). Ethical issues raised by genetic testing with oligonucleotide mocroarrays. Molecular Biotechnology, 23, 127–138. Grosse, S. D. (2005). Does newborn screening save money? The difference between costeffective and cost-saving interventions. Journal of Pediatrics, 146, 168–170. Grosse, S. D., Boyle, C. A., Kenneson, A., Khoury, M. J., & Wilfond, B. S. (2006). From public health emergency to public health services: The implications of evolving criteria for newborn screening panels. Pediatrics, 117, 923–929.
24
Don Bailey
Guralnick, M. (2005). Early intervention for children with intellectual disabilities: Current knowledge and future prospects. Journal of Applied Research in Intellectual Disabilities, 18, 313–324. Gurian, E. A., Kinnamon, D. D., Henry, J. J., & Waisbren, S. E. (2006). Expanded newborn screening for biochemical disorders: The effect of a false-positive result. Pediatrics, 117, 1915–1921. Hacia, J. G., & Collins, F. S. (1999). Mutational analysis using oligonucleotide microarrays. Journal of Medical Genetics, 36, 730–736. Han, X., Powell, B. R., Phalin, J. L., & Chehab, F. F. (2006). Mosaicism for a full mutation, premutation, and deletion of the CGG repeats results in 22% FMRP and elevated FMR1 mRNA levels in a high-functioning fragile X male. American Journal of Medical Genetics, 140A, 1463–1471. Hewlett, J., & Waisbren, S. E. (2006). A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening. Journal of Inherited Metabolic Disease, 20, 677–682. Hiraki, S., Ormond, K. E., Kim, K., & Ross, L. F. (2006). Attitudes of genetic counselors toward expanding newborn screening and offering predictive genetic testing to children. American Journal of Medical Genetics Part A, 140A, 2312–2319. Holtzman, N. A., & Watson, M. S. (1997). Promoting safe and effective genetic testing in the United States: Final report of the Task Force on Genetic Testing. Bethesda, MD: National Institutes of Health. Howell, R. R. (2006a). Introduction: Newborn screening. Mental Retardation and Developmental Disabilities Research Reviews, 12, 229. Howell, R. R. (2006b). The high price of false positives. Molecular Genetics and Metabolism, 87, 180–183. Howse, J. L., Weiss, M., & Green, N. S. (2006). Critical role of the March of Dimes in the expansion of newborn screening. Mental Retardation and Developmental Disabilities Research Reviews, 12, 280–287. Inlow, J. K., & Restifo, L. L. (2004). Molecular and comparative genetics of mental retardation. Genetics, 166, 835–881. Kemper, A.R., Hwu, W.-L., Lloyd-Puryear, M., Kishnani, P.S. (2007). Newborn screening for Pompe disease: A synthesis of the evidence. Pediatrics, 120, e1327–1334. Khoury, M. J., Gwinn, M., Burke, W., Bowen, S., & Zimmern, R. (2007). Will genomics widen or help heal the schism between medicine and public health. American Journal of Preventive Medicine, 33, 310–317. Khoury, M. J., Jones, K., & Grosse, S. D. (2006). Quantifying the health benefits of genetic tests: The importance of a population perspective. Genetics in Medicine, 8, 191–195. Koch, R., & de la Cruz, F. (1999). Historical aspects and overview of research on phenylketonuria. Mental Retardation and Developmental Disabilities Research Reviews, 5, 101–104. Materin, D., & Rinaldo, P. (2003, August). Newborn screening: Opportunities and challenges of tandem mass spectrometry. Clinical Laboratory News, 12–15. McGuire, A. L., Cho, M. K., McGuire, S. E., & Caulfield, T. (2007). The future of personal genomics. Science, 317, 1687. Mirrett, P. L., Bailey, D. B., Roberts, J. E., & Hatton, D. D. (2004). Developmental screening and detection of developmental delays in infants and toddlers with fragile X syndrome. Developmental and Behavioral Pediatrics, 25, 21–27. Padilla, C. D., & Therrell, B. L. (2007). Newborn screening in the Asia Pacific region. Journal of Inherited Metabolic Disorders, 30, 490–506. Plomin, R., & McGuffin, P. (2003). Psychopathology in the postgenomic era. Annual Review of Psychology, 54, 205–228. Pollit, R. J. (2007). Introducing new screens: Why are we all doing different things. Journal of Inherited Metabolic Disorders, 30, 423–429.
Newborn Screening for Intellectual Disability
25
Ramey, S. L., & Ramey, C. T. (1999). Early experience and early intervention for children ‘‘at risk’’ for developmental delay and mental retardation. Mental Retardation and Developmental Disabilities Research Reviews, 5, 1–10. Roberts, J. E., Hatton, D. D., & Bailey, D. B. (2001). Development and behavior of male toddlers with fragile X syndrome. Journal of Early Intervention, 24, 207–223. Rolland, J. S., & Williams, J. K. (2005). Toward a biopsychosocial model for 21st-century genetics. Family Process, 44, 3–24. Saadallah, A. A., & Rashed, M. S. (2007). Newborn screening: Experiences in the Middle East and North Africa. Journal of Inherited Metabolic Disorders, 30, 482–489. Sices, L., Feudtner, C., McLaughlin, J., Drotar, D., & Williams, M. (2003). How do primary care physicians identify young children with developmental delays? A national survey. Developmental and Behavioral Pediatrics, 24, 409–417. Skinner, D., Sparkman, K., & Bailey, D. B. (2003). Screening for fragile X syndrome: Parent attitudes and perspectives. Genetics in Medicine, 5, 378–384. Tarini, B. A., Christakis, D. A., & Welch, H. G. (2006). State newborn screening in the tandem mass spectrometry era: More tests, more false-positive results. Pediatrics, 118, 448–456. Therrell, B. L., & Adams, J. (2007). Newborn screening in North America. Journal of Inherited Metabolic Disorders, 30, 447–465. Therrell, B. L., & Hannon, W. H. (2006). National evaluation of U.S. newborn screening system components. Mental Retardation and Developmental Disabilities Research Reviews, 12, 236–245. Tunis, S. R., Stryer, D. B., & Clancy, C. M. (2003). Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association, 290, 1624–1632. United States General Accounting Office (2003). Newborn screening: Characteristics of state programs (Report GAO-03–449). Washington, DC: U.S. General Accounting Office. Walker, S. P., Wachs, T. D., Gardner, J. M., Lozoff, B., Wasserman, G. A., Pollitt, E., et al. (2007). Child development: Risk factors for adverse outcomes in developing countries. Lancet, 369, 145–157. Watson, M. S. (2006). Current status of newborn screening: Decision-making about the conditions to include in screening programs. Mental Retardation and Developmental Disabilities Research Reviews, 12, 230–235. Watson, M. S., Mann, M. M., Lloyd-Puryear, M. A., Rinaldo, P., & Howell, R. R. (Eds.) (2006). Newborn screening: Toward a uniform screening panel and system. Genetics in Medicine, 8(Supplement 1), 1S–252S. Wilson, J. M. G., & Junger, F. (1968). Principles and practice of screening for disease. Public Health Papers No. 34. Geneva: World Health Organization.
This page intentionally left blank
C H A P T E R
T W O
Responsive Parenting: Closing the Learning Gap for Children with Early Developmental Problems Susan H. Landry,* Heather B. Taylor,* Cathy Guttentag,* and Karen E. Smith† Contents 1. Introduction 2. School-Age Developmental Characteristics 2.1. Children born VLBW 2.2. Children with SB 2.3. Children with DS 3. Shared Challenges for Effective Learning 3.1. Motor control/motor learning 3.2. Attention regulation/information processing 3.3. Goal-directed behavior 3.4. Interrelated early core skills 4. What is Responsive Parenting? 4.1. Affective-emotional style 4.2. Cognitively supportive behaviors 4.3. Adapting to needs of the child 5. What Supports Responsive Parenting? 6. Evidence for the Specialized Support of Responsive Parenting for Core Deficits 6.1. Linking specialized responsive scaffolding to early learning problems 6.2. Maintaining focus of attention 6.3. Use of directives 6.4. Warm sensitivity, contingent responsiveness, and avoidance of restrictiveness 6.5. Rich language input 6.6. Bidirectionality of influence
* {
28 30 30 30 31 31 32 33 34 35 36 36 37 37 38 39 39 39 41 41 42 43
Department of Pediatrics, Children’s Learning Institute, The University of Texas Health Science Center, Houston, Texas 77030 University of Texas Medical Branch at Galveston, Houston, Texas 77030
International Review of Research in Mental Retardation, Volume 36 ISSN 0074-7750, DOI: 10.1016/S0074-7750(08)00002-5
#
2008 Elsevier Inc. All rights reserved.
27
28
Susan H. Landry et al.
7. Evidence from Longitudinal Studies for Closing the Learning Gap for At-risk Children 8. Evidence from Experimental Findings for Closing the Learning Gap 8.1. Effects of PALS on maternal behaviors 8.2. Effects of PALS on infant skills 8.3. The influence of aspects of responsiveness on domains of infant development 8.4. Evidence for individual profiles of parenting 8.5. The optimal timing for responsive parenting intervention 9. Summary and Conclusions, Implications and Future Directions 9.1. Summary and conclusions 9.2. Implications and future directions Acknowledgments References
44 45 46 47 47 48 49 50 50 52 54 54
Abstract Responsive parenting strategies have the potential to provide specific scaffolding for common deficits found in developmentally at-risk children. This chapter describes findings from our research conducted across the past two decades with three groups of children known to have increased risk for compromised outcomes in a range of developmental domains (e.g., motor, social). These groups include children born at very low birth weight (VLBW) with varying degrees of neonatal complications associated with preterm birth, those born with spina bifida, and those born with Down syndrome. Although these three groups have striking differences in their developmental profiles, they share a common set of developmental difficulties that can be ameliorated through responsive parenting. In this chapter, we describe our research in responsive parenting, including cross-sectional studies that demonstrate how specific parenting strategies can provide supportive scaffolding to address the common deficits found in these groups of children. Evidence is then provided from a longitudinal study that documents how responsive parenting can close the learning gap for one group of children, those born at VLBW. Finally, results from a random assignment, responsive parenting intervention study that included children born at VLBW are discussed. These findings provide support for a causal role of responsive parenting in promoting more optimal development for children at risk for developmental problems.
1. Introduction There is strong support for early childhood being a critically important time for environmental influences on brain development (Dawson, Klinger, Panagiotides, Hill, & Spieker, 1992; DiPietro, 2000; Elman et al., 1996; Neville et al., 1998). Recent evidence from basic science research and
Responsive Parenting
29
longitudinal behavioral and intervention studies reaffirms that brain development in the early years (birth to five) is influenced by experiences that affect learning, behavior, and physical and mental health throughout life (Dawson et al., 1992; DiPietro, 2000; Elman et al., 1996; Neville et al., 1998). These findings may be especially true for at-risk children who have to manage various problems that impact their development. There are many biological and environmental conditions that may place children at risk for suboptimal developmental outcomes in the cognitive/academic or social/ emotional domains. The term ‘‘at risk’’ can be used to describe children who do not currently show developmental problems (or who are too young to assess for such problems) but with risk factors in their background which may lead to later emerging problems. Alternatively, the term ‘‘at risk’’ can be used to describe children who have current delays or disorders and are likely to continue to struggle in their development. In this chapter, we review research on several different populations of children who represent both of these categories. Therefore, for the purposes of this chapter, the term ‘‘at risk’’ will be used to refer to children who have an above-average likelihood of experiencing later learning problems, whether due to currently existing disabilities and/or delays, or due to background factors which predispose them, statistically, to such difficulties. A substantial number of children are born each year with medical conditions that put them at risk for developmental difficulties, including children born at very low birth weight (VLBW), with spina bifida (SB), or Down syndrome (DS). Many of these children show difficulties in infancy that impact their development, and the influence of the parenting environment may be even greater for them than for typically developing children (Bornstein, 1985; Landry, Smith, Miller-Loncar, & Swank, 1997). One feature of the caregiving environment consistently reported to be important for children’s outcomes is a responsive parenting style (Bornstein & Tamis-Lemonda, 1989; Londerville & Main, 1981; Olson, Bates, & Bayles, 1984). Because a highlight of responsive parenting is the reciprocal connection between the child’s needs and the parent’s response, this style may have the potential to provide a buffering effect on the developmental problems often seen in children with special needs. This chapter describes findings from our research conducted across the past two decades that has explored the potential of responsive parenting to support the developmental needs of at-risk children. This research was conducted with three groups of children known to have increased risk for impairment in a range of developmental domains (e.g., motor, social). These groups include children born at VLBW with varying degrees of medical risk associated with preterm birth, those born with SB, and children with DS. Although the three groups have striking differences in their developmental profiles, as infants and young children they have some developmental difficulties in common and these are described first. These findings of similar early learning issues across groups provide support for
30
Susan H. Landry et al.
broader generalizations in regard to how these groups may benefit similarly from responsive parenting. Second, we define responsive parenting as it is described in two theoretical frameworks including four key behavioral aspects that comprise this style. This is followed by results from crosssectional studies that demonstrate how parenting strategies can provide specific scaffolding to ameliorate the common deficits found in these groups of children. Evidence is then provided from a longitudinal study that documents how responsive parenting can close the learning gap for one group of children, those born at VLBW. Finally, the causal role of a responsive parenting style in facilitating at-risk children’s development is supported with results from an experimental study with parents of young children, including those born at VLBW.
2. School-Age Developmental Characteristics In order to better understand the potential importance of early responsive parenting for the three targeted groups, it is useful to examine the longer term outcomes described in the literature for these children. As will be described, outcomes across the three groups are disparate in terms of intellectual status, motor skills, and language outcomes. However, all three groups have some degree of difficulty in cognitive, academic, and socialbehavioral areas.
2.1. Children born VLBW For school-age VLBW children, longitudinal studies have documented a high incidence of social, behavioral, and learning problems (Taylor, Hack, Klein, & Schatschneider, 1995). More adverse developmental outcomes may be associated with specific types of medical complications including acute and chronic respiratory complications (Goldson, 1983; Landry et al., 1984; Ruiz, LeFever, Hakanson, Clark, & Williams, 1981; Vohr, Bell, & Williamson, 1982) and intraventricular hemorrhage (IVH) (Landry, Fletcher, Denson, & Chapieski, 1993; Landry, Schmidt, & Richardson, 1989). Long-term learning problems may be due, in part, to early difficulties these children show in developing joint attention skills that allow them to learn from interactions with others.
2.2. Children with SB In addition to moderate to severe difficulties in gross motor development (Bushnell & Boudreau, 1993; Dennis et al., 2004; Landry, Jordan, & Fletcher, 1994b; Lomax-Bream, Barnes, Copeland, Taylor, & Landry,
Responsive Parenting
31
2007a), a broad range of neurobehavioral problems also are found for older children and adults with SB, including cognitive problems such as difficulty with focusing and shifting attention (Brewer, Fletcher, Hiscock, & Davidson, 2001; Dennis, Landry, Barnes, & Fletcher, 2006), visualperceptual problem solving (Dennis, Fletcher, Rogers, Hetherington, & Francis, 2002), and sequencing reasoning skills to carry out math procedures (Barnes et al., 2006; Dennis & Barnes, 2002). A majority also have academic problems such as reading comprehension (Barnes & Dennis, 2004). While there has been less research on the early precursors of these later developmental problems, information now is becoming available (Lomax-Bream et al., 2007b).
2.3. Children with DS Unlike the previous two groups of children, the majority of those with DS have long-term deficiencies in intellectual development and almost always function in an IQ range consistent with a mental retardation diagnosis (Ramirez & Morgan, 1998). In studies examining later language and communication development, there are particular problems in language production, syntax, and poor speech intelligibility (Roberts, Price, & Malkin, 2007). The most widely cited behavioral problems identified at later ages include impulsivity (Goldberg & Marcovitch, 1989) and problems with focused attention (Kasari, Freeman, Mundy, & Sigman, 1995). Unlike children with SB, considerable research has focused on the early development of those with DS (e.g., Ramirez & Morgan, 1998; Roberts et al., 2007) as well as the early influence of the caretaking environment for understanding variability in their outcome (Mahoney, Perales, Wiggers, & Herman, 2006; Tannock, 1988).
3. Shared Challenges for Effective Learning Although there are unique developmental issues specific to individuals and medical conditions, children with SB, DS, and those born VLBW share similar learning challenges in infancy. These common problems reflect difficulties in motor control/learning, regulating and shifting attention, and goal-directed behavior. In typically developing children, this core set of interrelated early skills becomes part of a foundation that helps learning. This in turn impacts the development of future skills necessary for success in a range of content domains including academic and social learning. Unfortunately, children with the above conditions have been found to demonstrate difficulty with these core skills.
32
Susan H. Landry et al.
3.1. Motor control/motor learning Developmentally at-risk infants often have difficulty with motor responses, especially motor timing and motor control/learning. Motor timing is related to a general lack of coordination and poor synchronization of movement. Motor control/learning causes problems on tasks requiring infants to learn and execute motor contingencies. Thelen and Smith (1995) posit that early success in effective motoric organization and exploration of the environment is essential in development of skills necessary for appropriate cognitive development. Motor impairment restricts the infant’s ability to explore the environment, thereby restricting sensory experiences. It may also distort sensory input experienced by the infant when handling objects. Piaget (1952) suggests that the extent that an infant learns about the world is formulated through the transactions between the infant’s own actions and objects. In this way, it is the coordination of sensorimotor activity that produces higher levels of cognitive functioning. Infants with DS typically have central hypotonia. Consequently, gross motor movements are often delayed. On the average, most children with DS do not sit up until 11 months of age or walk until 19 months (Winders, 1997), with boys being slightly more delayed than girls (Melyn & White, 1973). Nonetheless, children with DS may learn to run, ride bicycles, and participate in sports (Adirim & Fine, 2002). For infants with DS, motor difficulty may impact their ability to explore and learn from the environment. In one study conducted by Landry and Chapieski (1989), infants with DS demonstrated significantly more difficulties with motor organization than preterm infants when responding to mothers directing toy play. These infants were far more likely than preterm infants to respond to mother with a look, but they were less likely to reach for and manipulate toys during play. Infants with SB often have a complex array of physical symptoms which can include flaccid or spastic paralysis (Mazur, Stillwell, & Menelaus, 1986), sensory loss below the lesion level, and hydrocephalus. The extent of motor paralysis and sensory loss depends on the location of the lesion in the spinal cord (Liptak, 2002). In a longitudinal study on children with SB followed from 6 to 36 months, having SB was associated with lower levels of performance on the Bayley Motor Scale. Furthermore, on this motor measure, having a shunt or a higher lesion level also predicted significantly lower scores than having SB without a shunt or having lower lesion levels, respectively (Lomax-Bream et al., 2007a). Extremely low-birth-weight infants are often more likely than full-term infants to have motor difficulties (McCormick, McCarton, Tonascia, & Brooks-Gunn, 1993). Factors that increase the likelihood of motor difficulties include severity of neonatal complications including infections with chronic lung disease (Skidmore, Rivers, & Hack, 1990), and CNS insults (Paneth, 1993; Papile, Munsick-Bruno, & Schaefer, 1983; Pinto-Martin,
Responsive Parenting
33
Whitaker, Feldman, Van Rossem, & Paneth, 2000; Sinha, D’Souza, Rivlin, & Chiswick, 1990; Vohr et al., 1991). Anderson, Swank, Wildin, Landry, and Smith (1999) conducted a longitudinal study that followed children born prematurely from 6 months (corrected) to 54 months of age. Using a composite score including motor tone, motor coordination, and reflex subscales on a neurological examination, both low-risk and high-risk infants demonstrated higher neurological scores across all time points compared to full-term infants (higher scores ¼ more abnormality). Furthermore, the term infants demonstrated minimal change in neurological patterns over time, while the preterm groups (both high and low risk) demonstrated complex, nonlinear patterns of change in their neurologic scores. Whereas low-risk preterms demonstrated a trend toward normalization at 54 months, this was not the case for high-risk preterm infants.
3.2. Attention regulation/information processing At a very young age, typically developing infants are able to modulate arousal states and activate early attention behaviors. Infants’ ability to attend to their environment fosters learning from their surroundings. These attention modulation and activation skills improve with the support of mediators such as neurophysiological maturation and parent interactions (Block & Block, 1979; Kopp, 1982; Mischel & Patterson, 1979; Wertsch, 1979). Although there are many aspects of attention, this section will focus on two types of early visual attention processes in infants: attention getting (i.e., turning toward a stimulus) and attention holding (i.e., sustained fixation on the stimulus after turning). Adequate development in these attentional processes allows infants to move on to, and learn about, other environmental stimuli (Ruff & Lawson, 1991). It is important to document and understand attention difficulties found even in infancy if interventions are to be implemented. Children with motor problems often also have problems with attention (Kaplan, Wilson, Dewey, & Crawford, 1998). Even though they manifest differently in different groups (i.e., SB, DS), motor difficulties of various kinds may strain infants’ limited attentional capacities and reduce their ability to learn from their environment. Kaplan et al. (1998) postulated that attention deficit/hyperactivity disorder and other childhood developmental disorders show a high comorbidity due to brain dysmorphology during early brain development. It is well documented that the increased risk for attention-related school problems can have a negative impact on academic achievement for children with DS (Ramirez & Morgan, 1998), SB (Dennis et al., 2006), and those born at VLBW (Schothorst & van Engeland, 1996; Weindrich, Jennen-Steinmetz, Laucht, & Schmidt, 2003). Investigation of early attentional processes among infants with DS have found that these infants may have difficulty with both attention holding (Vietze, McCarthy, McQuiston, MacTurk, & Yarrow, 1983) and shifts in
34
Susan H. Landry et al.
looking at aspects of their environment (attention getting) (Krakow & Kopp, 1983). In addition, one study compared 6-month-old infants with DS (n ¼ 14) to mental and motor age-matched high-risk VLBW infants (n ¼ 15) (Landry & Chapieski, 1990). Results of this study on joint attention suggested that although infants with DS were able to shift their attention from interest in mother to interest in toys, they did so at a slower rate than the VLBW infants. In addition, infants were evaluated in their ability to hold attention on toys (i.e., mean length of time looking at toys). In regard to this sustained attention (i.e., attention holding), the average length of looking and the average length of examination of toys were not different for the two groups. However, infants with DS spent significantly less total time looking at toys and significantly more time looking at their mothers. Similarly, studies conducted on children born with SB or at VLBW demonstrated significant difficulty with attention getting but less difficulty with attention holding. For example, in one study (SB ¼ 47; Control ¼ 40), 18-month-old infants with SB took significantly longer to shift their attention from a blinking light to a face stimulus projected on a screen (i.e., attention getting) than typically developing infants (Taylor, Landry, Cohen, Barnes, & Swank, 2006). A similar result was found in a study conducted with infants born VLBW (n ¼ 14 with respiratory distress syndrome, RDS, and IVH; n ¼ 9 with RDS without IVH). Attention getting difficulties in this group were detected at 7 months corrected for prematurity, with the VLBW infants with IVH and RDS taking significantly longer to shift their attention than both the lower risk VLBW and typically developing infants (Landry, Leslie, Fletcher, & Francis, 1985). These same studies reported no difference in their samples of infants born VLBW (Landry et al., 1985) and with SB (Taylor et al., 2006) in their ability to habituate, or show a decremental response, to a familiar stimulus when compared to typically developing infants. When evaluating response to a novel stimulus, infants born VLBW did not differ in their ability to show an incremental response. In contrast, Taylor et al. (2006) found in their study that infants with SB had shorter fixation times to a novel stimulus compared to typically developing infants, and this finding was significantly related to infants’ motor scores, suggesting that infants with higher motor performance were more likely to have an incremental response to a novel stimulus than those with lower motor scores. This was true for both infants with SB and typical developing children.
3.3. Goal-directed behavior Goal-directed behavior is an important component of motivation, playing an essential role in successful learning (White, 1959). This can also be described as executive functioning or in other cases, rule-based problem solving. It is a complex, multifaceted construct that involves more than one psychological
Responsive Parenting
35
process. Some important components necessary for goal-directed behavior to occur include (1) identifying a particular interest, (2) planning the actions necessary to carry out the activity, and (3) initiating and persisting in these actions in order to achieve an identified goal. A fourth critical component of these goal-directed behaviors is that the child self-initiate purposeful action rather than being dependent on the structure provided by others. Research suggests that older children with developmental difficulties (including children born with SB, DS, or at VLBW) tend to have difficulty in regulating their behavior toward the achievement of particular goals. For example, findings regarding the performance of school-aged children with SB working on independent problem-solving tasks showed that these children had more difficulty maintaining goal-directed activities during play than did age- and IQ-matched typically developing children (Landry, Robinson, Copeland, & Garner, 1993). More specifically, the children with SB had difficulty sequencing their own behavior in order to reach a goal. Children with DS appear to experience particular difficulties with maintaining goal-directed behavior and inhibiting themselves from distraction. Kopp (1990) found that waiting and delay of gratification were particularly difficult for this group. Children with DS have also been found to demonstrate fewer social initiations than do mental age-matched control children. In one study by Landry, Garner, Pirie, and Swank (1994a), children with DS initiated fewer exchanges with their mothers but were comparable to typically developing children on self-directed behavior. Gilmore, Cuskelly, and Hayes (2003) evaluated planfulness and maintenance of goal-directed behavior in a sample of 26 children with DS compared to 43 typically developing children, matched for mental age (24–36 months). Both groups showed similar levels of competence, planfulness, and distractibility. But, children with DS demonstrated more difficulty with task-avoidant behavior. Children born very preterm or at extremely low birth weight have been found to exhibit considerable difficulty with executive functioning (maintaining goal-directed behavior) compared to normal birth peers at 8 years of age (Anderson, Doyle, & Victorian Infant Collaborative Study Group, 2004). In Anderson et al.’s (2004), they found preterm infants to have a global pattern of executive deficits rather than a specific pattern. This is consistent with other studies suggesting difficulties with impulse control, planning ability, motor sequencing, spatial working memory, spatial organization, and mental flexibility (Harvey, O’Callaghan, & Mohay, 1999; Luciana, Lindeke, Mills, & Nelson, 1999; Taylor, Hack, & Klein, 1998; Waber & McCormick, 1995).
3.4. Interrelated early core skills Core skills in attention, motor performance, and goal-directed behavior play a large role in learning. These skills are clearly interrelated as they impact infants’ ability to learn from their environment. For example, problems in
36
Susan H. Landry et al.
attentional capacity are critical to infants’ response to their environment (e.g. toy play) (Landry, 1995), and this process is also further complicated by motor difficulties. Impairment in these interrelated early core skills may in turn interfere with later, more complex goal-directed behavior.
4. What is Responsive Parenting? Responsiveness is an aspect of supportive parenting referred to in several theories and research frameworks, including attachment (Ainsworth, Blehar, Waters, & Wall, 1978; Sroufe, 1983), socio-cultural (Rogoff, 1990; Vygotsky, 1978), and socialization of young children (Grusec & Kuczynski, 1980; Maccoby & Martin, 1983). The literature supports at least four types of responsive behaviors: contingent responding, emotional/affective support, language input that supports developmental needs, and support for infant foci of attention. Responsiveness can be considered an overarching construct that includes a number of distinct but conceptually related behaviors, and their distinctiveness may be based in part on the type of support each provide (Martin, 1989; Van Egeren, Barratt, & Roach, 2001). Two components within a responsive parenting style include behaviors related to an affective-emotional style and those that are cognitively supportive.
4.1. Affective-emotional style An affective-emotional style of parenting is emphasized in the attachment framework and involves positive affect with high levels of warmth and nurturance (Darling & Steinberg, 1993), responses that are contingently linked to the child’s signals, and acceptance of the child as a unique individual (Ainsworth et al., 1978; Bornstein, 1985). Warm acceptance of infants’ needs and interests with responses that are contingent on infants’ signals are thought to support infants’ ability to self regulate by facilitating the development of mechanisms for coping with stress and novelty. In turn, a trust and bond with the caregiver is developed through the process of internalization (Ainsworth et al., 1978; Bornstein & Tamis-Lemonda, 1989). This encourages an interest and willingness in infants to explore their environment, to continue to signal, and to cooperate with caregiver requests (Baumrind, 1989; Darling & Steinberg, 1993). This process occurs through a three-term chain of events in which the infant signals, the caregiver responds in a prompt and sensitive manner, and the infant experiences that her needs are met in a predictable way (e.g., Bornstein & TamisLemonda, 1989). Maternal responsive behaviors such as warmth and contingent responsiveness are considered to provide affective-emotional
Responsive Parenting
37
support. Evidence indicates that they facilitate social development such as increased cooperation in young children (Lytton, 1977; Parpal & Maccoby, 1985) and may be even more important for the social functioning of developmentally at-risk children.
4.2. Cognitively supportive behaviors Cognitively supportive behaviors emphasized in a socio-cultural framework include support for the child’s focus of attention and rich language input. These in combination with affective-emotional support are thought to facilitate development of both social and cognitive skills (Landry, Smith, & Swank, 2006). Supporting a child’s focus of attention through maintaining appears to facilitate a young child’s learning by providing a structure that supports the young child’s immature attention and cognitive abilities (Akhtar, Dunham, & Dunham, 1991; Tomasello & Farrar, 1986). In contrast, redirecting attentional focus is thought to hinder a child’s ability to focus and process new information as it places increased demands on a young child’s capabilities. Along with this support for attentional skills, rich language input promotes the child’s ability to develop richer knowledge of how and why things work and are organized. While this is critical for both language development and background knowledge, it also plays an important role in facilitating a child’s social–emotional development, as it provides labels and explanations for feelings and social understanding. Maternal responsive behaviors that are cognitively responsive by maintaining rather than redirecting children’s interests have been found to facilitate the exploratory behaviors of toddlers (Landry, Garner, Denson, Swank, & Baldwin, 1993), while rich language input is predictive of greater cognitive and language skills as well as later reading (Dieterich, Assel, Swank, Smith, & Landry, 2006; Landry et al., 1990).
4.3. Adapting to needs of the child Another aspect of responsive parenting is the ability to adapt to the young child’s changing needs. Although some behaviors are supportive of learning at high levels across childhood (e.g., contingent responsiveness, rich language input), others such as the provision of structure, or directiveness, may need to change across time. Research has shown that in the infant and early toddler period, higher levels of structure may support children’s ability to understand what is expected of them and thus increase regulatory capacity and cooperation (Marfo, 1992). However, if this aspect of parenting remains at high levels into the early preschool years when children are becoming more capable of directing their own learning, it can actually compromise children’s ability to take initiative in their learning (Landry, Smith, Swank, & Miller-Loncar, 2000).
38
Susan H. Landry et al.
5. What Supports Responsive Parenting? As the child’s learning occurs through direct interactions with the parent, it is important to recognize that the parent’s ability to be responsive may be hindered and/or buffered by factors such as characteristics of the child, family economic status, and social and personal attributes of the caregiver. For example, characteristics of a child at risk for developmental delays can disrupt positive mother–child interactions (Goldberg, 1978; Kogan, 1980), particularly when the mother is already burdened with the problems associated with low socio-economic status (SES) (Drillien, 1964). Disorganized responses to stimulation (Als, Lester, & Brazelton, 1979) and difficult temperaments (Desmond, Wilson, Alt, & Fisher, 1980), characteristics frequently associated with developmentally at-risk infants, can cause parents to question their ability to adequately care for these infants. Since mothers with low SES, regardless of the medical status of their infants, have often been described as believing that their actions have little effect on their children, and as having lower expectations for their development (Hess & Shipman, 1965), these infants are likely to be in double jeopardy for poor mother–child interactions. A mother’s own child-rearing history may also influence her self-esteem and how she cares for her children (Belsky, Hertzog, & Rovine, 1986). Mothers who perceive that they were nurtured and had parents who were responsive to their needs have been found to provide high levels of responsiveness to normal and high-risk infants, while those with highly negative perceptions found it particularly difficult to parent responsively when they had a high-risk child (Hammond, Landry, Swank, & Smith, 2000). In addition, maternal psychological distress has been related to lower levels of maternal responsiveness and poorer developmental outcomes in their children (Bee et al., 1982; Field, 1987; Wilfong, Saylor, & Elksnin, 1991). This appears to occur even when psychological distress is at subclinical levels (Assel, Landry, Swank, Steelman, & Smith, 2002). Variability in child-rearing practices may be explained in part by social factors in the family’s environment that can serve to buffer the negative effects of factors such as low SES. A mother’s interactions with family and friends, for example, can act to buffer the stress of raising an at-risk child (Crockenberg, 1981; Gallagher, Cross, & Scharfman, 1981; Weinraub & Wolf, 1983). Social factors appear to influence caretaking behaviors even after taking into account the infant’s birth status and behavior (Feiring, Fox, Jaskir, & Lewis, 1987). The source and type of social support received by mothers can be important modifiers of caretaking behavior (Colletta & Gregg, 1981; Crnic, Greenberg, Ragozin, Robinson, & Basham, 1983). For example, mothers who report that family and friends provide assistance in caregiving and support them as a parent demonstrated a high level of responsive behaviors in interactions with children (Landry, Smith, Swank, Assel, &
Responsive Parenting
39
Vellet, 2001). However, a higher density of family members in a support network for a parent of a medically high-risk child may make it more difficult for the mother to feel supported, as the stress of this child is shared by everyone in the social network (Zarling, Hirsch, & Landry, 1988). In a recent intervention study, social support was found to be a unique predictor of mothers’ ability to move from an unresponsive style to a responsive style of parenting (Guttentag, Pedrosa-Josic, Landry, Smith, & Swank, 2006). This is an encouraging finding as interventions can provide greater degrees of social support for mothers with high-risk characteristics or from high-risk backgrounds (Dieterich, Landry, Smith, Swank, & Hebert, 2006).
6. Evidence for the Specialized Support of Responsive Parenting for Core Deficits 6.1. Linking specialized responsive scaffolding to early learning problems Previously in this chapter, we have described a range of early developmental difficulties that are similar across children with SB, DS, or VLBW. These include problems with regulating attention, processing new information, organizing motor movements to solve problems, and initiating goaldirected behavior in both social and cognitive problem-solving situations. In order to participate successfully in problem-solving tasks and social interactions, children need to be able to integrate these varied skills. The goal of the next section is to describe how specific responsiveness behaviors provide specialized support to buffer these common developmental difficulties that could compromise children’s learning. The theoretical framework that guided this work was the socio-cultural framework, where children’s learning is described as developing from a social context (Vygotsky, 1978). In this context, the parent provides a specialized form of support that allows the child to attend, process, and engage in a learning interaction in spite of having immature attentional and cognitive capacities. Thus, the caregiver’s support is a form of ‘‘other regulation’’ for the child, allowing him or her to begin to develop self-regulation abilities and take over a more active role in learning. The parent’s specialized support, or scaffolding, is the origin of the child’s later independent functioning, a critical milestone in a child’s development. The following studies examined maternal scaffolding and its effect on high-risk children’s learning.
6.2. Maintaining focus of attention Across all three of the developmentally at-risk groups, there are reports of difficulties in controlling attentional focus as well as shifting attention. Assisting a child in maintaining attentional focus is thought to be an
40
Susan H. Landry et al.
important supportive behavior because it does not require the child to inhibit a response to something of interest and redirect their attention to another object or topic. Thus, young children do not have to use their limited attentional and cognitive capacity to reorient and organize a response, and in contrast, can use this capacity to process information about the original object of interest. Examples of maintaining strategies include naming and talking about the object to which the child is actively attending, showing the child how to use the object, or moving the object closer to the child to facilitate reaching and grasping. In our research, these behaviors were coded by frequency counts of instances when mothers’ verbal or nonverbal behaviors maintained or supported their children’s current focus of attention. With consistent use of maintaining strategies, a parent should be able to support a higher level of learning, particularly for a child with early learning difficulties. The findings of Landry, Garner, Swank, and Baldwin (1996) provide an example of the facilitative support of maintaining attention for children who were born at high medical risk (HR),VLBW. The children’s ability to process information was assessed in this study by examining the probability of an infant showing a higher level exploratory play response following a maternal attention-directing request. Infants were observed during toy centered interactions with their mothers and coded for their level of play prior to a maternal request that either maintained or redirected their infants’ current focus of attention. Of interest was the level of play response that followed the maternal request. For HR, VLBW infants, level of play following a request was comparable to that of term-born and low medical risk (LR), VLBW infants if their mothers maintained their foci of interest. In contrast, they showed significantly lower levels of play behavior than did the other two infant groups following a request to redirect their attention. Similar support for maintaining was found in a study examining children with Down syndrome’s ability to control and regulate attention in problemsolving situations (Landry et al., 1989). Using a similar paradigm to that noted above, mothers’ attempts to maintain attention were more likely to be followed by children manipulating a toy than by a more passive response of looking at, and/or holding, the toy. Of importance, this responsiveness strategy was more effective in eliciting higher level responses from the children than any verbal technique such as asking questions or providing imperatives. In the presence of maintaining, when mothers gave or showed a toy to their child with DS, their children were more likely to display a higher level toy manipulation response than when mothers demonstrated the toy function. In another study, if the interest of a child with DS was followed up on by the mother, the child was more apt to cooperate with maternal requests at levels similar to normal controls in a social tea party situation (Landry et al., 1994a).
Responsive Parenting
41
Most recently, children with SB were found to show higher levels and faster growth trajectories in cognitive skills through 3 years of age when their mothers used higher levels of maintaining behaviors, even after controlling for family SES and child’s motor development (Lomax-Bream et al., 2007b). Similar results were found for language development, and the influence of maternal maintaining on these outcomes was comparable for those with SB and typically developing children.
6.3. Use of directives Preschool-age children with DS were more likely than mental age-matched controls to follow through with a request when their mothers’ request was a direction rather than a suggestion or question (Landry et al., 1994a). In a similar paradigm, use of directiveness at these ages interfered with VLBW children’s ability to follow a request (Landry & Chapieski, 1990). Thus, continued provision of high levels of structure across the preschool period may provide more effective scaffolding technique for children with DS but not those born at VLBW. The type of support that continued use of this technique provides for children with DS may be effective due to their greater need for help in understanding what is expected of them in light of their compromised cognitive skills. Other research has indicated that young children with DS whose mothers interacted with them in a highly responsive manner (i.e., sensitive, reciprocal, and playful) had higher cognitive development scores than those whose mothers engaged with them in a highly directive, teaching-oriented manner (Mahoney et al., 2006). Since that study used a cross-sectional design, however, it was not possible to determine the directionality of this correlation; it may be that mothers of higher functioning children found it less necessary to be so directive in their approach. In our studies of children born at VLBW, higher levels of directiveness at 2 years of age predicted higher levels of cognitive skill and cooperation with social requests. However, by 3 years of age, if mothers did not decrease in their use of this strategy and adopt a more choice-providing approach, their children’s cognitive goal-directed and social initiative skills were at lower levels by 4 years of age.
6.4. Warm sensitivity, contingent responsiveness, and avoidance of restrictiveness Through much of our research with children born VLBW, high correlations have been found between observations of warmth and contingent responsiveness. Therefore, many of our studies have combined these two responsiveness behaviors into a single score, warm flexibility, and examined the predictive influence on children’s skill development. For example, children who experienced higher levels of warm flexibility during infancy
42
Susan H. Landry et al.
were more likely to have higher levels of social responsiveness when interacting with their mothers at 4 years of age (Steelman, Assel, Swank, Smith, & Landry, 2002). In addition to this impressive direct effect, this maternal strategy had several indirect effects, one of which was through a positive influence on children’s language across 12–54 months. Maternal disciplinary preferences also mediated the relation between warm responsiveness and later social skills such that a mother who was warmly responsive was less likely to use physically punitive techniques. This, in turn, facilitated children’s cooperation during social interactions. Through factor analysis, we found that contingent responsiveness loads on the same factor as avoidance of restrictiveness (Landry et al., 2006). This makes sense given that restricting young children’s behaviors shows a disregard of their interests. It is important to note that the majority of maternal restrictions were not attempts to keep children safe but rather were imperative statements that limited the child’s actions (e.g., ‘‘Don’t put it in there’’ or ‘‘Stop pouring’’ while child engaged with toys). In a longitudinal study of children born at VLBW, high levels of restrictiveness predicted lower levels of initiating and cognitive skill for term and VLBW born children from 6 to 36 months of age (Landry et al., 1997). What was most striking about these results was the significantly greater influence that restrictiveness had for the children born at HR as compared to those at lower medical risk or term born. Mothers who frequently restrict medically high-risk children’s attempts to interact socially or explore their environment may interfere with the children’s learning to act on their own interests. This may occur, in part, because attempts to take an active role do not result in a predictable response from their caregivers. Thus, children whose early experiences are frequently interrupted with requests to stop doing something are not able to assume the development of independence in their learning at a normal rate.
6.5. Rich language input The quality of language input is well known to positively influence language development (Risley & Hart, 2006). However, it also can have a positive effect on children’s early executive processing skills that are thought to lay the foundation for later, more complex goal-oriented behaviors. In our longitudinal study of parenting and development of infants born at VLBW, greater maternal use of rich language input during the early preschool period was found to support children’s ability to sequence their behaviors at higher levels during an independent goal-directed play task and a search retrieval task (Landry, Miller-Loncar, Smith, & Swank, 2002). Verbal support (e.g., explanations, analogies) guides children to understand how to sequence their behavior to solve problems. This includes helping them understand associations between objects and their actions as well as verbal guidance that references specific planning strategies (Freund,
Responsive Parenting
43
1990). With this form of verbal support, children increase their capacity for self-regulation and ultimately become competent in solving problems on their own. Rich language input also was found to predict both verbal and nonverbal reasoning abilities at 6 years of age, with the relation between maternal language and nonverbal reasoning being stronger for those born at VLBW compared to term children (Smith, Landry, & Swank, 2000). Given that VLBW children have specific deficits in visual-motor problem solving, it is likely that this type of support that occurs during everyday interactions can help children with concept formation related to objects.
6.6. Bidirectionality of influence In correlational studies, the evaluation of the influence of parenting behaviors on child development can only be inferred, as there is always the possibility of bidirectional influences. This would mean that relations could be due to the child’s effect on the parent’s behavior, rather than vice versa or both. One means of further examining this question in a correlational, longitudinal study is through the use of cross-lag analyses. We previously examined cross-lag panel analyses from mother–child interactions in two studies with VLBW born children (Landry et al., 2000) and those with SB (Lomax-Bream et al., 2007b). Although the time periods varied slightly (1, 2, and 3 years of age in the VLBW cohort; 1, 1½, and 2 years of age for SB), the statistical approach was the same. In multiple models, the crosslag coefficients from mother to child with those from child to mother were compared to determine direction of influence. With the VLBW cohort, mothers’ maintaining the child’s focus of interest related to cognitive language skills from 1 to 2 years and 2 to 3 years of age, and to warm responsiveness across these same ages. However, there were no significant relations from the child’s social constructs to mothers’ maintaining, providing support that the direction of influence was from mothers’ maintaining to the child’s social behavior. The two child social constructs included responsiveness, which measures the child’s ability to respond to maternal requests, and initiating, which examines the child’s ability to guide maternal attention to an activity of interest. With the SB cohort, the maternal responsiveness construct included maintaining, warm sensitivity, and contingent responsiveness and the child construct was language skill. The results of the cross-lag analysis revealed that both the 1-year child language and responsiveness parenting constructs were significantly related to the 1½-year child language construct. In addition, both the maternal and child 1-year constructs were related to the 1½-year parenting. However, at the later ages, only the 1½-year parenting predicted the 2-year parenting construct. Thus, consistent with the ‘‘back and forth’’ influence noted by others (Bell, 1988; Braungart-Rieker, Garwood, & Stifter, 1997), at the
44
Susan H. Landry et al.
earlier age bidirectional influences were seen, while at later ages, the relation became one of mother effects on the child.
7. Evidence from Longitudinal Studies for Closing the Learning Gap for At-risk Children Two findings needed to support the critical role of responsive parenting in promoting children’s development are: (1) relations of high responsive levels with more positive trajectories of cognitive and social development as compared to slower developmental progress when responsiveness is absent and (2) evidence that the influence of responsive parenting is even greater for children with special needs. Landry et al. (2001) evaluated early responsiveness among families from lower SES backgrounds and for groups of term and VLBW born children, with a particular interest in whether early responsiveness played a special role in development or whether consistency in this parenting style over time was necessary for optimal outcomes. Four maternal clusters based on warm and contingent responsiveness behaviors observed early in infancy and toddlerhood (i.e., 6, 12, 24 months) and the preschool period (i.e., 3, 4 years) were identified: mothers who demonstrated high responsiveness across both developmental periods, mothers who demonstrated minimal responsiveness across both periods, mothers who showed high responsiveness during infancy but declined in the toddler period, and mothers who showed low levels during infancy with some increase in the toddler period. Children born preterm, including those born with the highest medical risk, who experienced consistently high maternal responsiveness were more likely to perform at levels similar to full-term children on social and cognitive development through entry into kindergarten. In contrast, all children parented with minimal responsiveness showed the poorest development. This was particularly detrimental for the HR VLBW children, who showed only 7.6 months of skill growth for every 12 months. This suggests that the impact of unresponsive parenting on children’s deficits may be twofold if the caregiving environment lacks responsiveness and the child is at greater risk for developmental problems. The importance of an early responsive caregiving environment was further demonstrated when the children were followed through 8 years of age, even after controlling for parenting during the school-age years (Landry et al., 2006). With this same cohort of children, mothers’ responsiveness predicted children’s reading comprehension skills at 8 years of age (Taylor et al., 2006). However, a significant interaction revealed that maternal responsiveness had a greater impact on later comprehension skills with children who had lower, rather than higher, cognitive abilities. This was most evident when mothers demonstrated high responsiveness in infancy.
Responsive Parenting
45
Longitudinal studies also may provide information about specific aspects of responsive parenting for promoting different areas of social and cognitive development. In this same cohort of children, those who received high levels of rich language input that provided information about labels and connections between objects and actions had significantly higher levels of reading achievement at 10 years (Dieterich et al., 2006). If children experienced this type of language input during the toddler period, they were more likely to have higher levels of executive processing skills during 1st grade (Landry et al., 2002). In our longitudinal study, inconsistency in responsive parenting appeared to be less optimal than consistency for children’s development, but was better than the absence of responsiveness. Although this was particularly true for growth in cognitive skills, children’s ability to respond in social interactions with their mothers showed a more complex picture. Those born term showed similar trajectories of growth in social skills if their mothers had high responsiveness at least across infancy. In contrast, the medically high-risk VLBW children required consistency in responsiveness across infancy and early childhood for the same level of skill. This may be due to the difficulty that the high risk, VLBW children had in internalizing the regulatory capacity and motivation to continue to respond socially when maternal responsiveness decreased. In this way, inconsistent responsiveness may disrupt the internalization of social regulatory behaviors for a group of children at higher risk for problems in social development. Our research is consistent with others’ longitudinal research on maternal responsiveness. For example, Bradley, Caldwell, and Rock (1988) measured responsiveness using the parental involvement and family participation subscales from the HOME inventory and found that early responsiveness predicted 10-year social behaviors, while cognitive outcomes were predicted by stability in parental involvement through age 10 years. Wakschlag and Hans (1999) also found maternal responsiveness in infancy to predict fewer behavior problems in middle childhood after controlling for concurrent parenting behaviors.
8. Evidence from Experimental Findings for Closing the Learning Gap Based upon results from our longitudinal studies of infants born at VLBW (described above), we set out to investigate whether parents of children born at risk could be assisted to enhance their specific responsive parenting practices to promote their children’s optimal developmental outcomes. Toward that end, we developed a responsive parenting intervention for mothers of infants and assessed its effectiveness through a systematic, randomized control design.
46
Susan H. Landry et al.
Our intervention curriculum, known as ‘‘Playing and Learning Strategies’’ (PALS) consisted of 10 home-based sessions, each lasting about 1.5 h. Sessions were conducted one-on-one by a trained facilitator. Facilitators used a detailed curriculum that included scripts to guide interactions with mothers, probing questions, and points for discussion, an approach necessary to ensure systematic implementation across families. However, facilitators were trained to use the curriculum in a flexible manner to meet the learning needs of individual families. The format for each PALS home visit included: (1) asking mothers to review their experiences across the last week related to their efforts to try the targeted behaviors; (2) describing the current visit’s target behavior; (3) watching and discussing with mother the educational videotape; (4) videotaping mothers interacting with their infants, with coaching from facilitator, in situations that mother selected (e.g., toy play, feeding, bathing); (5) supporting mothers to critique their behaviors and their infants’ responses during the videotaped practice; and (6) planning with mothers for when they could practice the targeted behaviors over the next week. Target behaviors were chosen for their support of premature infants’ immature abilities in signaling interest, shifting attention, organizing behaviors, and developing early communication skills. In the control condition, known as Developmental Assessment Sessions (DAS), families received the same number of home visits and their children received attention and informal assessment from the facilitator, but no parenting intervention was provided. Mothers and infants were assessed at four time points (i.e., Pre, Interim, Post, 3-month Follow-up), and the timing of intervention, as well as assessment administration and scoring, was conducted using corrections for infants’ gestational age. Growth curve modeling was used to examine change in maternal responsive behaviors and infant skills. The experimental study cohort included 264 mother–infant pairs from lower–middle to low SES backgrounds, whose study participation occurred when the infant was about 6–10 months of age. The VLBW infants were divided into two groups: LR, based on the presence of acute respiratory disorders and/or mild IVH, and HR, based on the presence of chronic respiratory disorders and/or more severe grades of IVH without hydrocephalus (e.g., Landry et al., 2001). A group of healthy full-term infants were recruited to match the demographics of those born VLBW. Families who spoke either English or Spanish were recruited as the study could be implemented in either language. Further information regarding the sample and procedures can be found in Landry, Smith, and Swank (2006).
8.1. Effects of PALS on maternal behaviors Positive improvement in mothers’ skills was found across a range of targeted behaviors in favor of mothers in the PALS as compared to DAS condition. Many effects were found for parents irrespective of the type of infant they
Responsive Parenting
47
were parenting. For example, following intervention, mothers in the PALS condition responded to children’s signals and learning needs in ways that were prompt, contingent, and appropriate more often than those in the DAS condition. PALS mothers also maintained their infants’ attention more, redirected less, and stimulated their children’s language development more through verbal scaffolding, labeling of objects and actions, and verbal encouragement. PALS mothers across all risk groups also showed more positive changes in warm sensitivity and voice tone compared with DAS mothers. Several findings were specific to the mothers of children born VLBW. For example, PALS mothers of LR VLBW infants showed higher levels and greater increases in positive affect than did DAS mothers of similar infants. PALS mothers of infants born HR VLBW used significantly lower levels of restrictive behaviors, and showed slower increases in these behaviors over time than did DAS mothers of VLBW infants.
8.2. Effects of PALS on infant skills Infants whose mothers received PALS demonstrated significantly greater increases in their use of words and showed lower levels of negative affect while playing with toys, particularly for those born HR VLBW. A trend for higher levels and greater increases in infant cooperation with maternal requests also was found if their mothers were in PALS versus DAS. Evidence of the ability to internalize the skills developed when interacting with their mothers was found in the target infants’ greater ability to use toys in goal-directed, functional, and more complex ways when playing alone. There was some evidence that the changes the target infants displayed with their mothers generalized to interactions with a novel adult. For example, infants whose mothers had received PALS, as compared to DAS, showed a greater increase in the use of words during interactions with the examiner, and those born LR VLBW were more cooperative with the examiner.
8.3. The influence of aspects of responsiveness on domains of infant development To address the question of whether different aspects of responsiveness were important in understanding the intervention effect on different skill domains, we first examined whether there was empirical support for considering different aspects within a broader construct of responsiveness. Such support was found through the identification of underlying factors that related to four types of responsiveness behaviors. These were stable over time and, in general, across contexts. The four factors were: (1) contingent responsiveness/lack of negative emotionality, (2) positive emotional
48
Susan H. Landry et al.
support, (3) responses to infant foci of attention, and (4) quality of language input. This empirical support is complementary to theoretical descriptions of these behaviors. Results from mediation models demonstrated that the different aspects of responsive behaviors, supported by the factor analyses, showed significant relations with cognitive and emotional skills, and that change in these maternal behaviors mediated the intervention effect on two infant outcomes: cooperation and use of words. This suggested that in order to optimize infant cooperation, mothers needed to show responsive behaviors that cut across theoretical frameworks and provided different types of support. This finding was applicable to children in all risk groups.
8.4. Evidence for individual profiles of parenting Further examination of the data from the PALS study (Guttentag et al., 2006) revealed that mothers could be grouped into four classes, or profile groups, that demonstrated distinct patterns of parenting skills prior to intervention. The four groups included mothers who demonstrated: (1) relatively low levels of warmth, responsiveness to signals, rich language input, and maintaining infant’s attentional focus; (2) moderate levels of each of these behaviors; (3) relatively high levels of each of these behaviors; and (4) a mixed style consisting of relatively high rich language input and maintaining, but low levels of warmth and responsiveness to infant signals. The emergence of this mixed profile group provided additional support for proposals that a responsive parenting style is comprised of distinct components that parents may possess to a greater or lesser degree, rather than only as a whole on a continuum. While no infant characteristics, including biological risk status, predicted the preintervention profile group membership, parenting beliefs did. Mothers with more child-centered parenting beliefs were significantly more likely to be in the relatively higher profile group than in the lower or mixed group. Following intervention, mothers who had been randomly assigned to the PALS intervention, regardless of initial profile group status and infant risk status, were more likely than comparison mothers to transition from weaker to stronger profile groups. Social support was the only significant predictor of positive change among intervention mothers. That is, mothers who perceived the availability of more social support were significantly more likely to retain their initial responsive parenting skills, and to increase, rather than decrease, their responsive behaviors over the course of the intervention. Thus, parenting beliefs and social support, both potentially modifiable maternal characteristics, appear to be important components to address when attempting to enhance and sustain mothers’ responsive parenting practices.
Responsive Parenting
49
8.5. The optimal timing for responsive parenting intervention Families who participated in PALS during infancy were re-randomized into either the Playing and Learning Strategies II or a Developmental Assessment condition (DAS II) when their children were, on average, 26 months of age (term, n ¼ 80; VLBW, n ¼ 86). This resulted in four study groups that allowed for the examination of whether a second toddler phase of intervention was needed to support mothers’ use of responsive behavior into the next developmental period; PALS I/DAS II, n ¼ 33; PALS I/PALS II, n ¼ 34; DAS I/PALS II, n ¼ 50; DAS I/DAS II, n ¼ 49. Intervention influences were found for all aspects of maternal responsiveness and child outcomes. However, the most optimal timing of the intervention was dependent on the type of support the maternal behavior provided to a child and the child’s biological risk status. Responsiveness behaviors best facilitated by PALS I included those that provided warmth and nurturance, whether or not mothers also received intervention during the toddler period. Warmth is described in the attachment framework as critically important across the first year of life for establishing a secure and trusting relationship between a mother and her infant (e.g., Ainsworth et al., 1978). Our results suggest that there is a unique salience about the early developmental period for intervention to support mothers’ expressions of warmth that will extend beyond the first year of life. In contrast, responsiveness behaviors that provided rich verbal input were best supported by PALS II even if mothers did not receive PALS I. Maternal responsiveness behaviors that were more complex because they required the mother to adopt and respond to the child’s changing developmental needs (e.g., contingent responsiveness, maintaining) required both phases of PALS for optimal results. Although the timing of intervention effects was found irrespective of children’s biological risk, several effects were especially salient for mothers of infants born at VLBW. For example, while PALS I resulted in lasting effects on mothers’ warmth across risk groups through the toddler period, those parenting children born HR, VLBW showed an added benefit if they also received PALS II. Higher levels of warmth have a stronger relation with more positive growth in cognitive and social skills for these children than for those born at term (e.g., Landry et al., 2001). An advantage for a later ‘‘dose’’ of PALS for mothers of HR, VLBW infants may be due to the mothers’ need for further facilitation of their efforts to respond in warm sensitive ways at a time when their toddlers are known to show considerable variability in organizing behavior and engaging in interactions with their caregivers (e.g., Landry, 1995). A second example of differential effects for children born at VLBW was the intervention’s effect on maternal expression of positive affect, another responsiveness behavior described in the attachment framework as critically important during the first year of life. For
50
Susan H. Landry et al.
mothers parenting children born at VLBW, positive affect was best facilitated by PALS if it occurred at least during the early period, and this influence was not seen for mothers of term children. One focus of PALS I was to help mothers appreciate and receive pleasure in their infants’ efforts. This focus seems to be particularly helpful for those parenting VLBW children, given their children’s greater vulnerability in learning new behaviors, and, perhaps, greater maternal concern regarding development. Facilitating mothers in this early period to notice and take pleasure in their infants’ attempts to interact, appears to promote a greater bond and acceptance of their children’s behavior in spite of their children’s risk status.
9. Summary and Conclusions, Implications and Future Directions 9.1. Summary and conclusions This chapter has described a body of research that demonstrates a common set of deficits across three groups of children at risk for later learning problems, and the importance of responsive parenting for supporting their development. We have reviewed evidence that children with different diagnoses (i.e., children with DS, SB, and those born preterm at VLBW) show early developmental vulnerability in several interrelated areas which impact their ability to learn and grow. These areas include motor control, attention regulation, and goal-directed behavior. Together, these foundational skills help children to take in information from the environment, organize and execute behavioral responses, and thus learn and build more complex skills through active engagement with objects and people. When disabilities or developmental delays hamper children’s abilities in these areas, they are at increased risk for continuing learning problems. They are also more vulnerable and may be more reliant than typically developing children on the support and scaffolding they receive through sensitive, responsive parenting. Responsiveness has been defined in our research as a group of distinct but related caregiving behaviors that cross theoretical frameworks and have potential to provide specialized support for at-risk children to be able to learn from interactions. This support can be viewed as comprising two major areas: affective/emotional support and cognitive support. In order to optimally enhance at-risk children’s development, both types of support should be provided during the early developmental years. Research has shown that providing one or the other (e.g., warmth without cognitive support, or rich language input without emotional sensitivity) is not sufficient. A variety of behaviors under the rubric of responsive parenting, encompassing both the major areas of support (e.g., maintaining children’s
Responsive Parenting
51
focus of attention, contingent responsiveness, rich language stimulation), may be able to buffer the effects of specific early core deficits so that they are less likely to interfere with the at-risk child’s learning. We have illustrated through a program of research with cross-sectional studies how different aspects of responsiveness support the development of all three groups of children in similar ways. An exception may be maternal directiveness, where there is evidence that some children show greater compliance with requests (though not necessarily stronger cognitive skills) when provided with higher levels of this form of support for longer periods of time. The essence of a responsive parenting style is paying close attention to the child’s communicative signals and responding promptly with supportive behaviors that are linked to the child’s signals. Thus, regardless of the child’s diagnosis, responsive parenting practices may support the individual child’s development by providing support where the child shows a need (e.g., encouragement to continue attending to an object of interest, assistance with visually guided reaching, hand-over hand assistance with goal-directed play actions, etc.). This high level of attunement and matching responses to the child’s needs has been shown to be particularly important for children born preterm, who may be more easily overwhelmed by too much stimulation, less adept at providing clear signals to the parent, and/or slower to organize a coordinated behavioral response than full-term, nondisabled children. Rich language input also has been shown to be a strong predictor of children’s later verbal and nonverbal reasoning abilities, and the relationship between maternal language stimulation and children’s later reading skills development was found to be even stronger for children at risk with low cognitive ability. Typically developing children appeared to benefit from responsive parenting practices as well, but they show greater resiliency in the face of suboptimal parenting and more stable developmental trajectories over time than at-risk children. Evidence has been presented that supports the above conceptualization by demonstrating, for example, that when parents of VLBW infants provide support for their focus of attention, their infants show higher levels of play behavior than when parents make requests that require their infants to shift their attention. By matching specific supportive behaviors to their infants’ needs, parents can positively impact VLBW children’s ability to focus and learn. Thus, parents can alter their children’s developmental trajectory in the positive direction, even amidst the challenges of poverty and their child’s medical vulnerabilities. These findings provide further support for recent evidence from basic science research highlighting the importance of the environment during the early years for brain development. Most promising are recent findings that a responsive parenting style can be taught to parents who may not previously have possessed these skills, that these skills and the positive impact on the child can be achieved in a relatively brief time frame, and that there may be optimal developmental
52
Susan H. Landry et al.
time windows for focusing on specific aspects of the responsive parenting style for maximum benefit. For example, during the first year of life it appears to be most critical for parents to become emotionally attuned to their VLBW infants, establishing a foundation of warmth, positive affect, and lack of unnecessary restrictiveness. During toddlerhood, the focus of responsive parenting must include provision of rich language stimulation (e.g., labeling objects and actions, describing and connecting objects to their functions) in order to best support VLBW children’s cognitive and language development. Contingent responsiveness needs to be provided consistently across infancy and toddlerhood to support optimal outcomes. This chapter also highlights the benefits of using longitudinal data to evaluate the influence of parenting behaviors on child development. There are numerous advantages of longitudinal studies over cross-sectional studies. Cross-sectional snapshots may provide a misleading picture of the impact of parenting on child development. For example, differences in outcomes may reflect factors already existing pre-onset and they do not allow researchers to learn how the parent–child relationship develops over time. In contrast, longitudinal studies can evaluate the development of parent– child relationships over time, as these are fundamentally longitudinal in nature. Researchers can model both the cross-sectional and time series trends as well as conduct cross-lag and/or growth curve analyses. Crosslag analyses are particularly helpful to respond to questions of directionality in this research (e.g., is impact from parent to child, or child to parent?). In this way, researchers can evaluate change and consider time precedents. It is important to note, however, that correlational studies do not demonstrate causality; experimental designs are required for this purpose.
9.2. Implications and future directions One important implication of the reviewed literature is that it is profitable to look at commonalities in children’s developmental issues and areas of vulnerability across different diagnostic categories. We have shown how children with diagnoses as diverse as SB, DS, and prematurity/VLBW show weaknesses in some similar areas, and that responsive parenting behaviors have been correlated with positive developmental outcomes within each of these populations. Often, bodies of research literature focus on the development of children with specific disorders, with little attention to commonalities and underlying developmental processes across these diagnostic groups. The fact that we do see similarities in early learning problems and the potential for responsiveness to parent-focused intervention across several types of at-risk populations of children suggests a level of robustness and generalizability of the conceptual framework of responsive parenting. However, to truly make this generalization, it is necessary to
Responsive Parenting
53
evaluate responsive parenting interventions using samples from additional diverse risk groups and random assignment to treatment conditions. There are several implications for future directions for this line of research. Continuing to investigate similarities and differences in the impact of specific parenting behaviors on children from different developmental risk groups (i.e., different medical or genetic disorders) will contribute to the literature on those disorders as well as to the responsive parenting literature. In addition, examining the impact of timing of intervention within different groups of at-risk children would allow comparison to the findings for children born at VLBW, leading to further understanding of these results. Establishing collaborations with clinicians who provide Early Childhood Intervention services to young children with disabilities may be beneficial in several ways. For example, these professionals have expertise in supportive environmental modifications that may enhance children’s ability to respond to parents’ efforts, such as adjustments in physical positioning to support upper body control, or specific techniques for working with children with visual or hearing impairments. Another example of the benefits of collaboration with ECI professionals is the potential for blending training in responsive parenting practices with the kinds of targeted skills development work that these clinicians typically provide. Such an approach may lead to greater willingness in parents to take a more active role in their child’s ECI activities. Carefully developed, randomized control designs are needed to investigate these issues. The role of social support for parents of at-risk children also needs further attention. Raising a child with special needs adds a level of complexity and stress to the typical challenges of parenting, which may be exacerbated or ameliorated by the quality of the parents’ social support system. Understanding the conditions under which support networks function most effectively, and exploring ways to build or enhance such networks for more isolated or discordant families may add a valuable component to the intervention research. We have begun to investigate these ideas by showing that providing community mentors to supplement a responsive parenting intervention with social support had a positive impact, over and above the parenting curriculum, on low-income mothers and their young children. We also showed in a separate study that among mothers receiving a responsive parenting intervention, social support predicted positive change in parenting behaviors. This area is important to continue to pursue, since families’ social networks can serve as an ongoing source of support and resources beyond the time-limited period of a parenting intervention. As we move forward toward establishing empirically supported approaches to optimizing the development of children at risk for later learning problems, it is important to recognize the critical role of responsive caregiving practices. By using a general set of responsive interaction skills, parents can address core areas of weakness in children with diverse
54
Susan H. Landry et al.
developmental profiles and diagnoses. In this way, a consistently responsive environment can begin to close the learning gap and help these children reach their potential as they grow.
ACKNOWLEDGMENTS This study was supported, in part, by NIH grants HD36099, HD25128, and HD046609.
REFERENCES Adirim, T., & Fine, K. M. (2002). Exercise, sports, and recreation. In M. L. Batshaw (Ed.), Children with disabilities (5th ed., pp. 659–668). Washington, D.C.: Paul H. Brookes Publishing Co. Ainsworth, M., Blehar, M., Waters, E., & Wall, S. (1978). Patterns of attachment: A psychological study of the strange situation. Hillsdale, NJ: Erlbaum. Akhtar, N., Dunham, F., & Dunham, P. J. (1991). Directive interactions and early vocabulary development: The role of joint attentional focus. Journal of Child Language, 18, 41–49. Als, H., Lester, B. M., & Brazelton, T. B. (1979). Dynamics of the behavioral organization of the premature infant: A theoretical perspective. In T. Field, A. M. Sostek, S. Goldberg, & H. H. Shuman (Eds.), Infants born at risk: Behavior and development (pp. 173–192). New York: SP Medical & Scientific Books. Anderson, A., Swank, P. R., Wildin, S., Landry, S. H., & Smith, K. E. (1999). Modeling analysis of change in neurologic abnormalities in children born prematurely: A novel approach. Journal of Child Neurology, 14, 502–508. Anderson, P. J., Doyle, L. W., & Victorian Infant Collaborative Study Group (2004). Executive functioning in school-aged children who were born very preterm or with extremely low birth weight in the 1990s. Pediatrics, 114, 50–57. Assel, M. A., Landry, S. H., Swank, P. R., Steelman, L. M., & Smith, K. E. (2002). How do mothers’ childrearing histories, stress, and parenting affect children’s behavioral outcomes? Child Care, Health, and Development, 28, 359–368. Barnes, M. A., & Dennis, M. (2004). Reading and writing skills in young adults with spina bifida and hydrocephalus. Journal of the International Neuropsychological Society, 10, 655–663. Barnes, M. A., Wilkinson, M., Boudousquie, A., Khemani, E., Dennis, M., & Fletcher, J. M. (2006). Arithmetic processing in children with spina bifida: Calculation accuracy, strategy use, and fact retrieval fluency. Journal of Learning Disabilities, 39, 174–187. Baumrind, D. (1989). Rearing competent children. In W. Damon (Ed.), Child development today and tomorrow (pp. 349–378). San Francisco: Jossy-Bass. Bee, H. L., Barnard, K. E., Eyres, S. J., Gray, C. A., Hammond, M. A., Spietz, A. L., et al. (1982). Prediction of IQ and language skill from perinatal status, child performance, family, characteristics, and mother–infant interaction. Child Development, 53, 1134–1156. Bell, R. C. (1988). Contributions of human infants to caregiving and social interaction. In G. Handel (Ed.), Childhood socialization (pp. 103–122). Hawthorne, NY: Aldine de Gruyter. Belsky, J., Hertzog, C., & Rovine, M. (1986). Causal analyses of multiple determinants of parenting: Empirical and methodological advances. In M. Lamb, A. Brown, & B. Rugoff (Eds.), Advances in Developmental Psychology (pp. 153–200). Hillsdale, N.J.: Lawrence Erlbaum Associates.
Responsive Parenting
55
Block, J. H., & Block, J. (1979). The role of ego-control and ego-resiliency in the organization of behavior. In W. A. Collins (Ed.), Minnesota symposia on child psychology Hillsdale, NJ: Lawrence Erlbaum Associates Inc. Bornstein, M. H. (1985). How infant and mother jointly contribute to developing cognitive competence in the child. Proceedings of the National Academy of Sciences of the United States of America, 82, 7470–7473. Bornstein, M. H., & Tamis-Lemonda, C. S. (1989). Maternal responsiveness and cognitive development in children. In M. H. Bornstein (Ed.), Maternal responsiveness: Characteristics and consequences (pp. 49–61). San Francisco: JosseyBass. Bradley, R. H., Caldwell, B. M., & Rock, S. (1988). Home environment and school performance: A ten year followup and examination of three models of environmental action. Child Development, 59, 852–867. Braungart-Rieker, J., Garwood, M. M., & Stifter, C. A. (1997). Compliance and noncompliance: The roles of maternal control and child temperament. Journal of Applied Developmental Psychology, 18, 411–428. Brewer, V. B., Fletcher, J. M., Hiscock, M., & Davidson, K. C. (2001). Attention processes in children with shunted hydrocephalus versus attention deficit-hyperactivity disorder. Neuropsychology, 15, 185–198. Bushnell, E. W., & Boudreau, J. P. (1993). Motor development and the mind: The potential role of motor abilities as a determinant of aspects of perceptual development. Child Development, 64, 1005–1021. Colletta, N. D., & Gregg, C. H. (1981). Adolescent mothers’ vulnerability to stress. The Journal of Nervous and Mental Disease, 169, 50–54. Crnic, K., Greenberg, M., Ragozin, A., Robinson, N., & Basham, R. (1983). Effects of stress and social support on mothers and premature and full-term infants. Child Development, 54, 209–217. Crockenberg, S. B. (1981). Infant irritability, mother responsiveness, and social support influences on the security of infant–mother attachment. Child Development, 52, 857–865. Darling, N., & Steinberg, L. (1993). Parenting style as context: An integrative model. Psychological Bulletin, 113, 487–496. Dawson, G., Klinger, L. F., Panagiotides, H., Hill, D., & Spieker, S. (1992). Frontal lobe activity and affective behavior of infants of mothers with depressive symptoms. Child Development, 63, 725–737. Dennis, M., & Barnes, M. A. (2002). Numeracy skills in adults with spina bifida. Developmental Neuropsychology, 21, 141–156. Dennis, M., Edelstein, K., Hetherington, R., Copeland, K., Frederick, J., Blaser, S. E., et al. (2004). Neurobiology of perceptual and motor timing in children with spina bifida in relation to cerebellar volume. Brain, 127, 1292–1301. Dennis, M., Fletcher, J. M., Rogers, T., Hetherington, R., & Francis, D. J. (2002). Objectbased and action-based visual perception in children with spina bifida and hydrocephalus. Journal of International Neuropsychological Society, 8, 95–106. Dennis, M., Landry, S. H., Barnes, M., & Fletcher, J. M. (2006). A model of neurocognitive function in spina bifida over the lifespan. Journal of International Neuropsychological Society, 12, 285–296. Desmond, M. M., Wilson, G. S., Alt, E. J., & Fisher, E. S. (1980). The very low birth weight infant after discharge from intensive care: Anticipatory health care and developmental course. Current Problems in Pediatrics, 10, 1–59. Dieterich, S. E., Assel, M. A., Swank, P. R., Smith, K. E., & Landry, S. H. (2006). The impact of early maternal verbal scaffolding and child language abilities on later decoding and reading comprehension skills. Journal of School Psychology, 43, 481–494. Dieterich, S. E., Landry, S. H., Smith, K. E., Swank, P. R., & Hebert, H. M. (2006). Impact of community mentors on maternal behaviors and child outcomes. Journal of Early Intervention, 28, 111–124.
56
Susan H. Landry et al.
DiPietro, J. A. (2000). Baby and the brain: Advances in child development. Annual Review Public Health, 21, 455–471. Drillien, C. M. (1964). The growth and development of the prematurely born infant. Edinburgh, Scotland: E. & S. Livingstone, Ltd. Elman, J. L., Bates, E. A., Johnson, M. H., Karmiloff-Smith, A., Parisi, D., & Plunkett, K. (1996). Rethinking innateness. Boston: MIT Press. Feiring, C., Fox, N. A., Jaskir, J., & Lewis, M. (1987). The relation between social support, infant risk status and mother–infant interaction. Developmental Psychology, 23, 400–405. Field, T. (1987). The affective self: Continuities and transformation from infancy. In J. Call, & E. Galenson (Eds.), Frontiers of infant psychology (pp. 38–54). Baltimore: University Park. Freund, L. S. (1990). Maternal regulation of children’s problem-solving behavior and its impact on children’s performance. Child Development, 61, 113–126. Gallagher, J. J., Cross, A., & Scharfman, W. (1981). Parental adaptation to a young handicapped child: The father’s role. Journal of the Division for Early Childhood, 3, 3–14. Gilmore, L., Cuskelly, M., & Hayes, A. (2003). Self-regulatory behaviors in children with Down syndrome and typically developing children measured using the Goodman Lock Box. Research in Developmental Disabilities, 24, 95–108. Goldberg, S. (1978). Prematurity: Effects on parent–infant interaction. Journal of Pediatric Psychology, 3, 137–144. Goldberg, S., & Marcovitch, S. (1989). Temperament in developmentally disabled children. In G. A. Kohnstamm, J. E. Bates, & M. K. Rothbart (Eds.), Temperament in childhood (pp. 387–403). Chichester, UK: John Wiley and Sons. Goldson, E. (1983). Bronchopulmonary dysplasia: Its relation to two-year developmental functioning in very low birth weight infants. In T. Field, & A. M. Sostek (Eds.), Infants born at risk: Physiological, perceptual, and cognitive processes (pp. 243–250). New York: Grune & Stratton. Grusec, J. E., & Kuczynski, L. (1980). Direction of effect in socialization: A comparison of the parent’s versus the child’s behavior as determinants of disciplinary techniques. Developmental Psychology, 16, 1–9. Guttentag, C., Pedrosa-Josic, C., Landry, S. H., Smith, K. E., & Swank, P. R. (2006). Individual variability in parenting profiles and predictors of change: Effects of an intervention with disadvantaged mothers. Journal of Applied Developmental Psychology, 27, 349–369. Hammond, M. V., Landry, S. H., Swank, P. R., & Smith, K. E. (2000). Relation of mothers’ affective developmental history and parenting behavior: Effects on infant medical risk. American Journal of Orthopsychiatry, 710, 95–103. Harvey, J., O’Callaghan, M., & Mohay, H. (1999). Executive function of children with extremely low birth weight: A case control study. Developmental Medicine and Child Neurology, 41, 292–297. Hess, R. D., & Shipman, V. C. (1965). Early experience and the socialization of cognitive modes in children. Child Development, 36, 869–886. Kaplan, B., Wilson, B. N., Dewey, D., & Crawford, S. G. (1998). DCD may not be a discrete disorder. Human Movement Science, 17, 471–490. Kasari, C., Freeman, S., Mundy, P., & Sigman, M. (1995). Attention regulation by children with Down syndrome: Coordinated joint attention and social referencing looks. American Journal of Mental Retardation, 100, 128–136. Kogan, K. L. (1980). Interaction systems between preschool handicapped or developmentally delayed children and their parents. In T. Field, S. Goldberg, D. Stern, & A. M. Sostek (Eds.), High-risk infants and children: Adult and peer interactions (pp. 227–247). New York: Academic Press Inc. Kopp, C. B. (1982). Antecedents of self-regulation: A developmental perspective. Developmental Psychology, 18, 199–214.
Responsive Parenting
57
Kopp, C. B. (1990). The growth of self-monitoring among young children with Down syndrome. In D. Cicchetti, & M. Beeghly (Eds.), Children with down syndrome: A developmental perspective (pp. 231–251). Cambridge, England: Cambridge University Press. Krakow, J. B., & Kopp, C. B. (1983). The effects of developmental delay on sustained attention in young children. Child Development, 54, 1143–1155. Landry, S. H. (1995). The development of joint attention in premature low birth weight infants: Effects of early medical complications and maternal attention-directing behaviors. In C. Moore, & P. J. Dunham (Eds.), Joint attention: Its origins and role in development (pp. 223–250). Hillsdale, New Jersey: Lawrence Erlbaum Associates. Landry, S. H., & Chapieski, M. L. (1989). Joint attention and infant toy exploration: Effects of Down syndrome and prematurity. Child Development, 60, 103–118. Landry, S. H., & Chapieski, M. L. (1990). Joint attention of six-month-old Down syndrome and preterm infants: I. attention to toys and mother. American Journal on Mental Retardation, 94, 488–498. Landry, S. H., Chapieski, M. L., Richardson, M., Palmer, J., & Hall, S. (1990). The social competence of children born prematurely: Effects of medical complications and parent behaviors. Child Development, 61, 1605–1616. Landry, S. H., Fletcher, J. M., Denson, S. E., & Chapieski, M. L. (1993). Longitudinal outcome for low birth weight infants: Effects of intraventricular hemorrhage and bronchopulmonary dysplasia. Journal of Clinical and Experimental Neuropsychology, 15, 205–218. Landry, S. H., Fletcher, J. M., Zarling, C. L., Chapieski, L., Francis, D. J., & Denson, S. E. (1984). Differential outcomes associated with early medical complications in premature infants. Journal of Pediatric Psychology, 9, 384–401. Landry, S. H., Garner, P. W., Denson, S., Swank, P. R., & Baldwin, C. (1993). Low birth weight (LBW) infants’ exploratory behavior at 12 and 24 months: Effects of intraventricular hemorrhage and mothers’ attention directing behaviors. Research in Developmental Disabilities, 14, 237–249. Landry, S. H., Garner, P. W., Pirie, D., & Swank, P. R. (1994a). Effects of social context and mothers’ requesting strategies on Down’s syndrome children’s social responsiveness. Developmental Psychology, 30, 293–302. Landry, S. H., Garner, P. W., Swank, P. R., & Baldwin, C. D. (1996). Effects of maternal scaffolding during joint toy play with preterm and full-term infants. Merrill-Palmer Quarterly, 42, 177–199. Landry, S. H., Jordan, T., & Fletcher, J. M. (1994b). Developmental outcome in children with spina bifida. In M. G. Tramontana, & S. R. Hooper (Eds.), Advances in child neuropsychology (pp. 86–118). New York: Springer-Verlag. Landry, S. H., Leslie, N. A., Fletcher, J. M., & Francis, D. J. (1985). Visual attention skills of premature infants with and without intraventricular hemorrhage. Infant Behavior & Development, 8, 309–322. Landry, S. H., Miller-Loncar, C. L., Smith, K. E., & Swank, P. R. (2002). The role of early parenting in children’s development of executive processes. Developmental Neuropsychology, 21, 15–41. Landry, S. H., Robinson, S. S., Copeland, D., & Garner, P. W. (1993). Goal-directed behavior and perception of self-competence in children with spina bifida. Journal of Pediatric Psychology, 18, 389–396. Landry, S. H., Schmidt, M., & Richardson, M. (1989). The effects of intraventricular hemorrhage on functional communication skills in preterm toddlers. Journal of Developmental and Behavioral Pediatrics, 10, 299–306. Landry, S. H., Smith, K. E., Miller-Loncar, C. L., & Swank, P. R. (1997). Predicting cognitive-linguistic and social growth curves from early maternal behaviors in children at varying degrees of biological risk. Developmental Psychology, 33, 1–14.
58
Susan H. Landry et al.
Landry, S. H., Smith, K. E., & Swank, P. R. (2006). Responsive parenting: Establishing early foundations for social, communication, and independent problem-solving skills. Developmental Psychology, 42, 627–642. Landry, S. H., Smith, K. E., Swank, P. R., Assel, M. A., & Vellet, S. (2001). Does early responsive parenting have a special importance for children’s development or is consistency across early childhood necessary. Developmental Psychology, 37, 387–403. Landry, S. H., Smith, K. E., Swank, P. R., & Miller-Loncar, C. L. (2000). Early maternal and child influences on children’s later independent cognitive and social functioning. Child Development, 71, 358–375. Liptak, G. S. (2002). Neural tube defects. In M. L. Batshaw (Ed.), Children with disabilities (5th ed., pp. 467–492). Washington, D.C.: Paul H. Brookes Publishing Co. Lomax-Bream, L., Barnes, M., Copeland, K., Taylor, H. B., & Landry, S. H. (2007a). The impact of spina bifida on development across the first three years. Developmental Neuropsychology, 31, 1–20. Lomax-Bream, L., Taylor, H. B., Landry, S. H., Barnes, M., Fletcher, J. M., & Swank, P. (2007b). Role of early parenting and motor skills on development in children with spina bifida. Journal of Applied Developmental Psychology, 28(3), 250–263. Londerville, S., & Main, M. (1981). Security of attachment, compliance, and maternal training methods in the second year of life. Developmental Psychology, 17, 289–299. Luciana, M., Lindeke, L., Mills, N., & Nelson, C. (1999). Neurobehavioral evidence for working memory deficits in school-aged children with histories of prematurity. Developmental Medicine and Child Neurology, 1999, 521–533. Lytton, H. (1977). Correlates of compliance and the rudiments of conscience in twoyear-old boys. Canadian Journal of Behavioral Science, 9, 242–251. Maccoby, E. E., & Martin, J. A. (1983). Socialization in the context of the family: Parent–child interactions. In P. H. Mussen, & E. M. Hetherington (Volume Editor) (Eds.), Handbook of child psychology: Vol. 4. Socialization, personality, and social development (4th, ed., pp. 1–101). New York: Wiley. Mahoney, G., Perales, F., Wiggers, B., & Herman, B. (2006). Responsive teaching: Early intervention for children with Down syndrome and other disabilities. Down Syndrome Research & Practice, 11, 18–28. Marfo, K. (1992). Correlates of maternal directiveness with children who are developmentally disabled. American Journal of Orthopsychiatry, 62, 219–233. Martin, J. (1989). Personal and interpersonal components of responsiveness. In M. H. Bornstein (Ed.), Maternal responsiveness: Characteristics and consequences (pp. 5–14). San Francisco: Jossey-Bass. Mazur, J. M., Stillwell, A., & Menelaus, M. (1986). The significance of spasticity in the upper and lower limbs in myelomeningocele. Journal of Bone and Joint Surgery—British Volume, 68-B, 213–217. McCormick, M. C., McCarton, C., Tonascia, J., & Brooks-Gunn, J. (1993). Early educational intervention for very low birth weight infants: Results from the Infant Health and Development Program. Journal of Pediatrics, 123, 527–533. Melyn, M. A., & White, D. T. (1973). Mental and developmental milestones of noninstitutionalized Down’s syndrome children. Pediatrics, 53, 542–545. Mischel, W., & Patterson, C. J. (1979). Effective plans for self-control in children. In W. A. Collins (Ed.), Minnesota symposia on child psychology (pp. 199–230). Hillsdale, NJ: Lawrence Erlbaum Associates Inc. Neville, H. J., Bavelier, D., Corina, D., Rauschecker, J., Karni, A., Lalwani, A., et al. (1998). Cerebral organization for language in deaf and hearing subjects: Biological constraints and effects of experience. Proceedings of the National Academy of Science, 95, 922–929. Olson, S. L., Bates, J. E., & Bayles, K. (1984). Mother–infant interaction and the development of individual differences in children’s cognitive competence. Developmental Psychology, 20, 166–179.
Responsive Parenting
59
Paneth, N. (1993). The causes of cerebral palsy. Recent evidence. Clinics in Investigative Medicine, 16, 95–102. Papile, L., Munsick-Bruno, G., & Schaefer, A. (1983). Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. Journal of Pediatrics, 103, 273–277. Parpal, M., & Maccoby, E. E. (1985). Maternal responsiveness and subsequent child compliance. Child Development, 56, 1326–1334. Piaget, J. (1952). The origins of intelligence in children. New York: International Universities Press. Pinto-Martin, J. A., Whitaker, A. H., Feldman, J. F., Van Rossem, R., & Paneth, N. (2000). Relation of cranial ultrasound abnormalities in low-birth weight infants to motor or cognitive performance at ages 2, 6, and 9 years. Developmental Medicine and Child Neurology, 41, 826–833. Ramirez, S. Z., & Morgan, V. (1998). Down syndrome. In L. Phelps (Ed.), Health-related disorders in children and adolescents: A guidebook for understanding and educating (pp. 254–265). Washington, DC: American Psychological Association. Risley, T. R., & Hart, B. (2006). Promoting early language development. In N. F. Wyatt, C. Ayoub, R. H. Bradley, J. E. Puma, & W. A. LeBoeuf (Eds.), The crisis in youth mental health: Critical issues and effective programs (pp. 83–88). Westport, CT: Praeger Perspectives/Greenwood Publishing Group. Roberts, J. E., Price, J., & Malkin, C. (2007). Language and communication development in Down syndrome. Mental Retardation and Developmental Disabilities Research Reviews, 13, 26–35. Rogoff, B. (1990). Apprenticeship in thinking. New York, NY: Oxford University Press. Ruff, H. A., & Lawson, K. R. (1991). Assessment of infants attention during play with objects. In C. E. Schaefer, K. Critlin, & A. Sandgrund (Eds.), Play diagnosis and assessment (pp. 115–129). New York: Wiley. Ruiz, M. D. P., LeFever, J. A., Hakanson, D. O., Clark, D. A., & Williams, M. L. (1981). Early development of infants of birth weight less than 1,000 grams with reference to mechanical ventilation in the newborn period. Pediatrics, 68, 330–335. Schothorst, P. F., & van Engeland, H. (1996). Long-term behavioral sequelae of prematurity. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 175–183. Sinha, S. K., D’Souza, S. W., Rivlin, E., & Chiswick, M. L. (1990). Ischaemic brain lesions diagnosed at birth in preterm infants: Clinical events and developmental outcome. Archives of Disease in Childhood, 65, 1017–1020. Skidmore, M. D., Rivers, A., & Hack, M. (1990). Increased risk of cerebral palsy among very low-birth weight infants with chronic lung disease. Developmental Medicine and Child Neurology, 32, 325–332. Smith, K. E., Landry, S. H., & Swank, P. R. (2000). Does the content of mothers’ verbal stimulation explain differences in children’s development of verbal and nonverbal cognitive skills. Journal of School Psychology, 38, 27–49. Sroufe, L. A. (1983). Infant-caregiver attachment patterns of adaption in preschool: The roots of maladaption and competence. In M. Perlmutter (Ed.), Minnesota symposium on child psychology (pp. 41–81). Hillsdale, NJ: Erlbaum. Steelman, L. M., Assel, M. A., Swank, P. R., Smith, K. E., & Landry, S. H. (2002). Early maternal warm responsiveness as a predictor of child social skills: Direct and indirect paths of influence over time. Journal of Applied Developmental Psychology, 23, 135–156. Tannock, R. (1988). Mothers’ directiveness in their interactions with their children with and without Down syndrome. American Journal of Mental Retardation, 93, 154–165. Taylor, H. B., Landry, S. H., Cohen, L., Barnes, M., & Swank, P. (2006). Early information processing among infants with spina bifida. Presented at the 34th annual meeting of International Neuropsychological Society in Boston, MA.
60
Susan H. Landry et al.
Taylor, H. G., Hack, M., & Klein, N. (1998). Attention deficits in children with <750 gm birth weight. Child Neuropsychology, 4, 21–34. Taylor, H. G., Hack, M., Klein, N., & Schatschneider, C. (1995). Achievement in children with birth weights less than 750 grams with normal cognitive abilities: Evidence for specific learning disabilities. Journal of Pediatric Psychology, 20, 703–719. Thelen, E., & Smith, L. B. (1995). A dynamic systems approach to the development of cognition and action. Cambridge, MA: MIT press. Tomasello, M., & Farrar, J. M. (1986). Joint attention and early language. Child Development, 57, 1454–1463. Van Egeren, L. A., Barratt, M. S., & Roach, M. A. (2001). Mother–infant responsiveness: Timing, mutual regulation, and interactional context. Developmental Psychology, 37, 684–697. Vietze, P. M., McCarthy, M., McQuiston, S., MacTurk, R., & Yarrow, L. J. (1983). Attention and exploratory behaviors in infants with down syndrome. In T. Field, & A. Sostek (Eds.), Infants born at risk: Perceptual and physical processes (pp. 251–268). New York: Grune & Stratton. Vohr, B., Bell, E. F., & Williamson, O. H. (1982). Infants with broncho-pulmonary dysplasia. American Journal of Diseases in Childhood, 136, 443–447. Vohr, B. R., Coll, C. G., Lobato, D., Yunis, K. A., O’Dea, C., & Williams, O. H. (1991). Neurodevelopmental and medical status of low-birth weight survivors of bronchopulmonary dysplasia at 10 at 12 years of age. Developmental Medicine and Child Neurology, 33, 690–697. Vygotsky, L. S. (1978). Mind in society: The development of higher psychological processes. Cambridge, United Kingdom: Harvard University Press. Waber, D. P., & McCormick, M. C. (1995). Late neuropsychological outcomes in preterm infants of normal IQ: Selective vulnerability of the visual system. Journal of Pediatric Psychology, 20, 721–735. Wakschlag, L. S., & Hans, S. L. (1999). Relation of maternal responsiveness during infancy to the development of behavior problems in high-risk youths. Developmental Psychology, 31, 147–169. Weindrich, D., Jennen-Steinmetz, C., Laucht, M., & Schmidt, M. (2003). Late sequelae of low birth weight: Mediators of poor school performance at 11 years. Developmental Medicine and Child Neurology, 45, 463–469. Weinraub, M., & Wolf, B. M. (1983). Effects of stress and social supports on mother–child interactions in single- and two-parent families. Child Development, 54, 1297–1311. Wertsch, J. V. (1979). From social interaction to higher psychological processes. Human Development, 22, 1–22. White, R. W. (1959). Motivation reconsidered: The concept of competence. Psychological Review, 66, 297–333. Wilfong, E. W., Saylor, C., & Elksnin, N. (1991). Influences on responsiveness: Interactions between mothers and their premature infants. Infant Mental Health Journal, 12, 31–40. Winders, P. C. (1997). Gross motor skills in children with Down syndrome: A guide for parents and professionals. Bethesda, MD: Woodbine House. Zarling, C. L., Hirsch, B. J., & Landry, S. H. (1988). Maternal social networks and mother– infant interactions in full-term and very low birth weight infants. Child Development, 59, 178–185.
C H A P T E R
T H R E E
Trisomy 21: Causes and Consequences Jeannie Visootsak and Stephanie L. Sherman Contents 61 64
1. Introduction 2. Major Cause of DS: Meiotic Nondisjunction in Oocytes 3. Prevalence and Survival of Individuals with DS Throughout the Life Span 4. Etiology of DS-Associated Medical Disorders 5. Neurodevelopmental Outcomes of Comorbid Medical Conditions in DS 6. Psychiatric and Neurobehavioral Issues in DS 7. Summary Acknowledgments References
72 77 82 87 89 90 90
Abstract Trisomy 21, leading to Down syndrome (DS), is the most common genetic cause of mental retardation, specific birth defects, and medical conditions. Clinical and epidemiological studies over the last 100 years have been primarily focused on infants with DS to determine the prevalence, cause, and clinical significance of the syndrome. Studies to understand the consequence of trisomy 21 with respect to the variability of specific DS-associated medical conditions and to determine how these conditions influence cognitive and behavioral outcomes are only just beginning. Here, we provide an overview of current clinical and epidemiological research that characterizes the causes of trisomy 21 and its medical consequences.
1. Introduction In this review, we will describe epidemiological approaches to understand the causes and consequences of trisomy 21, the genetic condition leading to Down syndrome (DS). To be clear, epidemiology and genetic
Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30033 International Review of Research in Mental Retardation, Volume 36 ISSN 0074-7750, DOI: 10.1016/S0074-7750(08)00003-7
#
2008 Elsevier Inc. All rights reserved.
61
62
Jeannie Visootsak and Stephanie L. Sherman
epidemiology provide approaches to study the patterns and causes of healthrelated traits in defined populations, with the latter paying specific attention to potential susceptibility genes and their interaction with environmental factors. Results from such studies form a foundation for interventional medicine. These types of clinical research studies are done best in parallel with basic science approaches that use experimental model systems to uncover underlying mechanisms that cause susceptibility. Although we will not review such studies here, they show tremendous promise to delineate the biological alterations that result from the extra dosage of chromosome 21 genes (for an example of a recent review, see Reeves & Garner, 2007). For DS, observational studies began in the mid-1800s when several astute physicians described groups of patients who had mental retardation and short stature along with specific facial characteristics including upslanting palpebral fissures, epicanthal folds, flat nasal bridge, and protruding tongue (Down, 1866; Esquirol, 1838; Se´guin, 1846, 1856). J. Langdon Down, after whom DS was named, contributed significantly to the progress of the study of DS by emphasizing that this set of clinical findings constituted a distinct entity, and affected individuals could be distinguished from the heterogeneous group of all those with intellectual disabilities. In an excellent review of the history of DS, Rynders and Pueschel (1982) continued the story of the recognition of DS through the late 1800s and early 1900s. Once DS was recognized as a separate medical condition, it became possible to identify determinants that play a role in its occurrence. The first to be linked to DS was increased parental age at the birth of the infant with DS (e.g., Thurston & Jenkins, 1931; Van der Scheer, 1927). Shortly thereafter, Penrose demonstrated clearly that advanced maternal age, not paternal age or birth order, was the key determining factor for DS (Penrose, 1933, 1934). In 1954, Penrose further suggested that there could be different causes of DS: he observed that approximately one-third of cases in his series were not associated with maternal age (Penrose, 1954). Further, in families with two affected siblings, the mean maternal age was lower compared to the general sample of infants with DS. With remarkable insight, he posited several plausible causes of DS: genetic susceptibility, unbalanced chromosomes caused by translocation, and factors associated with fluctuating endocrine disturbance. The next major advance in DS, and in fact human medical genetics as a whole, came with the advent of chromosome staining and karyotyping, leading to the ability to characterize the human chromosome complement. With this technological advance, the etiology of DS was identified in 1959 as the presence of an extra chromosome 21 (Book et al., 1959; Ford et al., 1959; Jacobs et al., 1959; Lejeune, 1959). More recent studies have shown that 95% of individuals with DS have an extra chromosome 21 as a result of meiotic nondisjunction, or the abnormal segregation of chromosomes
63
Trisomy 21
Meiosis I error
Meiosis II error
Homologs don’t separate
“Meiosis II” error
Homologs don’t separate
Sisters chromatids don’t separate
Sisters chromatids don’t separate
Figure 3.1 Illustration of the types of meiotic chromosomal nondisjunction errors in females. Only 1 of the 23 pairs of homologous chromosomes is shown for simplification. ‘‘MII’’ refers to meiosis [MII] errors that might be initiated in MI.
during gamete formation (Fig. 3.1). Of the remaining 5%, less than 1% is due to somatic mosaicism and the rest to chromosome 21 translocations. Interestingly, in 1964, Penrose proposed that the maternal age–dependent cases of DS could be due to meiotic nondisjunction, but succinctly stated that ‘‘The traditional explanation that the ovum becomes abnormal with age is unhelpful unless some attempt is made to link the supposed deterioration with the observed distribution curve.’’ (i.e., observed maternal age pattern) (Penrose, 1964). In summary, by the early 1960s, the syndrome hallmarks were described, the cytogenetic causes identified, and the most significant risk factor determined, namely, maternal age. DS, or trisomy 21, is now one of the most widely studied human aneuploid conditions. It is estimated that about 80% of conceptuses with an extra chromosome 21 are spontaneously lost during gestation, while some 20% are carried to term. In contrast, trisomies of other chromosomes seldom survive through gestation (for review, see Hassold & Hunt, 2001). More importantly, once medical complications at birth are appropriately treated, individuals with DS can live, on average, into their 50s or 60s, with full and productive lives if important educational, medical, and societal resources are provided. This review will survey the current field to focus attention on gaps in research. Thus, we will omit a large body of significant literature that truly pushed the field ahead to allow advances in technology and resources to make their mark. First, we will review the progress that has been made to
64
Jeannie Visootsak and Stephanie L. Sherman
understand the leading cause of trisomy 21, namely, meiotic nondisjunction. Next, we will review the aspects of mortality and morbidity among individuals with DS. We will show that the previous focus on the prevalence and survival of individuals with DS around birth has shifted to that in adults due to the significantly increased survival of individuals with DS over the years. We will outline some of the medical conditions that are prevalent among individuals with DS and finally discuss their influence on cognition, behavior, and mental health.
2. Major Cause of DS: Meiotic Nondisjunction in Oocytes As emphasized by Penrose in the early 1900s, the ability to identify the biological mechanisms and associated risk factors for trisomy 21 has benefited from studies that focus on a specific type of error. Soon after the chromosomal basis of DS became known in 1959, cytogenetic techniques allowed investigators to distinguish the underlying types of chromosome errors: (1) standard trisomy 21, (2) chromosome translocations, and (3) mosaicism (one normal cell line and one trisomic cell line). The use of chromosome heteromorphisms and DNA polymorphisms led to the ability to categorize chromosome 21 nondisjunction errors by parental origin (e.g., whether the error occurred in egg [‘‘maternal’’] or sperm [‘‘paternal’’]) and type of error (e.g., whether the error was initiated in meiosis I [MI] or meiosis II [MII] [Fig. 3.1] or postzygotic mitotic). To date, the largest study to categorize these nondisjunctional errors is the National Down Syndrome Project (NDSP), a population-based study conducted from 2000 to 2005 at six national sites representing 11% of annual births in the United States (Freeman et al., 2007). Through this population-based study, 907 infants born with DS were characterized based on the type of chromosome error. For a comparison group to examine risk factors for nondisjunction, 977 infants born without DS drawn from the same geographical areas were enrolled. Based on results from the NDSP (Table 3.1) and other population-based series (e.g., Gomez et al., 2000; Mikkelsen et al., 1995), over 90% of nondisjunction errors leading to trisomy 21 occur in the oocyte and the majority of those occur during MI. This pattern is similar to other trisomies due to chromosome nondisjunction (e.g., Hassold & Hunt, 2001). To date, most studies have focused on searching for risk factors related to maternal nondisjunction of chromosome 21 due to its frequent occurrence. We will do the same here in our review. A recent review provides an overview of our limited knowledge of paternal nondisjunction and its associated risk factors (Sherman et al., 2005).
65
Trisomy 21
Table 3.1 Origin of trisomy 21 Origin
Maternal Meiosis I (MI) Meiosis II (MII) Stage unknowna Subtotal Paternal Meiosis I (PI) Meiosis II (PII) Stage unknowna Subtotal Postzygotic mitotic Total informative cases (all)
N
Proportion
Percent
529 179 21 729
MI/(MI þ MII) ¼ 529/708 MII/(MI þ MII) ¼ 179/708
74.7 25.3
M/All ¼ 729/782
93.2
13 18 1 32 21 782
PI/(PI þ PII) ¼ 13/31 PII/(PI þ PII) ¼ 18/31
41.9 58.1
P/all ¼ 32/782 Mitotics/All ¼ 21/782
4.1 2.7
Stage unknown ¼ DNA markers in the centromeric region were not informative. Data taken from Freeman et al. (2007).
a
2.1. Advanced maternal age Advanced maternal age is possibly, by far, the most significant factor related to chromosome 21 nondisjunction. We and others have shown that the increased age of the mother at conception exerts its influence on chromosome segregation in the egg (Sherman et al., 2005; e.g., Antonarakis et al., 1992; Ballesta et al., 1999; Muller et al., 2000). That is, advanced maternal age is not observed among mothers whose offspring received the extra chromosome 21 from a nonmaternal source. Mothers of offspring with a nondisjunction error in spermatogenesis (paternal error) do not have an increased age (Petersen et al., 1993; Sherman et al., 2005; Yoon et al., 1996). Similarly, advanced maternal age is not present among women with an offspring with DS due to a postzygotic mitotic error (e.g., Antonarakis et al., 1993; Sherman et al., 2005) or a chromosome translocation (inherited or de novo) (Hook, 1983). Interestingly, advanced maternal age is a risk factor for both MI and MII maternal nondisjunction errors (e.g., Antonarakis et al., 1992; Muller et al., 2000; Sherman et al., 2005; Yoon et al., 1996). The timeline for oogenesis compared with spermatogenesis points to possible error-prone stages of egg formation. Meiosis is initiated in oocytes during fetal life around 12 weeks of gestation. After homologous chromosomes synapse and initiate recombination, meiosis arrests and remains in this state until the oocyte is recruited for ovulation. Thus, MI spans some 10–50 years depending on when that specific oocyte is ovulated. MII only extends over the 3- to 4-day ovulation period and is completed after fertilization. This timeline differs significantly
66
Jeannie Visootsak and Stephanie L. Sherman
from that in spermatogenesis which begins at puberty; cells entering meiosis move from one stage to the other without delay. Plausible explanations for maternal age–related nondisjunction in both MI and MII include, but are not limited to (1) an accumulation of toxic effects of the environment during the arrested state of the oocyte, (2) a degradation of meiotic machinery over time while in the arrested state, leading to a suboptimal resumption of MI and MII, and/or (3) a change in ovarian functioning due to suboptimal hormonal signaling. Most likely, several processes are affected by advanced maternal age; thus, more than one or all of these hypotheses may prove to be true. Several excellent reviews of hypotheses to explain the maternal age effect are available (e.g., Eichenlaub-Ritter, 1996; Gaulden, 1992) along with a recent review of hypotheses related to biological aging of the ovary (Warburton, 2005). One potential way to understand the maternal age effect is to examine maternal health factors and environmental exposures among mothers who have had a recognized pregnancy with chromosome 21 nondisjunction. Once a risk factor for nondisjunction is identified, it can be further evaluated in the context of biological aging to provide insight into the mechanism causing the maternal age effect. For example, biological aging of the ovary is characterized by a decline in the total oocyte pool, a decline in the number of antral follicles maturing per cycle and in reproductive hormonal changes. A decrease in the number of maturing follicles has been hypothesized to decrease the probability that one of them will be at the precise stage necessary for optimal response to follicle stimulating hormone (FSH), the trigger for ovulation. Warburton (1989) put forth the ‘‘limited oocyte pool’’ hypothesis suggesting that under these circumstances, the follicle ‘‘selected’’ for ovulation may be one whose oocyte is under- or overripe and thus more susceptible to chromosome malsegregation. In an excellent review, Warburton (2005) found inconsistent results among the studies that have examined the relationship between nondisjunction and biological aging of the ovary. For example, Freeman et al. (2000) found that mothers with a maternally derived chromosome 21 nondisjunction error were more likely to have a reduced ovarian complement (congenital or surgical) compared with mothers of infants without DS (odds ratio [OR] ¼ 9.61; 95% confidence interval [CI] ¼ 1.18–46.3). Women with reduced ovarian complement have a smaller oocyte reserve and thus would ‘‘mimic’’ an older woman. However, this observation has not been confirmed. Other indirect evidence to support ovarian aging specifically for chromosome 21 nondisjunction was reported by van Montfrans et al. (1999). They examined serum FSH levels taken on menstrual days 2, 3, or 4 in three consecutive cycles from 118 women who had a child with DS to 102 women who had at least 2 children and no history of a child with DS. Women were matched for age (all under age 40 years and no difference in group means) and for menstrual cycle history. They found higher levels of FSH, an indicator of decreased ovarian reserve, among
Trisomy 21
67
women with an infant with DS compared with controls. Results from their follow-up study that measured estradiol and inhibin B on this same study group suggested that the elevated FSH levels reflected early depletion of the primordial follicle pool (van Montfrans et al., 2002). A more recent case– control study compared maternal serum anti-mullerian hormone (AMH) levels, another marker for ovarian reserve. They measured AMH on banked serum collected for first trimester prenatal screening among 25 women who had a pregnancy with DS and among control samples that included women with an unaffected pregnancy and were individually matched for maternal age (within 2 years), gestational age (same completed week), and duration of storage (within a month). Although the sample size was limited, they did not find any differences in AMH levels during pregnancy between the women with a DS fetus and their controls (Seifer et al., 2007). In a recent review, Warburton (2005) concluded that much of the evidence to date suggests that, if processes of ovarian aging are related to chromosome nondisjunction, they probably involve factors other than those measured by oocyte or antral follicle pool size and reproductive hormone levels.
2.2. Recombination patterns along chromosome 21 alter the risk for maternal nondisjunction Aside from maternal age, only one additional factor has been shown to be unequivocally associated with maternal nondisjunction, that is, altered recombination patterns. Warren et al. (1987) provided the first evidence that a proportion of maternal nondisjunction errors was associated with reduced recombination along chromosome 21. In addition to the absence of an exchange, the location of an exchange along the nondisjoined chromosome is an important susceptibility factor for chromosome 21 malsegregation (Lamb et al., 2005a; Sherman et al., 2005). Briefly, examination of recombination along the maternal nondisjoined chromosome 21 has suggested three susceptibility exchange patterns: (1) no exchange leads to an increased risk of MI errors, (2) a single telomeric (i.e., end of chromosome) exchange leads to an increased risk of MI errors, and (3) a pericentromeric exchange leads to an increased risk of MII errors (Lamb et al., 1996, 1997) (Fig. 3.2). The association of maternal MII errors with a specific recombination pattern suggests that at least some proportion of MII errors are initiated in MI (e.g., Fig. 3.1). We will simply use the designation ‘‘MII’’ to indicate this suggestion. More recently, we have examined altered recombination patterns of maternal nondisjoined chromosomes 21 stratified by maternal age to gain insight into possible mechanisms of nondisjunction. The data on 400 maternal MI errors grouped by maternal ages <29 years, 29–34 years, and >34 years indicate that there are multiple causes of nondisjunction, some age dependent and others age independent (Lamb et al., 2005b). In a young
68
Jeannie Visootsak and Stephanie L. Sherman
no exchange MI error
single telomeric exchange
MI error
single peri-centromeric exchange MII error
Figure 3.2 Summary of the susceptible exchange configurations observed among maternal nondisjoined chromosomes 21 and their associated risks for MI or ‘‘MII’’ errors.
woman, meiotic machinery (spindle function, sister chromatid adhesive proteins, microtubule motor proteins, and so on) functions optimally and, as a result, can correctly segregate all but the most error-prone exchange configurations. For young women then, the most frequent risk factor for MI nondisjunction is the presence of a telomeric exchange. As a woman ages, her meiotic machinery may be exposed to an accumulation of environmental and age-related insults, becoming less efficient/more error-prone. For example, recent studies have indicated changes in gene expression in younger compared with older oocytes in both mouse (Hamatani et al., 2004; Pan et al., 2008) and human studies (Steuerwald et al., 2007). Gene profiles that were altered included those involved in cell cycle regulation, cytoskeletal structure, energy pathways, transcription control, and stress responses. Such changes could play a role in the abnormalities of meiotic spindle that have been frequently observed in oocytes of aged mothers (Battaglia et al., 1996; Eichenlaub-Ritter et al., 2004). Among these older oocytes, suboptimal exchange patterns still increase susceptibility to nondisjunction, but now even homologous chromosomes with optimally located exchanges are at risk. Over time, the proportion of nondisjunction due to normal exchange configurations increases as age-dependent risk factors exert their influence. As a result, the most prevalent exchange profile of nondisjoined oocytes shifts from susceptible to nonsusceptible patterns with increasing age of the oocyte. If ‘‘MII’’ errors are initiated in MI, exchange patterns among maternal age groups with ‘‘MII’’ errors are predicted to be similar to those observed for MI errors. Our current data contradict this hypothesis (Oliver et al., 2008). Among 58, 69, and 126 maternal MII errors grouped by maternal ages of
Trisomy 21
69
<29 years, 29–34 years, and >34 years, respectively, the proportion of susceptible pericentromeric exchanges increased with age, the opposite pattern to that observed in MI. This pattern indicates that there is an interaction with the effect of the pericentromeric exchange and advanced maternal age. We suggest two alternative explanations to fit these data. First, the pericentromeric exchange may establish a suboptimal condition that exacerbates the effect of maternal age–related risk factors. Alternatively, the pericentromeric exchange protects the bivalent from maternal age–related risk factors allowing the proper segregation of homologs, but not sister chromatids. This would represent a ‘‘true’’ MII error in the classical sense (Fig. 3.1). Clearly, additional work needs to be done to distinguish these alternatives.
2.3. Environmental influences on chromosome 21 nondisjunction Over the years, a large number of potential environmental influences have been identified in epidemiological studies of DS, but almost none have been replicated. Smoking at the time of pregnancy is an excellent example of the difficulties and limitations of such studies. Previously, a number of studies reported that women who smoke around the time of conception are at decreased risk for having an infant with DS (e.g., Chen et al., 1999; Hook & Cross, 1985, 1988; Kline et al., 1983, 1993; Shiono et al., 1986). One explanation for the negative association was that trisomic conceptuses were selectively lost prenatally among women who smoke (Hook & Cross, 1985; Kline et al., 1993). However, other studies have concluded that there is no association between DS and periconceptional smoking (e.g., Cuckle et al., 1990; Kallen, 1997; Torfs & Christianson, 2000). In contrast, Yang et al. (1999) analyzed periconceptional smoking among women less than 35 years with maternal MI and ‘‘MII’’ errors separately and found an increased frequency of smoking among women with ‘‘MII’’ errors only (OR ¼ 2.98; 95% CI ¼ 1.01–8.87). The odds ratio for this group of women increased significantly if the interaction term of periconceptional smoking and oral contraceptive use (2 month around conception) was modeled (OR ¼ 7.62; 95% CI ¼ 1.63–35.6). The authors speculated that this combined risk factor may compromise the blood flow surrounding the developing follicle, depleting the follicular fluid of oxygen. The resulting hypoxic environment may cause the meiotic machinery to malfunction. The hypothesis was based on the findings of Van Blerkom et al. (1997). They examined the oxygen content of follicular fluids from 1,000 follicles of equivalent size and ultrasonographic appearance taken from 116 in vitro fertilization (IVF) patients. Oocytes from severely hypoxic follicles were associated with high frequencies of chromosome disorganization on the metaphase spindle. Such disorganization could lead to nondisjunction and resulting aneuploidy. This speculation is similar to that proposed by
70
Jeannie Visootsak and Stephanie L. Sherman
Gaulden (1992) to explain maternal age–related nondisjunction. She suggested that the follicular microcirculation may be compromised in an aging ovary because of abnormal hormone signaling. Although the study of Yang et al. must be confirmed with a larger sample size, this example illustrates the potential of using identified risk factors to help dissect the maternal age effect. Other factors such as alcohol (e.g., Kaufman, 1983), maternal irradiation (e.g., Padmanabhan et al., 2004; Strigini et al., 1990; Uchida, 1979), fertility drugs (e.g., Boue & Boue, 1973), oral contraceptives (e.g., Harlap et al., 1979; Yang et al., 1999), spermicides (e.g., Rothman, 1983; Strobino et al., 1986), parity (reviewed by Chan, 2003), and low socio economic status (Christianson et al., 2004; Torfs & Christianson, 2003) have been implicated, but not confirmed. It seems almost certain that environmental risk factors for chromosome nondisjunction exist. Studies from model organisms make it clear that a wide variety of genetic and environmental disturbances can affect aneuploidy levels. Most recently, Dr. Hunt and her team have convincingly shown that exposure of oocytes in mice to bisphenol A (BPA) has a detrimental effect on mammalian oogenesis. BPA is an estrogenic chemical that is a component of polycarbonate plastics, resins lining food containers, and additives in a variety of consumer products; thus, it is present in almost all environments. In their first series of experiments, Hunt et al. (2003) found that, in the female mouse, short-term, low-dose exposure during the final stages of oocyte growth was sufficient to cause meiotic effects and that those effects increased the risk of aneuploidy. More recently, they have shown that exposure of developing oocytes during MI prophase in vivo, at doses comparable to human exposure, leads to synaptic defects and increased levels of recombination (Susiarjo et al., 2007). In the mature female, these aberrations lead to increased rates of aneuploidy in eggs and embryos. Further work indicated that BPA acts as an estrogen antagonist and suggests that the oocyte is sensitive to estrogen during early oogenesis. Understanding the influence of BPA, as well as other endocrine disruptors, on humans is an intense area of research. Certainly, understanding important risk factors, such as BPA, helps to address a major public health concern. Identification of such factors in humans is particularly difficult as oocyte development is initiated during fetal life and continues until the oocyte is ovulated. Full evaluation requires knowledge of the grandmother’s as well as the mother’s exposures. Large population-based studies that separate individuals with DS by type of nondisjunction error will increase the power to identify risk factors that have remained elusive. New epidemiological study designs and/or large prospective cohort designs of two or more generations will be needed to capture information from women and their mothers to reliably examine environmental exposures throughout the lifecycle of the oocyte. Clearly such studies will be difficult and labor intensive.
Trisomy 21
71
In this case, model systems may be more efficient to address maternal grandmother exposures.
2.4. Candidate genes for chromosome 21 nondisjunction Model organisms have been used to identify genes that are important in the proper segregation of chromosomes. Genes involved in the meiotic process (e.g., homolog pairing, assembly of the synaptonemal complex, chiasmata formation, sister chromosome cohesion, meiotic spindle formation) may predispose an organism to chromosome nondisjunction. To date, a large study to investigate the association of variants in these genes with nondisjunction of human chromosome 21 has not been conducted. Candidate gene studies of the folate pathway provide the best example of genetic epidemiological approaches being used to evaluate the association of genetic variants with nondisjunction. James et al. (1999) provided preliminary evidence that the C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene increased the chance of having a child with DS (OR ¼ 2.6; 95% CI ¼ 1.2–5.8). This polymorphism is associated with an elevation in plasma homocysteine and/or low folate status. The authors hypothesized that low folate status, whether due to dietary or genetic factors, could induce centromeric DNA hypomethylation and alterations in chromatin structure. Such alterations could adversely affect DNA–protein interactions required for centromeric cohesion and meiotic segregation. Later studies of the MTHFR C677T polymorphism, as well as several other allelic variants in genes in the folate pathway (e.g., MTHFR A1298C, MTRR A66G, MTR C2756G, RFC1 A80G), generated inconsistent results, most likely due to limited sample sizes, varying population characteristics, and sampling strategies. Moreover, some studies examined single gene effects, while others included gene–gene and gene–nutrition interactions. Still others examined biomarkers such as total plasma homocysteine levels. Although a thorough review is beyond the scope of this chapter, some important findings can be highlighted. Most studies that have examined blood homocysteine levels, a broad-spectrum indicator of nutritional and/or genetic impairment in folate/B12 metabolism, have documented a significantly higher level among the mothers of children with DS compared with control mothers, irrespective of population origin (Bosco et al., 2003; da Silva et al., 2005; James et al., 1999; Martinez-Frias et al., 2006; Takamura et al., 2004; Wang et al., 2007). As studies that examined one or two variants of MTHFR provided inconsistent results, Zintzaras (2007) conducted a comprehensive meta-analysis using strict criteria to evaluate the results from 11 case–control studies that examined MTHFR C677T, MTHFR A1298C, and/or MTRR A66G variants to the maternal risk for DS. The analysis was complicated by the statistically significant heterogeneity between studies. Nevertheless, the meta-analyses using several
72
Jeannie Visootsak and Stephanie L. Sherman
approaches indicated that the pooled odds ratios were not significant for any of the variants. The cumulative meta-analysis of MTHFR C677T showed a trend toward an association as the amount of data increased. Overall, the author suggested that there was insufficient evidence for claiming or denying an association for the gene variants. More recent studies have focused on the interaction among genes in the folate pathway adjusting for covariants and continue to find intriguing correlations (e.g., Biselli et al., 2008; Bosco et al., 2003; Coppede et al., 2006; da Silva et al., 2005; Hobbs et al., 2000; Martinez-Frias et al., 2006; Rai et al., 2006; Scala et al., 2006, 2007; Wang et al., 2008). In all studies that examined multiple variants, they found that the effect was additive (e.g., Biselli et al., 2008; Hobbs et al., 2000; Martinez-Frias, 2008; Rai et al., 2006; Scala et al., 2006; Wang et al., 2008) Clearly, this story needs to be pursued. Future studies should focus on gene–gene and gene–nutrition interactions in the folate pathway using large sample sizes, appropriate controls, and genetic epidemiological methods that adjust for possible confounding due to population substructure.
3. Prevalence and Survival of Individuals with DS Throughout the Life Span The survival prospect of individuals with DS in developed countries has improved considerably over time with the shift from institutional care to community-based care, improved clinical interventions, and overall health of the population. For example, survival to 1 and to 10 years was estimated to be 76% and 65% in a birth cohort in the United States from the years 1950–1967 (Fabia & Drolette, 1970a). Although not directly comparable, a more recent study showed that the 1- and 10-year survival rates in another US birth cohort from the years 1979–1998 was 93% and 89%, respectively (Rasmussen et al., 2006). Significant increases in survival have been noted in other developed countries as well (reviewed in Glasson et al., 2002). Even more importantly, the overall life expectancy of an individual with DS has increased significantly and is estimated to be about 60 years in developed countries (e.g., Glasson et al., 2002). This impressive change over time should shift our research emphasis to assessing causes of morbidity and mortality throughout the life stages of an individual with DS, in addition to obtaining accurate estimates of prevalence. We will provide recent examples of both types of studies to indicate the direction of the field. An important point to reiterate is that the majority of pregnancies of fetuses with trisomy 21 are spontaneously lost prior to term. For example, the rate of fetal loss has been estimated to be about 40% between the time of chorionic villus sampling (CVS) and birth and about 25% between amniocentesis and birth, although these estimates are not straightforward to derive
Trisomy 21
73
(for review, see Cuckle, 1999; Snijders, 1999). More recently, Savva et al. (2006) conducted a survival analysis on follow-up of 5,177 prenatally diagnosed cases of DS to determine if spontaneous loss depended on maternal age. They found that the rate of loss increases with increasing maternal age. The average fetal loss rate between the time of CVS and term was 32% (95% CI ¼ 26–38) and increased from 23% (95% CI ¼ 16–31) to 25–44% (33–56) for women aged 45. The average fetal loss rate between the time of amniocentesis and term was 25% (21–31) and increased from 19% (14–27) to 33% (26–45) across the same age range. Importantly, this does not include the loss prior to recognizing a pregnancy or prior to prenatal diagnosis. Thus, the estimates of the prevalence among live births not only exclude those pregnancies that were medically terminated but also those that were spontaneously lost.
3.1. Mortality and morbidity among individuals with DS Before examining trends in prevalence, it is helpful to provide an overview of the causes of mortality and morbidity over the life span of individuals with DS. A recent study has provided an excellent framework to consider these issues by dividing the lifespan into four time periods: (1) prenatal, (2) childhood, and adolescence (0–18 years), (3) adulthood (19–40 years), and (4) senescence (>40 years) (Bittles et al., 2007). We will use this study as an example of one that begins to identify increased length of survival of individuals with DS and provides a focus for future efforts. The study of Bittles et al. was based on the successful registration of individuals with DS by the Disability Services Commission of Western Australia. This commission is a primary support agency for those with intellectual disability in Western Australia since 1952. Thus, one limitation of the study is that some proportion of individuals may not get registered with the commission. Nevertheless, the study data are based on the electronic linkage of 1,332 individuals with DS in the Disability Services Commission from 1953 to 2000 with the (1) Western Australia Cancer Registry (1981 to present), (2) the Western Australia Death Registry and the state Coroner’s office, and (3) the National Death Index (1980 to present). In addition, information on overall DS survival trends for the Western Australia population from 1980 to 2004 was obtained from the Western Australia Birth Defects Registry. We will only highlight some of the findings of each period to show the value of the data collected. In the prenatal stage/birth stage, this study indicated that the overall prevalence of DS (live births, fetal deaths, and medical terminations) per 1,000 births increased from 1.1 to 2.9 per 1,000 births in 1980–2004, respectively. This increase paralleled the increase in maternal age in the population. In 1980, 4.8% of women giving birth in Western Australia were
74
Jeannie Visootsak and Stephanie L. Sherman
35 years or older compared with 18.6% in 2004. This trend has been observed in other populations as well (see below). The next stage of life, infancy to early adulthood proves to be a medically vulnerable one. About half of the 298 deaths identified among the 1,332 individuals with DS occurred before age 18 and about 36% before age 5. As in other studies, the leading causes of death between ages 0–18 years were pneumonia and other respiratory infections (33%) and congenital heart defects (CHDs) (13%). Because children with DS have a >20-fold increased risk of developing leukemia in childhood (see below), this condition was further examined during this life stage. Data from the Western Australia Cancer Registry indicated that about 54% (14/26) of cancers recorded in individuals with DS were childhood leukemia. Twelve of 14 cases were diagnosed before 5 years of age and in 4 cases it was fatal. In adulthood (19–40 years), the investigators noted that many agerelated health problems and/or medical disorders in DS begin earlier than in the general population. About 13% of the 298 deaths between 1953 and 2002 occurred in the 19–40 year age group. The main causes of death recorded were pneumonia and other respiratory infections (23%), cardiac, renal, and respiratory failure (10%), and cancers (8%). Cerebrovascular accident and coronary artery disease were recorded as causes of death in about 5% and 3% of the cases, respectively. Lastly, about 30% of individuals with DS registered in the Disability Services Commission cohort were aged >50 years at the time of death and 25% died between 57 and 62 years. Information on cause of death was available for 97 of the 111 deceased persons >40 years of age. Pneumonia and other respiratory infections were the most common causes of death (40%), followed by coronary artery disease (9.9%), cardiac, renal, and respiratory failure (9.0%) cerebrovascular accident (6.3%), and cancers (5.4%). Alzheimer’s dementia was listed as a contributory cause of death in only three cases. The above account of causes of mortality only shows a limited picture of the medical problems encountered by those with DS. The use of information from death certificates is fraught with problems as pointed out by others (e.g., Rasmussen et al., 2006; Shin et al., 2007; Yang et al., 2002), but still provides a basic overview. The age-associated morbidity patterns of DS are an area of considerable clinical research. The study of van Allen et al. (1999) indicated that significant health problems among adults with DS include untreated congenital heart anomalies (16%), acquired cardiac disease (16%), pulmonary hypertension (8%), recurrent respiratory infections/aspiration (30%), complications from presenile dementia/Alzheimer-type disease (42%), adultonset epilepsy (37%), osteoarthritic degeneration of the spine (32%), osteoporosis with resultant fractures of the long bones (55%) or vertebral bodies (30%), and untreated atlantooccipital instability (8%). In addition, they showed that acquired sensory deficits including loss of vision due to
Trisomy 21
75
early onset of adult cataracts (50%), recurrent keratitis (21%), or keratoconus (16%), and measurable hearing loss (25%) were significant problems. Importantly, population-based surveillance of common medical conditions in adults with DS is infrequent. Henderson et al. (2007) found that 48% of adults with DS had not seen a doctor in the previous 12 months and 33% had not had a medical assessment in the previous 3 years. Untreated hypothyroidism, a common problem for adults with DS may lead to symptoms that mimic cognitive decline; it may also be associated with decreased energy, and weight gain (Finesilver, 2002). The causes and consequences of obesity in individuals with DS have only recently been studied (e.g., Fonseca et al., 2005; Melville et al., 2005). As Barnhart and Connolly (2007) emphasize, a shift must be made from disability prevention to the prevention of conditions that limit activity and participation of adults with DS. Consideration of exercise and healthy diet regimen will positively affect the overall health of adults with DS and, thus, will increase their quality of life.
3.2. Implication of factors that influence the prevalence of DS The recent report by Canfield et al. (2006) provides an excellent example of a large study to obtain an estimate of the birth prevalence of DS in the United States and to identify factors that may influence prevalence estimates. Eleven birth surveillance systems used active-case finding methods to identify all pregnancy outcomes with DS, including live births, fetal deaths, spontaneous and induced abortions. The national estimate for DS based on the surveillance of 22% of births in the United States and maternal age– adjusted prevalence was 13.65 (95% CI ¼ 13.22–14.09) per 10,000 live births, or 1/733. This suggests that 5,400 of the approximate 4 million infants born each year in the United States have DS. Canfield et al. further investigated the maternal age–adjusted prevalence rates among three major maternal racial/ethnic groups in the United States: non-Hispanic white, non-Hispanic black, and Hispanic. Compared with non-Hispanic white mothers, the prevalence ratio was 0.77 (95% CI ¼ 0.69–0.87) for non-Hispanic black mothers and 1.12 (95% CI ¼ 1.03–1.21) for Hispanic mothers. The causes of the increased prevalence among Hispanic and decreased prevalence among non-Hispanic black mothers are important to discern. Differences could be related to variation among surveillance systems: The authors state that each surveillance system differed in its access to prenatal records and diagnoses, spontaneous abortions, fetal deaths, and live births. If ability to ascertain information at various gestational time points varied by racial/ethnic groups, prevalence estimates would differ. Alternatively, prevalence rates could be influenced by factors that affect access to health care, such as socioeconomic status or education (e.g., Coory et al., 2007; Khoshnood et al., 2004, 2006). Differences could be due to racial/ethnic variation in use of prenatal care, prenatal diagnosis,
76
Jeannie Visootsak and Stephanie L. Sherman
and/or pregnancy termination (e.g., Forrester & Merz, 1999; Siffel et al., 2004). Lastly, important environmental exposures (e.g., smoking, nutrition, socioeconomic status) or genetic risk factors (e.g., variants involved in meiosis, oocyte development, or fetus survival) could vary by racial/ethnic group. Each one of these explanations is plausible and carries significant implications for future public health interventions. A significant number of important studies have been conducted that examine the birth prevalence of DS among populations using various methods of case ascertainment. Hook and his colleagues have contributed significantly to this field, not only in terms of study design and statistical methods but also in presenting results from populations with different demographics (e.g., Carothers et al., 1999, 2001; Hecht & Hook, 1996; Hook, 1981, 1983; Hook et al., 1995, 1999). In a review of 49 population groups using an index to allow comparison between studies, Carothers et al. (1999) suggested that ‘‘real’’ variation between population groups probably amounts to about 25%. Interestingly, the pattern of prevalence estimates among the racial/ethnic groups identified in this meta-analysis is the same as that observed in Canfield et al. (2006): There was an increase in the prevalence among individuals of Hispanic origin compared with those of African-American or African origin. This prevalence variation observed among groups defined by their ‘‘self-reported’’ race/ethnicity needs to be dissected. The categorization of race/ethnicity is imprecise and displays considerable in-group heterogeneity. This measure becomes more imprecise with ever-increasing numbers of individuals classified as multiethnic and multiracial. Nevertheless, there is considerable motivation to identify the underlying cause of the differences in prevalence observed among groups. The prevalence of DS among births in a specific population, of course, depends on the maternal age structure of the population, the availability of prenatal diagnosis, the option for elective terminations, and the culture’s attitude toward pregnancy terminations as well as the prospect of caring for a disabled child. Recent studies have not shown large changes in the prevalence of DS among live births over time (e.g., Bittles et al., 2007; Dolk et al., 2005; Iliyasu et al., 2002; Khoshnood et al., 2004; Rosch et al., 2000). For example, in the ethnic/racial diverse population of the fivecountry metropolitan area of Atlanta, GA, the proportion of pregnancies among women in their late 30s has increased in recent years. Interestingly, the prevalence of DS among infants of women in this age group has also shown an increase (Besser et al., 2007; Siffel et al., 2004). The reasons for this stabilization or slight increase of prevalence among births needs to be further tracked to better understand (1) the consequence of screening for trisomic conceptuses and the use of prenatal diagnosis as an intervention, (2) the decisions that families are making with respect to timing of pregnancies and use of prenatal diagnoses, and (3) the public health allocation of resources to accommodate these trends.
Trisomy 21
77
As emphasized by many, it is essential to obtain accurate estimates of survival rates among individuals with DS. Survival rates differ among racial/ ethnic groups and suggest that additional studies are needed to understand such differences (e.g., Besser et al., 2007; Day et al., 2005; Rasmussen et al., 2006; Yang et al., 2002). Studies to assess prevalence of individuals with DS in adolescence and adulthood are just beginning. For example, Besser et al. (2007) recently conducted a study of children with DS born in metropolitan Atlanta, GA, from 1979 to 2003 ascertained from a population-based birth defects registry. These ascertained cases were followed using linkage to vital records and the National Death Index. The prevalence was estimated by dividing the children surviving with DS by the population obtained from the US Census estimates. They found that there were 13.0 per 10,000 live births with DS in 2003 and 8.3 per 10,000 ages 0–19 years. The prevalence of DS among 0–14 year olds increased over time, which parallels the studies outlined above that show improved medical care. Importantly, within each 5-year cohort, the prevalence decreased with age and this decrease was greater among blacks than among whites. This discrepancy between racial/ ethnic groups has also been observed using other approaches (Rasmussen et al., 2006; Yang et al., 2002). The next step is to understand the cause of the differential mortality rates to provide for those who are most at risk for childhood morbidity and mortality.
4. Etiology of DS-Associated Medical Disorders Almost universally, individuals with DS have characteristic facial features, mental retardation, and hypotonia; however, even these features vary in severity. Importantly, other features including specific birth defects and medical disorders vary considerably. They are present at a higher frequency among individuals with DS compared with the general population; however, these DS-associated conditions are not present in all individuals with an extra chromosome 21. For example, CHDs occur in about 50% of individuals with DS, gastrointestinal tract abnormalities (e.g., duodenal stenosis or atresia) occur in about 5–10%, and childhood leukemia in about 1%; these all occur at significantly higher frequencies than in the general population (for review, see Epstein, 2001). Thus, the extra chromosome 21 either (1) ‘‘sensitizes’’ the genetic background and unmasks variability in the rest of the genome and/or (2) leads to increased chromosome 21 variability, directly influencing susceptibility. Patterson (2007) reviewed possible molecular mechanisms resulting from trisomy 21 that lead to manifestations of DS. Two important epidemiological questions are (1) Among individuals with DS, what is the prevalence of a specific trait and is it increased or
78
Jeannie Visootsak and Stephanie L. Sherman
decreased compared with those without DS? and (2) What are the associated factors that explain the reduced penetrance and variable expression of DS-associated traits? There are few studies to date that have addressed these significant questions using population-based strategies (e.g., Fabia & Drolette, 1970b; Freeman et al., 1998; Kallen et al., 1996; Stoll et al., 1990; Torfs & Christianson, 1998). One example of a recent population-based study that examined both questions is that conducted by Torfs and Christianson (1998, 1999). They studied 2,894 confirmed cases of DS collected through the California Birth Defects Monitoring Program (CBDMP) between 1983 and 1993. They compared the frequencies of specific birth defects among infants with DS to those in 2.5 million newborn infants from the same population. They recorded 61 major birth defects known to be uniformly ascertained through the CBDMP, that is, those that could be diagnosed in an infant through age one or those that require early action. Forty-five defects were significantly more common in DS. For example, the chance for atrioventricular septal defects (AVSD, or sometimes called atrioventricular canal) was increased 1,000-fold over that for infants without DS. Other cardiac defects were also increased including atrial septal defects (ASD), ventricular septal defects (VSD), and defects of cardiac valves. Gastrointestinal defects were about 20 times more common in infants with DS. Duodenal atresia and annular pancreas had the highest risk ratios (265 and 430, respectively). Most defects of the primary developmental field and midline defects were either not significantly associated or not observed in infants with DS (e.g., anencephaly, spina bifida, encephalocele, and diaphragmatic hernia). In the next section, we will review two DS-associated disorders to probe further into studies that ask the second question: What factors are associated with the reduced penetrance and variable expression of DS-associated traits? CHDs will provide an example of a condition that is just beginning to be dissected with respect to etiology. Next, we will describe recent studies on DS-associated childhood leukemia. For this disorder, researchers have made some progress with respect to understanding the genes that may be involved in susceptibility. We discuss both disorders further as examples of conditions that may influence later cognitive and behavioral outcomes. We will not review another important DS-associated condition, that of Alzheimer disease. This is due to space limitations, but we point to a recent review of this significant area of focus (Zigman & Lott, 2007; also see Chapter 4).
4.1. DS-associated CHDs Most studies have shown that about 45–50% of infants with DS have CHDs with one defect, namely AVSD, being particularly common. Several recent reports have suggested that the distribution of CHDs in DS varies by race/ ethnicity (de Rubens et al., 2003; Ferencz et al., 1997; Jacobs et al., 2000;
Trisomy 21
79
Khoury & Erickson, 1992b; Lo et al., 1989; Marino, 1996; Torfs & Christianson, 1999), but most population-based studies have not had broad ethnic representation. We have recently analyzed data collected from the NDSP to examine variation in rates of CHD in a racially/ethnically diverse US population (Freeman et al., 2008). The noted limitations of the study can be stated first: (1) only families in which the mother spoke English or Spanish were eligible and (2) pregnancy losses, medical terminations, fetal deaths, or infants who died after birth but before the family could be enrolled were not included. First, we found that 44% of infants with DS have CHDs, a rate consistent with other studies (Freeman et al., 1998; Kallen et al., 1996; Stoll et al., 1998; Torfs & Christianson, 1998). We then estimated the proportion of cases with specific types of heart defects, knowing that infants with DS were particularly susceptible to AVSD. We found in the NDSP study population that a partial or complete AVSD was present in 17% of eligible infants (39% of those with a reported CHD), a rate similar to that found in most other studies (Calzolari et al., 2003; Fixler & Threlkeld, 1998; Freeman et al., 1998; Frid et al., 1999; Kallen et al., 1996; Rowe & Uchida, 1961; Stoll et al., 1998; Torfs & Christianson, 1998; Wells et al., 1994). In contrast to the similar estimates of AVSD among infants with DS, ASD and VSD rates vary widely among studies: 4–42% and 11–44%, respectively (Calzolari et al., 2003; Fixler & Threlkeld, 1998; Freeman et al., 1998, 2008; Frid et al., 1999; Kallen et al., 1996; Rowe & Uchida, 1961; Spahis & Wilson, 1999; Stoll et al., 1998; Torfs & Christianson, 1998; Wells et al., 1994). We then examined demographic characteristics of infants with specific types of CHD to determine if such factors provide insight into susceptibility. The NDSP was particularly useful for the analyses of race/ethnicity, as it includes three ethnic groups represented at greater than a 10% frequency: non-Hispanic white, non-Hispanic black, and Hispanic. This permitted a direct examination of possible differences in CHD rates among ethnic groups. AVSDs demonstrated the most striking ethnic differences. Specifically, black infants with DS had about twice the risk of AVSD as white infants (OR ¼ 1.98; 95% CI ¼ 1.31–2.99) whereas Hispanics had one-half the risk of whites (OR ¼ 0.60; 95% CI ¼ 0.40–0.99). Similar ethnic differences in AVSD rates at multiple sites strengthen the overall NDSP findings. In contrast, we found no significant ethnic differences in VSD rates in the NDSP as a whole or among the sites. For ASD, we noted a marginally significant increased OR for blacks compared with white infants with DS. This observed increase among black infants could be a true increase or may be due to the diagnostic misclassification of AVSD as ASD. This needs to be further examined. We also found a predominance of females among infants with AVSD (OR ¼ 2.06; 95% CI ¼ 1.55–2.75), which has been reported previously in infants with and without DS (Ferencz et al., 1997; Harris et al., 2003; Kallen et al., 1996; Park et al., 1977; Pinto et al., 1990). Interestingly, some studies
80
Jeannie Visootsak and Stephanie L. Sherman
have reported that males with DS have a significantly greater life expectancy compared with females with DS (Fabia & Drolette, 1970a; Glasson et al., 2003; Leonard et al., 2000), although not all report this difference (Day et al., 2005; Dupont et al., 1986; Malone, 1988; Mastroiacovo et al., 1992; Mulcahy, 1979; Rasmussen et al., 2006; Yang et al., 2002). If true, this observation is contrary to the male:female ratio in the general population and in most individuals with intellectual disabilities. One explanation provided for this difference may be an increased preponderance of CHD, in particular AVSDs, among females with DS (Glasson et al., 2003). Clearly more research needs to be done to understand these ethnic/racial and gender differences. Both of these parameters are surrogates for many characteristics that may prove to be susceptibility factors. One example of a study that began to further examine factors that underlie susceptibility to DS-associated birth defects is that of Torfs and Christianson (1999). They compared demographic information, pregnancy, and medical histories, and use of tobacco, alcohol, and coffee among mothers of infants with DS with and without specific birth defects in a case/control study based on 687 infants with DS. Taking CHD and tobacco use as an example, smoking was found to be associated with CHD overall (OR ¼ 2.0; 95% CI ¼ 1.2–3.2) and specifically, with AVSD, ASD, and tetralogy of Fallot. Maternal race, age, parity, income, and education did not confound the association. Others have examined smoking and DS-associated CHD and have not found a significant association; however, comparison of studies is difficult as sample sizes were smaller, the timeframe of tobacco use differed (prior to conception vs during the first trimester), and the diagnostic methods used to identify and classify CHD were older (e.g., Fixler & Threlkeld, 1998; Khoury & Erickson, 1992a). Nevertheless, the combined results suggest smoking may be a risk factor. However, as suggested by Torfs and Christianson (1999), at least in their dataset, smoking only played a small role in susceptibility for abnormal heart development among those with DS, as the frequency of periconceptional smoking was low and the association modest.
4.2. DS-associated leukemia Several studies have now documented that although the overall incidence of cancer in individuals with DS is similar to that of the general population, it shows a strikingly different profile of cancer types (e.g., Hasle et al., 2000; Patja, 2006; Sullivan et al., 2007; Yang et al., 2002). For example, in a population-based study of 2,814 individuals with DS, the incidence of solid tumors was reduced by about one-half in all age groups; however, leukemia occurred 10- to 20-fold more frequently among those with DS (Hasle et al., 2000). Importantly, the largest relative risk for leukemia was observed in children with DS under age five. In this group, acute myeloid leukemia (AML) was 153-fold more frequent than in the general population.
Trisomy 21
81
Moreover, the incidence of acute megakaryoblastic leukemia (AMKL) is estimated to be 500-fold increased in children with DS compared with the general population (Zipursky et al., 1992). AMKL explains about 62–86% of AML in children with DS, a significant increase compared with the general pediatric population (Creutzig et al., 2005; Lange et al., 1998). Comparison of AML associated with and not associated with DS indicates that distinct phenotypes exist. The median age of onset is much younger—about 2 years compared with 8 years in the general population (Creutzig et al., 2005; Lange et al., 1998). Also, many times a myelodysplastic syndrome with thrombocytopenia and/or anemia and abnormal bone marrow morphology precedes AML in DS, but is usually de novo in nonsyndromic AML children (Zipursky et al., 1987, 1994). A remarkable feature of DS-associated AML is the sensitivity to therapy (e.g., Kudo et al., 2007; Lange, 2000; Ravindranath et al., 1992); disease resistance and recurrence are uncommon. In fact, children with DS have been found to be more sensitive or responsive to chemotherapy. Until treatments were altered, high rates of toxicity occurred, which sometimes led to mortality (Craze et al., 1999; Lange et al., 1998). In addition to AML, about 10% of infants with DS develop transient myeloproliferative disorder (TMD) (Hitzler & Zipursky, 2005). TMD in newborns with DS is characterized by circulating blasts with morphologic features of leukemic cells. Studies have shown that these immature megakaryoblasts are clonal and are present in the liver, bone marrow, and peripheral blood (e.g., Kurahashi et al., 1991; Miyashita et al., 1991). In a recent study of 48 newborns with DS and TMD, 25% were asymptomatic, but the others had a significant elevation of blast counts with consequences such as bruising, respiratory distress, and liver dysfunction (Massey et al., 2006). Although TMD usually resolves spontaneously within 3 months, a small percentage of neonates develops severe and sometimes fatal complications. These include hepatic fibrosis or hydrops (e.g., Dormann et al., 2004; Schwab et al., 1998). Although considered transient, recent studies have shown that 20–30% of neonates who recover from TMD develop AMKL within 3–4 years (Hitzler & Zipursky, 2005; Massey et al., 2006). There is evidence that TMD and AMKL arise from a common precursor; however, the underlying mechanism of the susceptibility of children with DS to leukemia is only beginning to be understood (reviewed in Hitzler, 2007). One of the major breakthroughs has been the discovery that nearly all of children with DS who develop either TMD or AMKL have mutations in the transcription factor GATA1 (Ahmed et al., 2004; Groet et al., 2003; Hitzler et al., 2003; Rainis et al., 2003). GATA1 is an X-linked gene that encodes a zinc-finger transcription factor. This factor is essential for normal erythroid and megakaryocytic differentiation. Although the mechanism of action is still not understood, another question comes to the forefront: How
82
Jeannie Visootsak and Stephanie L. Sherman
does the mutation in the X-linked GATA1 gene cause a leukemic condition in individuals with an extra chromosome 21? The current thinking is that such mutations interact with chromosome 21 specific genes and/or with nonchromosome 21 genes that are not regulated appropriately as a consequence of the extra chromosome 21. This interaction(s) need to explain both the variability of the presence of TMD in neonates and the conversion of TMD to AMLK in a subset of individuals. One candidate gene that is located on chromosome 21 is RUNX1. This hematopoietic transcription factor has been shown to interact physically and functionally with GATA1 (Elagib et al., 2003; Xu et al., 2006), although the mechanisms of the interaction are not well understood. Intense research is ongoing to better define the interaction between GATA1 and RUNX1, and to identify factors involved in this leukemic process.
4.3. Summary The above description provides examples of both epidemiological and molecular approaches that are being taken to begin to address the etiology of specific disorders for which individuals with DS are significantly predisposed. Additional basic epidemiological studies need to be conducted to understand these associations throughout the life span of those with DS. New bioinformatic approaches that take advantage of large, epidemiological databases and of anonymized electronic medical records, may allow new questions to be answered (e.g., Hodapp et al., 2006). In addition, these studies in concert with molecular approaches will begin to provide insight into the etiology of, for example, abnormal heart development or Alzheimer disease, in the context of trisomy 21, but may also contribute to the understanding of these conditions in general.
5. Neurodevelopmental Outcomes of Comorbid Medical Conditions in DS Despite our wealth of knowledge regarding the cognitive and behavioral phenotypes of DS, the influence of DS-associated medical problems is often not considered in neurodevelopmental outcome studies. Here, we will review the current knowledge on the relationship of several DSassociated medical conditions and neurodevelopmental outcome after providing an overview of the cognitive phenotype in DS.
Trisomy 21
83
5.1. Overview of cognitive phenotype in DS DS is the most prevalent genetic cause of mental retardation with its own unique cognitive, adaptive, and behavioral profiles. Unlike other genetic conditions, individuals with DS are typically diagnosed in the newborn period based on their distinctive physical characteristics. Thus, DS should be an ideal model to study the link between infancy to aging with respect to cognitive and behavioral phenotypes. As emphasized previously, the vast majority of our current knowledge on DS focuses on the early childhood and the adult years. Research is needed to connect these two endpoints to identify how symptoms evolve and change over time, especially from the adolescent through young adult years (Dykens, 2007). To this end, in 2006, the US Congress mandated that the National Institutes of Health (NIH) establish a trans-NIH taskforce charged with creating a research plan to identify, create, and implement programs to maximize and maintain cognitive function throughout the lifespan of individuals with DS. The resulting NIH DS Working Group’s 2007 Research Plan on DS highlights the need for more research focused on identifying the cognitive phenotype of DS throughout the lifespan, especially studies on comorbid psychiatric and medical conditions. The degree of cognitive deficits in individuals with DS varies from mild to moderate mental retardation with a typical range of 40–72 (Nicham et al., 2003). Children with DS between 6.5 and 8.0 years have IQ levels between 45 and 71 (mean 55.6) compared to adolescents with DS between 12.2 and 25.9 years with IQ levels between 28 and 47 (mean 37.6) (Melyn & White, 1973). Performance strengths are recognized on visual–spatial tasks compared with short-term memory auditory and verbal tasks ( Jarrold et al., 2002; Wang & Bellugi, 1994). Indeed, the cognitive deficits in DS may further delay language learning, as cognitive abilities serve as prerequisites for acquiring certain linguistic achievement (Abbeduto et al., 2001). Age-related decline in IQ is seen in individuals with DS, typically in the third or fourth decades, which may or may not be influenced by dementia (Devenny et al., 2000). In adulthood, 70% of individuals with DS function in the moderate–severe range, 20% in the mild–moderate range, and 8% in the mild range (Devenny et al., 2000; Temple et al., 2001). The mean IQ level is 45 by adulthood with significant variability in the range of IQ levels (Carr, 1994). It is usually a challenge to distinguish between the presence of early dementia and the declines related to normal aging process and lifelong cognitive deficits (Devenny et al., 2000; Chapter 4). In a longitudinal study conducted by Devenny et al. (1996), adults with DS with suspected or possible dementia of Alzheimer type show significant decline in cognitive abilities compared to nondemented adults.
84
Jeannie Visootsak and Stephanie L. Sherman
5.2. Impact of DS-associated CHDs on neurodevelopmental outcome As reviewed previously, about half of infants with DS have CHDs, with many having to undergo surgery for repair. Several neurodevelopmental studies in typically developing children with CHDs have shown neurocognitive and psychomotor deficits (Mahle et al., 2006), yet the impact of CHD in children with DS has not been described. In a cross-sectional study design, we compared 6 children with DS and AVSD (mean age 17 months) with 11 children with DS without a CHD (mean age 16 months) and found significant developmental delay in the group with AVSD (unpublished data). Those with AVSD had a greater developmental age delay difference compared with age-matched children with DS without CHDs, as indicated by a 2.91 month delay in the cognitive domain, 3.72 months delay in expressive language, 1.91 months delay in receptive language, and 1.00 month delay in gross motor. These preliminary data emphasize the need for further study to understand why these differences occur and to identify treatment strategies that may ameliorate these delays. There are many factors that must be considered in neurodevelopmental outcome studies in children with CHD. For instance, Gaynor et al. (2007) have suggested that patient-specific factors are more important than intraoperative factors (e.g., race, birth weight) in determining neurodevelopmental outcome in children with CHDs. This finding is important because there are significant ethnic and gender differences in the prevalence of CHDs, specifically for AVSD as described above. Furthermore, abnormal brain microstructure and metabolism noted shortly after birth in newborns with CHD suggests that these newborns have impaired brain development in utero, possibly related to impaired cerebral oxygen and substrate delivery prenatally (Donofrio et al., 2003). A recent study by Miller et al. (2007) describes a high incidence of injury to white matter that resembled periventricular leukomalacia in term newborns with CHD. This morphology is similar to that seen in premature infants and is related to impaired brain development that is detected preoperatively, shortly after birth. Hence, newborns with CHD are at risk for impaired brain development in utero. Longitudinal studies are needed to understand the neurodevelopment outcome of individuals with DS and CHD, possibly beginning with fetal brain development.
5.3. Impact of DS-associated leukemia on neurodevelopmental outcome As described above, the incidence of AMKL is estimated to be 500-fold increased in children with DS compared with the general population. Although there have not been any studies that examine the neurodevelopmental
Trisomy 21
85
outcome of children with DS and leukemia, some studies have investigated the neurodevelopment of typically developing children with acute lymphoblastic leukemia (ALL). In the past, cranial radiation therapy resulted in declines in intelligence among survivors of childhood ALL (Fletcher & Copeland, 1988). As a result, pediatric oncologists began to substitute intrathecal chemotherapy for CNS prophylaxis in an attempt to improve cognitive outcomes. Intrathecal chemotherapy improved survival rates and appeared to be less detrimental to a child’s neurocognitive development when compared to cranial radiation therapy. Yet, ALL survivors receiving intrathecal chemotherapy continue to demonstrate slight decline on cognitive and academic abilities (Copeland et al., 1996). Research is needed to understand the influence of leukemia treatment on the neurodevelopmental outcome in children with DS, given the increased risk of leukemia in this cohort.
5.4. Impact of DS-associated obstructive sleep apnea on neurodevelopmental outcome Children with DS are at greater risk for development of obstructive sleep apnea syndrome (OSAS), with an estimated incidence of 30–60% compared to 0.7–2.0% in the general pediatric population (Gislason & Benediktsdottir, 1995; Marcus et al., 1991; Stebbens et al., 1991). OSAS includes episodes of apnea and hypopnea, and hypoventilation with hypercarbia and episodes of sleep fragmentation with increased arousals during sleep (Shott, 2006). Predisposing factors in DS include abnormal small upper airway, mid-face, and mandibular hypoplasia, large adenoids, protruding tongue, generalized hypotonia, and obesity (Shott, 2006). Sleep fragmentation and increased sleep arousals may impair daytime functioning, resulting in learning and behavior problems (Marcus et al., 1991). Despite the high frequency of OSAS and multiple predisposing risk factors, neurodevelopmental outcome studies do not currently exist in children with DS and OSAS. In studies involving typically developing children, OSAS is correlated with lower IQ performance testing and behavioral problems, including inattention and hyperactivity (Bass et al., 2004; Chervin et al., 2002).
5.5. Impact of DS-associated seizure disorder on neurodevelopmental outcome Seizure disorder is the most common neurologic disorder associated with mental retardation, with the prevalence of 4–8 per 1,000 in individuals with mental retardation compared to 3–4 per 1,000 in the general population (Steffenburg et al., 1995). The prevalence appears to increase with decreasing cognitive abilities with 28–38% in the profound mental retardation range and 14% with mild mental retardation (Steffenburg et al., 1995). In
86
Jeannie Visootsak and Stephanie L. Sherman
individuals with DS, the prevalence of seizures is higher than the general population, but lower than among individuals with mental retardation of other etiologies (Goldberg-Stern et al., 2001). Studies have indicated the rates of epilepsy to be 8% of children and adolescents with DS and 16% in adults with DS (Goldberg-Stern et al., 2001; Prasher, 1995). The type of seizure disorders vary in children with DS with 47% partial seizures, 32% infantile spasm, and 21–69% tonic-clonic seizures (Goldberg-Stern et al., 2001; Stafstrom et al., 1991). Stafstrom et al. (1991) conducted a large, retrospective study of 737 individuals with DS and seizure disorders and hypothesized that the increased susceptibility to seizures is likely to be associated with the hypoxia caused by cardiovascular complications, including congenital heart disease, severe intracardiac shunts, infection, and neonatal hypoxia or ischemia. In addition, reduced inhibitory interneurons, altered neuronal structure, and increased excitability of membranes may play a role in epileptogenesis in DS (Stafstrom et al., 1991). There is also a bimodal distribution of seizure onset with early-onset seizures in childhood and late-onset seizures in middle-aged individuals. The late-onset seizures in older individuals may be related to the presence of underlying changes of Alzheimer’s disease (Mann, 1988). Children with both epilepsy and mental retardation are at heightened risk for behavioral problems and psychopathology. In children with mental retardation and epilepsy, 57% had at least one psychiatric diagnosis, including autistic spectrum disorder, autism-like condition, Asperger syndrome, attention/deficit hyperactivity disorder, and conduct and tic disorder (Steffenburg et al., 1996). There have been no studies to date on the impact of seizures on the intellectual outcome and behavior of children with DS. Case studies have revealed that the neurodevelopmental outcome has been poor despite relatively good seizure control in children with DS and infantile spasms (Goldberg-Stern et al., 2001). Three of five children with DS and infantile spasm displayed autistic-like features (Goldberg-Stern et al., 2001). Additional studies are needed to understand the intellectual and behavioral profile of individuals with DS and seizures in order to plan effective intervention to improve their neurodevelopmental outcome.
5.6. Impact of DS-associated hearing loss on neurodevelopmental outcome Children with DS have a three times higher likelihood of developing chronic ear disease and secondary hearing loss than children with other developmental delays (Dahle & McCollister, 1986). The higher incidence is attributed to their anatomic anomalies, including mid-face hypoplasia, easily collapsible eustachian tube, stenotic ear canals, and small external canals (Shott, 2006). Furthermore, children with DS have frequent upper respiratory infections, possibly caused by the immaturity of the immune
Trisomy 21
87
system (Shott, 2006). Shott et al. (2001) has shown that with aggressive medical and surgical management of chronic middle ear effusions and chronic otitis media starting soon after birth, only 2% had hearing loss after the first year in the study. Studies have shown that even a mild hearing loss can affect a child’s articulation (Bess, 1985). Children with DS have language deficits, particularly in expressive language, vocabulary production, and speech intelligibility, which may be further complicated by their chronic ear disease and hearing loss (Shott, 2006). The small oral cavity, open mouth posture, protruding tongue, and irregular dentition may further affect their speech production. Overall, there is significant weakness in communication compared to daily living and socialization skills (Dykens et al., 2006), which may hinder independent living and inclusion in the community (Chapman & Hesketh, 2000). Thus, aggressive monitoring and management of chronic otitis media is recommended to prevent hearing loss and consequently, deficits in communication skills.
6. Psychiatric and Neurobehavioral Issues in DS In the past, neurobehavioral disorders in individuals with mental retardation were often ignored and assumed to be linked to their cognitive deficits. Clinicians may attribute these behavioral and psychiatric problems to the intellectual disability. This bias is often referred to as ‘‘diagnostic overshadowing’’ as clinicians may not consider the presence of a dual diagnosis, co-occurrence of mental retardation and a psychiatric disorder, in their evaluation (Lovell & Reiss, 1993; Reiss et al., 1982). Because this is a significant area of clinical research in DS and one that will lead to improved treatment of symptoms associated with DS, we will provide an overview of the topic. Individuals with DS are at much higher risk for having a wide array of psychiatric and behavioral disorders, yet the rate is lower compared with individuals with mental retardation of other etiology. Approximately 20–40% of individuals with DS have clinically elevated maladaptive behavior (Chapman et al., 1998; Coe et al., 1999; Dykens & Kasari, 1997; Dykens et al., 2002), which is low compared with children with other intellectual disabilities. However, comparison of these rates to typical peers and siblings of children with DS indicates that their behavioral problems are significant. In a study of children with DS between age 5 and 15 years compared with their siblings without developmental delay, children with DS exhibit more overall maladaptive behavior, including inattention and impulsivity (Cuskelly & Dadds, 1992).
88
Jeannie Visootsak and Stephanie L. Sherman
The patterns of behavioral disorders appear to change with increasing age (Chapman et al., 1998; Dykens et al., 2002; Nicham et al., 2003). For example, externalizing disorders (dominant, opposition, hyperactivity, impulsivity, inattention) are more frequent during childhood, whereas internalizing behavior problems (shyness, decreased confidence) are more common in adolescence and adulthood (Nicham et al., 2003). Dykens et al. (2006) also revealed similar patterns in a cohort of 211 individuals with DS. Increased externalizing symptoms (aggression and delinquency) is present between 4 and 19 years in contrast to older adolescents who are vulnerable to internalizing symptoms (withdrawal, somatic, anxiety). This shift in behavior from childhood to adolescence appears unique in DS because individuals in other groups with intellectual disability do not have similar age-related withdrawal (Dykens, 2003). Dykens et al. (2002) have postulated that subtle increases in internalizing symptoms over the adolescent period may increase the risk for later-onset depressive disorders, mood or behavioral changes. The risk for psychopathologies continues through adulthood, and it becomes a challenge to determine if it is influenced by age-related cognitive decline or to clinical dementia of the Alzheimer type (Holland et al., 2000). In addition to Alzheimer’s disease, adults with DS are prone to depression, with an estimated rate of 11%, compared to only 4% in adults with other mental retardation (Collacott et al., 1992). Depressed mood, crying, decreased interest, psychomotor slowing, fatigue, appetite/weight change, and sleep disturbance are symptoms observed in individuals with DS and major depression (Capone et al., 2006). Lack of interest in activities with withdrawal, mutism, psychomotor retardation, low mood, decreased appetite, weight loss, and insomnia may be present. Verbal expression of preoccupations of suicide, death, and guilt are not common in adults with DS and major depression (Myers & Pueschel, 1995). Risks for depression that are unassociated with dementia include several factors associated with the challenges in transitioning from childhood to adulthood. As children with DS become older, they become aware that they are different, with loss or changes in relationships with peers (Capone et al., 2006). Furthermore, they may not have the appropriate mechanism to cope with stress, transitions, and changes in their life. They are also prone to obesity and other medical issues, such as hypothyroidism, which may lead to a sedentary life style. As a result, withdrawal and depression may begin to emerge. In adults with DS, the early, preclinical stages of dementia include behavioral and personality changes as opposed to memory changes (Ball et al., 2006). Thus, symptoms of depression and dementia of the Alzheimer type in adults with DS may appear very similar. In adults with DS and dementia, low mood, restlessness, disturbed sleep, excessive uncooperativeness, and auditory hallucination may be present (Cooper & Prasher, 1998).
Trisomy 21
89
Since the symptoms of dementia and depression are closely related, it is important to consider both conditions in the differential diagnosis in order to provide appropriate treatment. Co-occurrence of autism spectrum disorder (ASD) or pervasive developmental disorders in DS may exist. The prevalence of ASD among children with DS ranges from 1 to 13% (Capone et al., 2005; Kent et al., 1999; Myers & Pueschel, 1991). Kent et al. (1999) estimated the prevalence of ASD in children with DS to be 7% using the Childhood Autism Rating Scale, Asperger Syndrome Screening Questionnaire, and International classification of Diseases (ICD-9) criteria. Capone et al. (2005) estimated a prevalence rate of 13% from clinic population, although the ascertainment may be biased since subjects are based on referrals. In this cohort, the DS and ASD group has lower IQ levels and higher levels of lethargy, stereotypy, and hyperactivity compared to DS without ASD. Additionally, Myers et al. (1995) sampled 497 individuals with DS and reported 13% of children under age 10 with externalizing behavioral problems, 20% of those between 10 and 20 years of age, and 25% of those over 20 years of age. The most significant problems include attention, conduct/ oppositional, and aggressive behaviors in those younger than 20 years. Other findings include 1% with infantile autism, 9% with childhood psychosis, 15% conduct problems, and 3% emotional disturbances. Similar to children with DS, psychiatric disorders are not common in adults with DS compared to adults with intellectual disabilities of other etiology. In 164 adults with DS, the prevalence of a psychiatric disorder is 26% compared to other studies which revealed a 32–59% rate in adults with mental retardation (Lund, 1985; Myers & Pueschel, 1995). Symptoms of delusions and hallucinations may exist together with social isolation, bland affect, apathy, and sleep disturbance in adults with DS and psychiatric disorders, and are often mistaken for major depression (Capone et al., 2006; Myers & Pueschel, 1994). Although psychiatric disorders seem uncommon in adults with DS, there continues to be gaps in our knowledge regarding the development and course of these problems across the lifespan (Dykens, 2007). It is essential to have standardized criteria and diagnostic procedures for adults with DS in order to improve intervention and treatment for these individuals and their families.
7. Summary Importantly, the prevalence of DS at birth has the potential to increase with the trend for women to extend their reproductive life span into their late 30s and 40s. Moreover, individuals with DS now have an increased life expectancy due to community-based care and medical and health
90
Jeannie Visootsak and Stephanie L. Sherman
improvements; thus, they have the potential to live long and productive lives. In this review, we have indicated the need to conduct additional epidemiological studies to determine the prevalence, cause, and clinical significance of the syndrome throughout the lifespan. From this knowledge, we can begin to determine the influence of specific DS-associated medical conditions on cognitive and behavioral outcomes. This will lead to appropriate intervention and treatment to enhance the quality of life for individuals with DS.
ACKNOWLEDGMENTS NIH/NCRR 1KL2RR025009, National Down Syndrome Society, Emory Egleston Children’s Research Center ( JV); NIH R01 HD38979, and NIH R01 HL083300 (SLS).
REFERENCES Abbeduto, L., Evans, J., & Dolan, T. (2001). Theoretical perspectives on language and communication problems in mental retardation and developmental disabilities. Mental Retardation and Developmental Disabilities Research Review, 7, 45–55. Ahmed, M., Sternberg, A., Hall, G., Thomas, A., Smith, O., O’Marcaigh, A., et al. (2004). Natural history of GATA1 mutations in Down syndrome. Blood, 103, 2480–2489. Antonarakis, S. E., Avramopoulos, D., Blouin, J. L., Talbot, C. C., Jr., & Schinzel, A. A. (1993). Mitotic errors in somatic cells cause trisomy 21 in about 4.5% of cases and are not associated with advanced maternal age. Nature Genetics, 3, 146–150. Antonarakis, S. E., Petersen, M. B., McInnis, M. G., Adelsberger, P. A., Schinzel, A. A., Binkert, F., et al. (1992). The meiotic stage of nondisjunction in trisomy 21: Determination by using DNA polymorphisms. American Journal of Human Genetics, 50, 544–550. Ball, S. L., Holland, A. J., Hon, J., Huppert, F. A., Treppner, P., & Watson, P. C. (2006). Personality and behaviour changes mark the early stages of Alzheimer’s disease in adults with Down’s syndrome: Findings from a prospective population-based study. International Journal of Geriatric Psychiatry, 21, 661–673. Ballesta, F., Queralt, R., Gomez, D., Solsona, E., Guitart, M., Ezquerra, M., et al. (1999). Parental origin and meiotic stage of non-disjunction in 139 cases of trisomy 21. Annals of Genetics, 42, 11–15. Barnhart, R. C., & Connolly, B. (2007). Aging and Down syndrome: Implications for physical therapy. Physical Therapy, 87, 1399–1406. Bass, J. L., Corwin, M., Gozal, D., Moore, C., Nishida, H., Parker, S., et al. (2004). The effect of chronic or intermittent hypoxia on cognition in childhood: A review of the evidence. Pediatrics, 114, 805–816. Battaglia, D. E., Goodwin, P., Klein, N. A., & Soules, M. R. (1996). Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Human reproduction, 11, 2217–2222. Bess, F. H. (1985). The minimally hearing-impaired child. Ear and Hearing, 6, 43–47. Besser, L. M., Shin, M., Kucik, J. E., & Correa, A. (2007). Prevalence of Down syndrome among children and adolescents in metropolitan Atlanta. Birth Defects Research A Clinical and Molecular Teratology, 79, 765–774.
Trisomy 21
91
Biselli, J. M., Goloni-Bertollo, E. M., Zampieri, B. L., Haddad, R., Eberlin, M. N., & Pavarino-Bertelli, E. C. (2008). Genetic polymorphisms involved in folate metabolism and elevated plasma concentrations of homocysteine: Maternal risk factors for Down syndrome in Brazil. Genetic Molecular Research, 7, 33–42. Bittles, A. H., Bower, C., Hussain, R., & Glasson, E. J. (2007). The four ages of Down syndrome. European Journal of Public Health, 17, 221–225. Book, J. A., Fraccaro, M., & Lindsten, J. (1959). Cytogenetical observations in Mongolism. Acta Paediatrica, 48, 453–468. Bosco, P., Gueant-Rodriguez, R. M., Anello, G., Barone, C., Namour, F., Caraci, F., et al. (2003). Methionine synthase (MTR) 2756 (A ! G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. American Journal of Medical Genetics A, 121, 219–224. Boue, J., & Boue, A. (1973). Increased frequency of chromosomal anomalies after induced ovulation. The Lancet, i, 679–680. Calzolari, E., Garani, G., Cocchi, G., Magnani, C., Rivieri, F., Neville, A., et al. (2003). Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). European Journal of Epidemiology, 18, 773–780. Canfield, M. A., Honein, M. A., Yuskiv, N., Xing, J., Mai, C. T., Collins, J. S., et al. (2006). National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999–2001. Birth Defects Research A Clinical and Molecular Teratology, 76, 747–756. Capone, G., Goyal, P., Ares, W., & Lannigan, E. (2006). Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome. American Journal of Medical Genetics C Seminars in Medical Genetics, 142, 158–172. Capone, G. T., Grados, M. A., Kaufmann, W. E., Bernad-Ripoll, S., & Jewell, A. (2005). Down syndrome and comorbid autism-spectrum disorder: Characterization using the aberrant behavior checklist. America Journal of Medical Genetics A, 134, 373–380. Carothers, A. D., Castilla, E. E., Dutra, M. G., & Hook, E. B. (2001). Search for ethnic, geographic, and other factors in the epidemiology of Down syndrome in South America: Analysis of data from the ECLAMC project, 1967–1997. American Journal of Medical Genetics, 103, 149–156. Carothers, A. D., Hecht, C. A., & Hook, E. B. (1999). International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age. Journal of Medical Genetics, 36, 386–393. Carr, J. (1994). Long-term-outcome for people with Down’s syndrome. Journal of Child Psychology and Psychiatry, 35, 425–439. Chan, A. (2003). Invited commentary: Parity and the risk of Down’s syndrome—caution in interpretation. American Journal of Epidemiology, 158, 509–511. Chapman, R. S., & Hesketh, L. J. (2000). Behavioral phenotype of individuals with Down syndrome. Mental Retardation and Developmental Disabilities Research Review, 6, 84–95. Chapman, R. S., Seung, H. K., Schwartz, S. E., & Kay-Raining, B. E. (1998). Language skills of children and adolescents with Down syndrome: II. Production deficits. Journal of Speech, Language and Hearing Research, 41, 861–873. Chen, C. L., Gilbert, T. J., & Daling, J. R. (1999). Maternal smoking and Down syndrome: The confounding effect of maternal age. American Journal of Epidemiology, 149, 442–446. Chervin, R. D., Archbold, K. H., Dillon, J. E., Panahi, P., Pituch, K. J., Dahl, R. E., et al. (2002). Inattention, hyperactivity, and symptoms of sleep-disordered breathing. Pediatrics, 109, 449–456. Christianson, R. E., Sherman, S. L., & Torfs, C. P. (2004). Maternal meiosis II nondisjunction in trisomy 21 is associated with maternal low socioeconomic status. Genetics in Medicine, 6, 487–494.
92
Jeannie Visootsak and Stephanie L. Sherman
Coe, D. A., Matson, J. L., Russell, D. W., Slifer, K. J., Capone, G. T., Baglio, C., et al. (1999). Behavior problems of children with Down syndrome and life events. Journal of Autism and Developmental Disorders, 29, 149–156. Collacott, R. A., Cooper, S. A., & McGrother, C. (1992). Differential rates of psychiatric disorders in adults with Down’s syndrome compared with other mentally handicapped adults. British Journal of Psychiatry, 161, 671–674. Cooper, S. A., & Prasher, V. P. (1998). Maladaptive behaviours and symptoms of dementia in adults with Down’s syndrome compared with adults with intellectual disability of other aetiologies. Journal of Intellectual Disability Research, 42, 293–300. Coory, M. D., Roselli, T., & Carroll, H. J. (2007). Antenatal care implications of population-based trends in Down syndrome birth rates by rurality and antenatal care provider, Queensland, 1990–2004. Medical Journal of Australia, 186, 230–234. Copeland, D. R., Moore, B. D., Francis, D. J., Jaffe, N., & Culbert, S. J. (1996). Neuropsychologic effects of chemotheraphy on children with cancer. A longitudinal study. Journal of clinical Oncology, 14, 2826–2835. Coppede, F., Marini, G., Bargagna, S., Stuppia, L., Minichilli, F., Fontana, I., et al. (2006). Folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women. American Journal of Medical Genetics A, 140, 1083–1091. Craze, J. L., Harrison, G., Wheatley, K., Hann, I. M., & Chessells, J. M. (1999). Improved outcome of acute myeloid leukaemia in Down’s syndrome. Archives of Diseases in Childhood, 81, 32–37. Creutzig, U., Reinhardt, D., Diekamp, S., Dworzak, M., Stary, J., & Zimmermann, M. (2005). AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia, 19, 1355–1360. Cuckle, H. (1999). Down syndrome fetal loss rate in early pregnancy. Prenatal Diagnosis, 19, 1177–1179. Cuckle, H. S., Alberman, E., Wald, N. J., Royston, P., & Knight, G. (1990). Maternal smoking habits and Down’s syndrome. Prenatal Diagnosis, 10, 561–567. Cuskelly, M., & Dadds, M. (1992). Behavioural problems in children with Down’s syndrome and their siblings. Journal of Child Psychology and Psychiatry, 33, 749–761. da Silva, L. R., Vergani, N., Galdieri, L. C., Ribeiro Porto, M. P., Longhitano, S. B., Brunoni, D., et al. (2005). Relationship between polymorphisms in genes involved in homocysteine metabolism and maternal risk for Down syndrome in Brazil. American Journal of Medical Genetics A, 135, 263–267. Dahle, A. J., & McCollister, F. P. (1986). Hearing and otologic disorders in children with Down syndrome. American Journal of Mental Deficiency, 90, 636–642. Day, S. M., Strauss, D. J., Shavelle, R. M., & Reynolds, R. J. (2005). Mortality and causes of death in persons with Down syndrome in California. Developmental Medicine and Child Neurology, 47, 171–176. de Rubens, F. J., del Pozzo, M. B., Pablos Hach, J. L., Calderon, J. C., & Castrejon, U. R. (2003). Heart malformations in children with Down syndrome. Revista Espan˜ola de Cardiologia, 56, 894–899. Devenny, D. A., Krinsky-McHale, S. J., Sersen, G., & Silverman, W. P. (2000). Sequence of cognitive decline in dementia in adults with Down’s syndrome. Journal of Intellectual Disability Research, 44, 654–665. Devenny, D. A., Silverman, W. P., Hill, A. L., Jenkins, E., Sersen, E. A., & Wisniewski, K. E. (1996). Normal ageing in adults with Down’s syndrome: A longitudinal study. Journal of Intellectual Disability Research, 40, 208–221. Dolk, H., Loane, M., Garne, E., De, W. H., Queisser-Luft, A., De, V. C., et al. (2005). Trends and geographic inequalities in the prevalence of Down syndrome in Europe, 1980–1999. Revue d’e´pide´miologie et de sante´ publique, 53(Spec No 2), 2S87–2S95.
Trisomy 21
93
Donofrio, M. T., Bremer, Y. A., Schieken, R. M., Gennings, C., Morton, L. D., Eidem, B. W., et al. (2003). Autoregulation of cerebral blood flow in fetuses with congenital heart disease: The brain sparing effect. Pediatrics Cardiology, 24, 436–443. Dormann, S., Kruger, M., Hentschel, R., Rasenack, R., Strahm, B., Kontny, U., et al. (2004). Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome. European Journal of Pediatrics, 163, 374–377. Down, J. L. (1866). Observations of an ethnic classification of idiots. London Hospital, Clinical Lecture Report, 3, 259–262. Dupont, A., Vaeth, M., & Videbech, P. (1986). Mortality and life expectancy of Down’s syndrome in Denmark. Journal of Mental Deficiency Research, 30, 111–120. Dykens, E. M. (2003). Anxiety, fears, and phobias in persons with Williams syndrome. Developmental Neuropsychology, 23, 291–316. Dykens, E. M. (2007). Psychiatric and behavioral disorders in persons with Down syndrome. Mental Retardation and Developmental Disabilities Research Review, 13, 272–